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Abstract
Angiogenesis is found deregulated in many pathologies, including cancer where it is re-
quired for tumour progression and metastasis. Although much has been learnt from in
vitro studies of angiogenesis, it is increasingly accepted that biological processes can
differ significantly between in vitro and in vivo contexts, with whole-body responses de-
termining phenotype.
I describe the development of a novel compressive sensing optical projection tomography
(CS-OPT) platform using fluorescence microscopy, which enables live, whole organism
imaging of adult zebrafish. Through incorporating contemporary compressive sensing
algorithms the acquisition time is dramatically reduced, enabling decreased anaesthesia
leading to improved zebrafish viability. The platform has been shown to provide accurate
3-dimensional quantifications of tumour volume and vascularisation using an adult ze-
brafish model of tumour progression. The model has a mCherry labelled vasculature and
an inducible, liver specific cancer driven by the expression of oncogenic krasV12 labelled
with eGFP. This model recapitulates human hepatocellular carcinoma.
The platform is minimally invasive as zebrafish can be repeatedly imaged throughout
development, from larvae to adult, without reducing viability. Therefore, CS-OPT should
be beneficial for longitudinal mechanistic and drug development studies of tumour pro-
gression and angiogenesis.
With this in mind novel zebrafish models have been developed through genome edit-
ing techniques. The generation of an inducible knockout ptena zebrafish line that lacks
functional ptenb was also attempted with the aim of creating a more metastatic cancer
model to better reflect human disease. Furthermore, I performed studies to optimise both
the anaesthetic regime and inducer treatment, which will be important for future studies.
Thus, the developed CS-OPT modality is a powerful imaging platform for longitudinal
mechanistic and drug development studies within whole organisms. This has been shown
in the context of tumour progression and angiogenesis, but has the potential for further
developmental and pathophysiological applications.
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Introduction
1.1 Angiogenesis
The physiological process of angiogenesis is the formation of blood vessels from those
pre-existing. During embryonic growth and organ development it establishes and remod-
els the primary vascular plexus created by vasculogenesis, the formation of new blood
vessels from angioblasts. Furthermore angiogenesis is an essential process in the female
reproductive system and in adult repair mechanisms such as wound healing (Risau and
Flamme, 1995). Physiological angiogenesis provides all cells with an adequate supply
of nutrients and metabolites, whilst removing waste products. Therefore, regulation is of
importance to prevent inadequate or unrequired vascularisation, which lead to pathologies
such as ischemia and cancer.
1.1.1 Modes of Physiological Vessel Formation
There are two forms of physiological angiogenesis, sprouting and non-sprouting (also
known as intussusception). Sprouting of vessels occurs upon sensing an angiogenic stim-
ulus. Firstly pericytes begin to detach, which usually ensheath endothelial cells, pro-
mote survival and prevent unnecessary proliferation. Subsequently the surrounding base-
ment membrane and extracellular matrix (ECM) are degraded by matrix metalloproteases
(MMPs). As this occurs the endothelial cells intercellular junctions begin to loosen al-
lowing a provisional ECM scaffold to be formed from plasma proteins leaving the vessel.
One endothelial cell is designated the tip cell, which can sense the angiogenic stimulus
through filopodia on the protruding surface. Proximal endothelial neighbours, known as
stalk cells, elongate and proliferate to create the sprout that can then migrate through the
modified ECM. Functional vessels are formed once a lumen has been developed and the
endothelium stabilised through pericyte recruitment and coverage (Papetti and Herman,
2002; Carmeliet and Jain, 2011).
Non-sprouting angiogenesis involves the splitting of a pre-existing vessel into two daugh-
ter vessels to expand the vascular network. The process commences with proliferation
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of the endothelial cells within a vessel to create a large lumen (Risau, 1997). Endothe-
lial cells from opposing sides of the vessel then protrude towards one another and form
a cylindrical bridge, which becomes a perforated transvascular pillar of ECM. The pillar
is stabilised internally through pericyte coverage and can then expand along the vessel to
enable it to split entirely (Burri and Tarek, 1990). The mechanism is much faster and eco-
nomical than sprouting angiogenesis, however it is not invasive so cannot penetrate new
tissue or repair vessels during wound healing (Burri et al., 2004). Due to the differing
benefits it is likely that the form of angiogenesis favoured differs between tissues and is
dependent upon existing vessel number.
1.1.2 Angiogenic Regulation
Regulation of angiogenesis is important to maintain homeostasis and prevent pathologies.
It is usually extensively controlled and coordinated through membrane bound proteins,
diverse biomechanical forces and primarily the expression of soluble molecules known
as pro and anti angiogenic factors (Papetti and Herman, 2002). These angiogenic factors
include, but are not limited to, fibroblast growth factor (FGF), platelet-derived growth
factor (PDGF), hepatocyte growth factor (HGF), angiogenin, angiostatin, endostatin and
vascular endothelial growth factor (VEGF).
VEGF (also known as VEGF-A) is the principle driver of the angiogenic process. It
is a part of a family of homodimeric glycoprotein growth factors, whereby there are 5 iso-
forms. Amongst other functions VEGF induces angiogenic sprouting, whilst stimulating
ECM degradation and enabling vascular leakage. This leads to the production of the pro-
visional ECM scaffold (Ferrara et al., 2003). The loss of a single allele of VEGF causes
lethality with an evident lack of organised vasculature and a reduced number of blood
vessels, emphasising its importance (Ferrara et al., 1996; Carmeliet et al., 1996). As a
result it has been highly characterised since its discovery by Ferrara and Henzel (1989)
and its signalling is now believed to be an essential rate-limiting step in coordinating an-
giogenic progression (Ferrara, 2002; Ferrara et al., 2003).
There are two receptor tyrosine kinases (RTKs) primarily located on endothelial cells to
which VEGF is a ligand, these are VEGF receptor 1 (VEGFR1/ Flt-1) and VEGF receptor
2 (VEGFR2/ KDR/ Flk-1). Significant evidence indicates that VEGFR2 is the major me-
diator of the VEGF angiogenic response. It is lethal when homozygous deficient, result-
ing in a clear lack of both organised blood vessels and endothelial cell maturity (Shalaby
et al., 1995). This is consistent with the VEGF-/- phenotype (Ferrara et al., 1996). Upon
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Figure 1.1: VEGF signalling in angiogenesis through VEGFR2. Ligand binding
causes VEGFR2 dimerisation and autophosphorylation, resulting in subsequent
phosphorylation of target proteins that promote cell survival, migration, prolifer-
ation and vascular permeability. Figure from (Ivy et al., 2009).
ligand binding VEGFR2 dimerises, autophosphorylates and then proceeds to phosphory-
late target proteins. Its known targets include Ras GTPase activating protein (RasGAP),
phospholipase C-γ (PLCγ), focal adhesion kinase (FAK) and phosphoinositide 3-kinase
(PI3K) among others (Ferrara et al., 2003; Ivy et al., 2009). Figure 1.1 highlights the re-
sulting downstream signalling events that promote cell survival, migration, proliferation
and vascular permeability, ultimately all driving angiogenesis.
VEGFR1/ Flt-1 signalling is considerably different and not yet fully understood. VEGFR1
deficient organisms are also embryonic lethal, however they phenotypically have an ex-
cessive amount of endothelial precursor cell proliferation and lack of organisation (Fong
et al., 1995). This differs from the VEGFR-/- phenotype. Furthermore, a kinase defi-
cient mutant of VEGFR1 does not lead to any histological differences or defects in the
vasculature during development, so it does not appear to propagate an angiogenic sig-
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nal (Hiratsuka et al., 1998; Ferrara et al., 2003). Based upon these findings it has been
speculated that VEGFR1 could act as a negative regulator of the VEGF signal through
sequestering the ligand, preventing signal propagation through VEGFR2.
Due to the evident importance of the VEGF signal, and other angiogenic factors, tight
spatial and temporal control is required. Tissue hypoxia is one of the major regulatory
mechanisms. Oxygen sensitive transcription factors known as hypoxia-inducible factors
(HIFs) independently regulate VEGF and other genes involved in different stages of the
angiogenic process (see Table 1 in Pugh and Ratcliffe (2003) for greater detail). HIF-1 is
the key mediator and is composed of two subunits, hypoxia dependent HIF-1α and con-
stitutively expressed nuclear protein HIF-1β . In the presence of oxygen HIF-1α is pro-
lyl hydroxylated and binds to the tumour suppressor protein Von Hippel-Lindau (VHL).
This causes subsequent ubiquitination and proteosomal degradation, Figure 1.2 (Maxwell
et al., 2001; Semenza, 2002). When tissues exceed the oxygen diffusion distance of ap-
proximately 100-200 µm from a blood vessel HIF-1α cannot be hydroxylated or subse-
quently degraded (Thomlinson and Gray, 1955; Semenza, 2000). As a result it dimerises
with HIF-1β to create a functional HIF-1 transcription complex that is capable of binding
hypoxia-response elements (HREs) in the promotors of pro-angiogenic genes (Semenza,
2002; Pugh and Ratcliffe, 2003). Once again the importance of these proteins within the
angiogenic process is evident when analysing deficient systems. Reduced VEGF expres-
sion was observed under hypoxic conditions within Hif1α -/- mice and embryonic stem
(ES) cells, which resulted in histological similarities to VEGF deficient mice (Iyer et al.,
1998).
HIF-1α degradation can also be inhibited in non-hypoxic conditions through particular
growth factors and signalling pathways. These include the PI3K pathway upregulating
HIF-1α protein expression and the MAPK pathway transactivating HIF-1α for functional
activation. Both of these pathways involve growth factors, oncogenes and tumour sup-
pressors, Figure 1.2 (Semenza, 2000, 2002; Sang et al., 2003).
1.1.3 Pathophysiological Angiogenesis
Angiogenic regulation is found disrupted in many pathologies, whereby the balance of
pro and anti-angiogenic factors has been disturbed. When anti-angiogenic factors dom-
inate, such as angiostatin and endostatin, the result can be vessel regression, endothelial
cell dysfunction and lack of required revascularisation. As a consequence the vasculature
does not sufficiently meet the requirements of the tissues, which can lead to ischemic
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Figure 1.2: Oxygen dependent and independent regulatory mechanisms involved
in the expression of the HIF-1 transcription factor complex. Figure adapted from
Semenza (2002).
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pathologies, such as cardiovascular diseases, neurodegenerative disorders and impaired
wound healing, amongst others (Carmeliet, 2003, 2005).
However, when there is an inordinate amount of pro-angiogenic factors the “angiogenic
switch” is said to be activated and subsequently excessive vascularisation occurs. Many
pathologies are reliant on vascular development for progression of the disease state. This
is so for age-related macular degeneration (AMD), the third most common cause of blind-
ness worldwide (World Health Organisation, 2010). Unnecessary neovascularisation of
the choroidal vessels into the sub retinal space results in damaging the surface of the retina
(Witmer et al., 2003). The angiogenic stimulation is unknown, however an upregulation
of several pro angiogenic factors, including VEGF, is consistently observed (Michalska-
Małecka et al., 2015). A further example of excessive vascularisation is cancer, where the
three most lethal cancers, lung, liver and stomach cancer respectively, were responsible
for over 3 million deaths in 2012 alone (Ferlay et al., 2012).
1.1.4 Angiogenesis Assays
Quantitatively analysing angiogenesis is of interest to understand the underlying physio-
logical and pathophysiological mechanisms as well as to determine therapeutic efficacy of
anti-angiogenic drugs. Ideal assays would truly replicate the process and enable reliable
and repeatable quantitative results in a robust and rapid manner. Typically key angiogenic
measures include the number of vessels/outgrowths, vessel length, vessel diameter, vessel
branching and vascular density (Staton et al., 2009). Currently a combination of in vitro,
ex vivo and in vivo approaches are used.
The majority of in vitro approaches are rapid and reproducible but focus on endothe-
lial cells alone, therefore the lack of support cells, ECM and the differing environment
can cause limitations. These include cell proliferation studies that quantify changes in
cell number, differentiation studies that look for formation of tubule structures and cell
migration studies through 3-D transfilter assays or by 2-D scratch assays (Staton et al.,
2009).
To overcome the limitations of in vitro studies tissue sections can be cultured in a 3D
matrix, to provide ex vivo assays. Angiogenesis is analysed through the formation of
microvessel outgrowths from the tissue sample and is quantified through vessel number,
length and area. These studies are thought to better replicate in vivo angiogenesis due to
being grown in a specific matrix and the explant containing support cells, such as smooth
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muscle and pericytes (Auerbach et al., 2003; Staton et al., 2009). The aortic ring assay is
used most frequently, although these large vessel fragments do not accurately represent
the microvasculature that usually undergo the angiogenic process in vivo (Auerbach et al.,
2003). The same is true for human explant models using placental or umbilical blood ves-
sels for preclinical screening research (Staton et al., 2009). The chick aortic arch assay
addresses this, where 12 day old chick explants have properties similar to microvascula-
ture endothelial cells. However, being an embryonic explant the tissue was undergoing
rapid proliferation prior to dissection, therefore this may misrepresent the stimulation of
non-proliferative endothelial cells in adult angiogenesis (Auerbach et al., 2003; Staton
et al., 2009).
Observing angiogenesis in vivo is essential to complement in vitro and ex vivo studies
for a full understanding, whereby the environmental and global systems involved in the
process are present.
1.2 Cancer
1.2.1 Tumour Angiogenesis
Angiogenesis has been studied in the context of cancer for the past 100 years, when it
was first observed within tumours. It is a fundamental requirement of tumour progres-
sion, through neovascularisation providing oxygen and nutrients for tumour growth as
well as a possible route for metastasis (Gimbrone et al., 1972; Hanahan and Weinberg,
2011). Metastasis is the primary cause of death through tumour malignancy, causing
angiogenesis to be a key therapeutic target for cancer. Anti-VEGF drugs, such as the
humanised monoclonal antibody Avastin, are used in combination with chemotherapy to
prevent metastasis and tumour growth in many cancers, as well as other angiogenic dis-
eases (Kim et al., 1993; Ferrara and Kerbel, 2005; Carmeliet and Jain, 2011).
Tumours can use additional modes of angiogenesis as well as the physiological approaches
described in Section 1.1.1. The tumour cells can migrate along and hijack the existing vas-
culature in a process known as vascular co-option. Alternatively tumour vessels can be
lined with either tumour cells through vascular mimicry or by endothelial cells derived
from cancer stem-like cells (Carmeliet and Jain, 2011).
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1.2.2 Tumour Biology
Tumours, both benign and malignant, are masses of abnormal tissue that disrupt essen-
tial processes and create unfavourable internal environments. This occurs through the
breakdown of normal cell and tissue physiology, which proves fatal. Tumour acquisition
is seen to be a multistep process whereby crucial defensive mechanisms are deregulated
by the accumulation of genetic alterations (Hanahan and Weinberg, 2000). The defence
mechanisms are signalling pathways that enable the cell to respond to extracellular sig-
nals, therefore producing desired characteristics when required to effectively maintain
homeostasis. Consequently, cancer is thought of as a disease of cell signalling, whereby
signalling networks are hijacked through gain of function mutations in oncogenes and
loss of function mutations in tumour suppressors (Hanahan and Weinberg, 2000).
Ras proteins (HRas, KRas and NRas) are the most commonly activated oncogenes in
human cancers and other members of their signalling pathways are also frequently found
deregulated (Downward, 2003). Ras is a small GTPase protein that acts to stimulate both
the ERK and PI3K signalling pathways, Figure 1.3. Therefore, their gain of function mu-
tations drive cellular proliferation, growth, survival and invasion, Figure 1.3 (Semenza,
2000; Roberts and Der, 2007). A prime example of a tumour suppressor is phosphatase
and tensin homolog (PTEN), which is the second most commonly mutated or deleted tu-
mour suppressor within human cancers (Yin and Shen, 2008). PTEN is a phosphatase
protein that negatively regulates PI3K through removing phosphates from its downstream
target phosphatidylinositol (3,4,5)-trisphosphate (PIP3), Figure 1.3. PTEN loss of func-
tion mutations are shown to drive tumour formation by enhanced cell proliferation, growth
and survival (Di Cristofano et al., 1998; Cully et al., 2006). It has been shown in numer-
ous studies that a decrease in PTEN expression coupled with an increased Ras activity
leads to more metastatic and aggressive tumours (Dankort et al., 2009; Nogueira et al.,
2010; Wang et al., 2012).
The majority of examined human cancers are shown to have increased expression of the
principle pro-angiogenic factor VEGF (see Table 1 in Ferrara and Davis-Smyth (1997)).
Studies have shown inhibiting its action reduces both tumour size and vessel density (Kim
et al., 1993; Ferrara and Davis-Smyth, 1997; Papetti and Herman, 2002). The upregula-
tion of VEGF and other pro-angiogenic factors are a result of increased HIF-1 expression,
which is found frequently overexpressed in human cancers (Talks et al., 2000). This arises
through several key tumour characteristics. Firstly, as the tumour cells proliferate to form
a mass the central cells become deprived and hypoxic, therefore stimulating the HIF path-
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way shown in Figure 1.2 (Thomlinson and Gray, 1955; Maxwell et al., 2001). In addition
the genetic regulation of HIF-1 can be implicated through activating and inhibiting muta-
tions of oncogenes and tumour suppressors, respectively, that have arisen through tumour
procurement (Semenza, 2000). Such examples include the upregulation of Ras and the
loss of PTEN that have previously been discussed. A further example is loss of VHL
protein function, leading to constitutive activation of the HIF pathway through transcrip-
tion (Maxwell et al., 1999; Zhong et al., 2000). Figure 1.2 highlights how the functional
changes of these proteins would result in oxygen independent expression and transcrip-
tional activity of HIF-1.
1.2.3 Tumour Vasculature Properties
Due to the deregulation of angiogenesis, tumour vasculature is seen to have key charac-
teristics that differ from physiological vessels. The vascular network is seen to be aber-
rant and chaotic with an abnormal branching pattern, lacking the hierarchal structure of
healthy physiological vasculature (Semela and Dufour, 2004). The tumour vessels are
also seen to have a greater variation in diameter and are more permeable, a likely cause
of immaturity, which further facilitates metastasis (Konerding et al., 1999; Papetti and
Herman, 2002). During tumour progression angiogenic measures show an increase in
vessel number, vessel branching and vascular density (McMahon et al., 2001; Semela and
Dufour, 2004; Vakoc et al., 2009).
1.3 Zebrafish
Recently zebrafish, Danio rerio, have become a popular model organism for a variety
of biological studies, including development, angiogenic disease and cancer (Serbedzija
et al., 1999; Stoletov and Klemke, 2008). This is a result of their many beneficial features,
including a fully sequenced, highly conserved genome, ability to easily perform large
scale, in vivo research and high number of offspring (Amatruda et al., 2002; Lieschke
and Currie, 2007; Stoletov and Klemke, 2008). Furthermore, the external fertilisation and
development of the zebrafish embryo, coupled with its transparent nature, enables high-
resolution optical imaging and ease of genetic manipulation (Barriuso et al., 2015). As a
result large scale forward genetics and mutagenesis based studies can be researched in a
vertebrate system (Lieschke and Currie, 2007; Lu et al., 2015).
Zebrafish also have a rapid generation time. By 72 hours post fertilisation (hpf) they
hatch from the chorion and reach the larvae stage (Kimmel et al., 1995). When zebrafish
24
CHAPTER 1. INTRODUCTION
Figure 1.3: A schematic of the oncogene Ras and tumour suppressor PTEN sig-
nalling pathways. Ras promotes typical cancer cell characteristics, including tran-
scription, cell survival, protein synthesis and proliferation. PTEN is the negative
regulator of PI3K and suppresses these typical cancer cell characteristics when func-
tioning correctly. Figure taken from Cully et al. (2006).
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larvae reach 5 days post fertilisation (dpf) they are capable of independent feeding and
have an inflated swim bladder (Kimmel et al., 1995; Sprague et al., 2006). At 30 dpf ze-
brafish reach the juvenile life stage, which is followed by adult life stage when they have
reached sexual maturity (Sprague et al., 2006). This is usually at 90 dpf.
1.3.1 Mutant Non-Pigmented Lines
Due to their optical transparency zebrafish embryos are often a chosen model (Lieschke
and Currie, 2007). However, this has severe limitations due to the immaturity of key
biological processes implicated in disease pathophysiology, such as the vasculature and
immune systems within cancer models. Zebrafish have three different types of chro-
matophore that contribute to their pigmentation and striped appearance. These are melanophores
that create the black pigmented stripes, reflective iridophores and yellow coloured xan-
thophores. Early pigmentation begins to appear from 24 hpf, which progressively fills in
throughout development (Kimmel et al., 1995; Sprague et al., 2006).
Casper is a transgenic zebrafish line developed by White et al. (2008) that remains op-
tically transparent throughout its entire lifetime, Figure 1.4d. Its lack in pigmentation is
a result of homozygous expression for two mutants, nacre and roy. The nacre mutant is
a single base change mutation in the mitfa gene that consequently produces a truncated
transcription factor, resulting in a complete lack of melanophores, Figure 1.4b (Lister,
1999). The roy mutant is a spontaneous mutation that has not yet been mapped, but its ho-
mozygous expression results in a total deficiency of iridophores and fewer melanophores,
Figure 1.4c (White et al., 2008). Despite being ideal for fluorescence studies casper a low
viability (approximately 50%) has been observed by the UCL fish facility that limit their
breeding capabilities and this could potentially cause inaccuracy in disease studies. As
a result a different mutant line with greater viability has been introduced. These fish are
called TraNac and they physically identical to those with the casper phenotype, Figure
1.5. The difference is due to TraNac fish being homozygous recessive for a mitochondrial
gene called transparent (tra) alongside nacre, opposed to roy (Krauss et al., 2013). The
mutation present in the tra gene results in a truncated form of the mitochondrial protein
mpv17, which leads to a loss of iridophores alongside a strong reduction in melanophores.
This is shown in Figure 1.5a, which mimics the roy mutant in Figure 1.4c.
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Figure 1.4: Pigmented wild type (a) and pigmentation mutant (b-d) zebrafish. b)
shows the nacre mutant with a lack of melanophores, c) the roy mutant with lack
of iridophores and reduction of melanophores and d) shows the optically clear dou-
ble mutant casper zebrafish that lacks both melanophores and iridophores. Figure
adapted from White et al. (2008).
Figure 1.5: The transparent (tra) pigmentation mutant causes a lack of iridophores
and reduction of melanophores in adult zebrafish (a) and combining this with the
nacre mutant results in the non-pigmented, optically clear double mutant TraNac
zebrafish, which completely lack melanophores and iridophores (b). Figure (a)
adapted from Krauss et al. (2013).
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1.3.2 Zebrafish Cancer Models
Zebrafish are proven to be important model organisms for researching cancer biology and
they are seen to be very similar to humans with respect to their genome, gene expression
and histology (Amatruda et al., 2002; Lieschke and Currie, 2007; White et al., 2013).
Cancer models in zebrafish can be generated in several ways. Initially carcinogen treat-
ment was used to spontaneously form tumours. This was advantageous due to the tumour
being analysed within the true microenvironment. However, the spontaneity results in tu-
mours that were difficult to identify in particular tissues, low incidence rates and late onset
(Stoletov and Klemke, 2008). Zebrafish have also been widely used for xenograft models
where human cancer cells are transplanted into the fish. This enables studies of human
cancer cell progression, angiogenesis and metastasis within a whole vertebrate organism
that is amenable for high throughput screens, pharmacological studies and high resolu-
tion imaging (Stoletov et al., 2007; Stoletov and Klemke, 2008; Konantz et al., 2012;
Barriuso et al., 2015). To prevent rejection and successfully engraft the cancerous cells
the zebrafish must be immunocompromised or under 30 dpf, where they lack an intact
immune system (Stoletov and Klemke, 2008; White et al., 2013; Barriuso et al., 2015).
Consequently the human pathology cannot be fully recapitulated as the immune system
is known to closely interact with tumours in the progression of the disease state (Hana-
han and Weinberg, 2011). This could heavily bias results. For these reasons transgenic
zebrafish models of cancer can be favourable (Nguyen et al., 2012; White et al., 2013).
1.3.2.1 Existing Transgenic Cancer Models
Transgenic cancer models usually involve the overexpression of an oncogene to drive
tumour formation. One such zebrafish model is the BRAFV 600E driven melanoma (Pat-
ton et al., 2005). BRAFV 600E is the most common oncogenic mutant of B-Raf, which
is from the Raf family of serine kinases that are downstream effectors of Ras (Figure
1.3). Single base substitution mutations that activate BRAF are present within 66% of
malignant melanomas and 80% of these are BRAFV 600E (Davies et al., 2002). Only when
expressed with a loss of p53 tumour suppressor function did this oncogene driven model
produce malignant melanoma, which had great histological similarities to human pathol-
ogy (Patton et al., 2005). However, this system is inefficient as only 6% of transgenic
fish lead to malignant melanoma phenotypes. An alternate zebrafish melanoma model is
driven by melanocyte expression of oncogenic HRASG12V alone. This model produces
neoplasia with spreading lesions and expansile nodules within 90% of animals by 12
weeks post fertilisation (wpf) (Michailidou et al., 2009). Within this model it was shown
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that the Raf-Mek-Erk pathway was required and sufficient for neoplasia initiation but the
PI3K pathway was essential for malignant progression (Michailidou et al., 2009). Both of
the described melanoma models lack temporal control due to the spontaneity of tumour
formation, so early tumour development stages may be missed. Furthermore, as these
models are dependent upon melanocyte function and pigmentation, non-pigmented trans-
parent lines cannot be used and the opportunity for optical imaging is not possible after
the embryo life stage.
An alternative transgenic cancer model is the hepatocellular carcinoma (HCC) model
developed by Nguyen et al. (2012). HCC is the most prevalent and malignant form of
liver cancer within humans, where Ras is active approximately 50% of the time and its
downstream signalling pathways (shown in Figure 1.3) are always found upregulated (Vil-
lanueva and Llovet, 2011; Nguyen et al., 2011, 2012). For example, this upregulation can
occur through mutational activation of the upstream RTK epidermal growth factor re-
ceptor (EGFR) or inactivation of RasGAP that negatively regulates Ras activity (Baines
et al., 2011; Nguyen et al., 2011, 2012). Furthermore, approximately 85% of Ras mu-
tations within human cancer are within KRAS, the essential member of the Ras family
(Downward, 2003). For these reasons the model is comprised of the zebrafish kras gene
oncogenic mutant krasV 12 and it is N-terminally labelled with enhanced green fluorescent
protein (eGFP). The expression of this oncogenic mutant is under spatial and temporal
control through an inducible system utilising the liver specific promoter fatty acid bind-
ing protein 10 (fabp10). Induction of tumour progression is dosage-dependent, whereby
the level of krasV 12 expression is dependent on inducer concentration. Interestingly, re-
moval of the inducer results in liver tumour regression and increased apoptosis, indicat-
ing ‘oncogene addiction’ is required for tumour maintenance (Nguyen et al., 2012). This
HCC zebrafish model recapitulates the human disease as molecular hallmarks, signalling
pathways and gene signatures are shown to be conserved (Nguyen et al., 2011).
1.3.2.2 Zebrafish Model of Tumour Angiogenesis
The HCC model zebrafish by Nguyen et al. (2012) has been adapted for studying angio-
genesis within tumour development and progression. This tumour angiogenesis model
zebrafish, TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12), inducibly ex-
presses the eGFP-tagged oncogenic krasV 12 transgene specifically in hepatocytes through
the Tet-On system. The Tet-On system uses two elements to control gene expression, a re-
verse tetracycline-dependent transactivator (rtTA) protein and a tetracycline response ele-
ment (TRE) promoter sequence. The rtTA protein recognises and binds the TRE sequence
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to elicit downstream effector protein expression only when tetracycline, or a derivative
such as doxycycline, is bound (Bockamp et al., 2002). Within this zebrafish model the
rtTA element is downstream of the fabp10 liver specific promoter and the TRE sequence
is upstream of the eGFPKRASV 12 transgene. Therefore oncogenic krasV12 is specifically
expressed within hepatocytes and is dependent upon the presence and concentration of
the inducer, doxycycline. Consequently tumours can be initiated when desired through
the simple addition of doxycycline. This model is non-pigmented throughout its entire
life span as a consequence of the TraNac mutant background. Also, the zebrafish have
a red fluorescent vasculature due to mCherry fluorophore expression under the control
of the endothelial specific promoter for KDR (VEGFR2). As a result fluorescent read-
outs regarding tumour and vasculature physiology can be acquired throughout the entire
lifespan of the zebrafish using optical imaging techniques. Figure 1.6 shows this tumour
angiogenesis zebrafish model in the embryo and adult. The liver tissue is fluorescing
green and the vessels are fluorescing red, where within the embryo individual primitive
vessels are visible including the dorsal aorta (DA), the posterior cardinal vein (PCV) and
the intersegmental vessels (SV) (Isogai et al., 2001).
Figure 1.6: The tumour angiogenesis zebrafish model, TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12), with a red fluorescent vas-
culature and a green fluorescent liver tumour driven by the presence of doxycycline.
a) shows the embryo at 4 dpf with 4 days of doxycycline treatment, highlighting
the dorsal aorta (DA), posterior cardinal vein (PCV) and the intersegmental vessels
(SV). b) shows the adult at 122 dpf after 2 weeks of doxycycline treatment. The
embryo image was acquired using widefield microscopy and the adult image is a
single maximum intensity projection using optical projection tomography.
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1.3.3 Genomic Editing Techniques
Genetic analysis is an important approach to understanding the regulation of biological
processes at the molecular level and zebrafish are prime model organisms for this type of
research (Amatruda et al., 2002; Lieschke and Currie, 2007). Within the past few years
novel genome editing techniques have been characterised to readily study gene function in
zebrafish with ease, where it was previously difficult to implement loss of function muta-
tions (Auer and Del Bene, 2014). These recent techniques include transcription activator-
like effector nucleases (TALENs) and clustered regularly interspaced short palindromic
repeats (CRISPRs). Both of these are able to modify particular genes of interest through
introducing double strand breaks (DSBs) in targeted regions of DNA, Figure 1.7 (Dahlem
et al., 2012; Hisano et al., 2014). This results in the induction of DNA repair mecha-
nisms, such as non-homologous end joining (NHEJ) or homology directed repair (HDR),
Figure 1.8. NHEJ repairs the DSB by fixing the two ends back together, but in doing so
insertions or deletions (indels) are incorporated into the sequence resulting in frameshift
mutations and defective proteins. Conversely, HDR uses a template of double stranded
DNA to repair the break, therefore inserting precise sequences of DNA that have been
designed and supplied (Sander and Joung, 2014; Hisano et al., 2014).
TALENs elicit their DSB through protein “arms”. These arms are comprised of a DNA
binding domain, designed to target the specific DNA sequence of interest, fused to a
homodimeric FokI nuclease domain, Figure 1.7a. The specific DNA binding is achiev-
able through approximately 20 highly conserved TALE repeats of 33-35 amino acids in
length. These repeats recognise particular DNA bases through hypervariable residues
called repeat-variable di-residues (RVDs) (Dahlem et al., 2012; Joung and Sander, 2013).
Only when two arms are approximately 10-20 nucleotides apart can they bring the FokI
nuclease domains together and elicit the DSB. The region of DNA between the two spe-
cific arm targets is called the spacer and this is where DSB occurs. This technique is
precise and unlikely to elicit off target effects through cleavage being dependent on ori-
entation and sequence of two specific 20 nucleotide DNA sequences (Miller et al., 2011;
Joung and Sander, 2013).
Alternatively, CRISPRs function through the use of a single guide RNA (gRNA) and
an accompanying Cas9 nuclease. The gRNA is composed of a 20 nucleotide DNA bind-
ing region, where Watson-Crick pairing occurs to complementary DNA. Following this
is a 3 nucleotide protospacer adjacent motif (PAM) and a downstream region that can
recruit the nuclease Cas9 (Auer and Del Bene, 2014). Through customising the DNA
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(a) TALEN
(b) CRISPR
Figure 1.7: Schematics of the two genome editing techniques, TALENs and
CRISPRs. a) TALENs function through two protein arms containing DNA bind-
ing domains that bind approximately 10-20 nucleotides apart bringing homodimeric
FokI nuclease domains together to elicit a DSB. DNA binding occurs through TALE
arrays that contain repeat-variable di-residues (RVDs) that recognise particular nu-
cleotides. b) CRISPR gRNA binds to target DNA regions, followed by the required
PAM sequence, through complementary base pairing and recruits a Cas9 nuclease
to cleave the desired target. Figure adapted from Auer and Del Bene (2014).
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Figure 1.8: DNA repair mechanisms used to fix double strand breaks. The left hand
side illustrates Non-Homologous End Joining (NHEJ), whereby the two ends are
brought back together incorporating insertion or deletion mutations. The alternate
mechanism, on the right, is Homology Directed Repair (HDR) that uses template
DNA to fix the break, which can be used to incorporate precise modifications. Figure
from Sander and Joung (2014).
binding nucleotides within the gRNA CRISPRs can target and bind specific loci, recruit
Cas9 and produce a DSB 3 nucleotides upstream of the PAM domain (Jao et al., 2013;
Hwang et al., 2013; Sander and Joung, 2014), Figure 1.7b. This causes more efficient and
robust modification of gene sequence than the aforementioned TALENs, where the muta-
genesis rate is consistently greater than 75% (Jao et al., 2013; Sander and Joung, 2014).
It is also far less complex to design and produce the elements for CRISPR mutagenesis
compared to synthesising and assembling an array of TALE protein repeats. However,
there is a greater risk of off-target effects as it is reliant on a single 20 nucleotide stretch
of DNA opposed to two that require correct spacing to elicit a response. There are now
numerous tools available to help prevent this (Hsu et al., 2013; Auer and Del Bene, 2014).
Recently both TALENs and CRISPRs have also been used in zebrafish to perform pre-
cise knock-in mutations at DSBs through HDR (Bedell et al., 2012; Chang et al., 2013;
Auer and Del Bene, 2014). This is achieved through using donor DNA that has sequence
homology to the regions either side of the produced DSB. The optimal structure of the
donor DNA is unknown and debatable, where different research groups are using DNA
in circular, linear, single stranded or double stranded forms with relatively low efficiency
(Genome Editing Session Workshop- Zebrafish Platform, The Allied Genetics Confer-
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ence 2016). Bedell et al. (2012) have shown a TALEN mediated knock-in using a single
stranded DNA (ssDNA) donor template containing a 34bp modified LoxP (mLoxP) site.
This knock-in was targeted to an exon and had 10.3% insertion efficiency, where half
of these were precise insertions with no additional indels. The mLoxP insertion was
designed to disrupt the TALEN recognition sequence within the DNA, therefore the in-
sertion will not be prone to further gene editing once incorporated. A CRISPR mediated
approach has been described by Chang et al. (2013) where the same mLoxP sequence
has been fully incorporated into the targeted exon in 1 of 12 tested embryos. However
this was not precise and indels were seen around the insertion site. The donor template
used here was also ssDNA and the insertion was targeted within the CRISPR recognition
sequence, once again to prevent additional gene editing.
1.4 Imaging Modalities
Although much has been learnt from in vitro studies, the absence of integrative organ
systems and true cellular environments limits their relevance and utility when studying
disease and aiding drug development. In vivo studies can overcome this. Performing
live global imaging of model organisms can provide spatial and temporal information of
dynamic interactions at the molecular and signalling level (Ntziachristos et al., 2005).
1.4.1 The “Imaging Gap”
Whole model organism imaging at a reasonable resolution has been problematic due to the
“mesoscopic imaging gap” that has become apparent between available imaging modal-
ities (Sharpe, 2003; McDonald and Choyke, 2003). At one end of the imaging scale
whole human, macroscopic, imaging techniques are available, such as magnetic reso-
nance imaging (MRI) and computed tomography (CT) scans. These provide non-invasive
3-dimensional (3-D) imaging of internal structures within large specimens, however their
achievable resolution is low (McDonald and Choyke, 2003). At the other end of the scale
high resolution is achievable through microscopy techniques. One such example is 2-
photon confocal microscopy, which also enable fluorescence readouts due to being an
optical technique. Confocal images are gradually constructed through scanning the focal
point of a laser along the sample to create optical sections, which is time consuming. This
technique requires whole sample illumination and as a result the samples are prone to
phototoxicity and photobleaching from prolonged exposure.
Intravital imaging can be achieved utilising 2-photon confocal microscopy or other mi-
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croscopy techniques, but the maximal penetration depth is < 1mm (Potter et al., 1996;
Vakoc et al., 2009; Conway et al., 2014). Therefore 3-D imaging of model organisms is
reliant upon sacrifice, serial sectioning and subsequent digital reconstruction or is limited
to the surface of optically clear specimens or those that have been prepared with a chronic-
transparent window (Jain et al., 2002). The implantation of transparent window chambers
is an invasive procedure that has significant disadvantages. The surgery disrupts the tis-
sue being observed and this could bias results. For example, when studying angiogenesis
the window is likely to disrupt the existing vasculature and physiological angiogenesis
could occur for wound healing. Additionally, only subcutaneous tissues can be studied
and the size of tumours and duration of the study are restricted due to the limited space
and window degradation (Palmer et al., 2011; Moy et al., 2011).
1.4.2 Mesoscopic Imaging Techniques
There have been two different approaches to developing imaging modalities capable of
whole organism mesoscopic imaging, spanning the micrometer to centimetre size range.
The first has been to adapt the larger scale medical imaging techniques to image smaller
specimens with higher resolution, such as micro computed tomography (microCT) and
micro magnetic resonance imaging (microMRI). MicroCT can achieve cellular resolution
of whole organisms comparable to the resolution and information achievable through his-
tological analysis, if the specimen is not too large and is also imaged in segments (Betz
et al., 2007; Cheng et al., 2011). The achievable resolution of microMRI, which is of-
ten insufficient for distinguishing particular tissues, is dependent upon the strength of the
magnet and subsequently the modality is costly (Sharpe, 2003). Furthermore, neither of
the aforementioned imaging techniques are able to image coloured dyes or fluorescent
markers that are frequently used in biological assays. As a result sacrifice is often re-
quired for specific tissue imaging.
The second approach was to develop novel photonics based imaging techniques. One
example is light sheet microscopy (LSM), which has reduced photobleaching and pho-
totoxicity compared to 2-photon confocal microscopy. Only a thin, 2-dimensional (2-D)
sheet of tissue selected for imaging is illuminated at any one time, creating optical sec-
tions. Numerous optical sections can be acquired throughout the specimen and can be
used to create 3-D images. It is a fast imaging modality compared to other tomographic
techniques, such as MRI and CT, and can achieve deep tissue penetration with subcellular
resolution (Huisken and Stainier, 2009). Optically clear organisms up to 1 cm in size can
be imaged, using multiple acquisitions and 3-D image stitching to overcome the mm size
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field of view (Mayer et al., 2014). However, this is at the expense of resolution. Larger
light sheets are required for uniform illumination within larger samples, therefore result-
ing in high lateral resolution but low axial resolution (Mayer et al., 2014). Additionally,
LSM is only capable of fluorescence imaging and so brightfield (transmission) informa-
tion that is important for many studies is not achievable (Mayer et al., 2014). It is also
expensive as cost of implementation is approximately $30,000 (Santi, 2011).
1.4.3 Optical Projection Tomography
Optical projection tomography (OPT) is a mesoscopic imaging modality developed by
Sharpe et al. (2002) that is analogous to the optical version of X-ray CT. Like LSM, OPT
provides the advantages of fluorescence imaging and low phototoxicity associated with
the widefield illumination. However, it also enables brightfield imaging, ease of scaling to
image larger samples in a single acquisition and the cost of implementation is relatively
low, comparable to that of a widefield microscope (Sharpe et al., 2002; Sharpe, 2003).
OPT also offers the opportunity to reduce light dose and acquisition time using compres-
sive sensing (CS) iterative reconstruction algorithms previously developed for X-ray CT
(Correia et al., 2015). Due to its fluorescence and transmission imaging capability the
system can take advantage of the numerous fluorescent dyes and markers that are readily
available and have been frequently used to study tissues and genes (Sharpe et al., 2002).
Using OPT high resolution images of whole specimens up to 15 mm in depth can be
achieved (Sharpe et al., 2002). However, OPT is not capable of the subcellular resolution
achievable by LSM (Santi, 2011; Mayer et al., 2014).
Specimens for imaging are placed within an index matched chamber and are subjected
to widefield illumination. Transmitted light travels through two lenses positioned to max-
imise the depth of focus and subsequently 2-D projections are captured on a camera imag-
ing chip (CIC). Within the projection each row of pixels represent an approximate line
integral through the specimen. As the imaging chamber rotates multiple projections are
acquired at different angles, therefore depth information can be rendered for each line
integral to reconstruct 2-D transverse images (Sharpe, 2003). These 2-D images can be
stacked to produce a 3-D image. A schematic of the OPT imaging apparatus is shown in
Figure 1.9.
The crucial disadvantage to the system is the requirement of a transparent specimen with
a homogenous refractive index. Previously OPT imaging has been performed using spec-
imens that have been sacrificed and optically cleared (Sharpe et al., 2002; McGinty et al.,
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2008) or those that are naturally transparent, such as the zebrafish embryo (McGinty et al.,
2011; Correia et al., 2015; Andrews et al., 2016). Zebrafish embryos have been beneficial
for many studies, however they have considerable limitations when studying some bio-
logical processes due to development of the animal being key. This is true when studying
cancer where a mature vasculature and immune system are required to provide accurate
representations of the human disease (Hanahan and Weinberg, 2011). Non-pigmented
mutant lines of zebrafish, such as TraNac described in Section 1.3.1, that remain suffi-
ciently transparent throughout their entire lifespan could enable live, adult imaging using
OPT (Bassi et al., 2011; Fieramonti et al., 2012). However, due to internal organs the
organisms do lack a consistent refractive index and so light scatter could cause unwanted
artefacts during reconstruction.
To enable accurate live, adult imaging it is important that the non-pigmented zebrafish
reach a deep level of anaesthesia where there is no response to external stimuli, Table
1.1. Furthermore, this level of anaesthesia needs to be maintained for prolonged periods
of time without resulting in detrimental or lethal side effects. This is required as the 3-D
reconstruction algorithms are reliant upon motionless specimens (Kak and Slaney, 1988;
Sharpe et al., 2002).
1.5 Tomographic Reconstruction
1.5.1 Filtered Back Projection
3-D reconstruction of OPT images is conventionally performed using filtered back pro-
jection (FBP):
I(x,z) =
∫ pi
0
[∫ ∞
−∞
Sθ (w)|w|e2piiwrdw
]
dθ . (1.1)
Every x row of pixels within the acquired 2-D (r,y) projection, P, is treated as a 1-
dimensional (1-D) projection of the transverse slice through the specimen, where r is
the polar co-ordinate (xcos(θ)+ zsin(θ)) for the x− z plane. This is indicated by the
red ellipse and line in Figure 1.9 and illustrated within Figure 1.10. Observing these 1-D
projections over all captured angles, Pθ (r), produces the fluorescence intensity sinogram
(r,θ), where θ is the acquisition angle. The signal is subjected to deconvolution to ac-
count for the spatial frequency when sampling through filtering in the Fourier domain.
The Fourier transform of Pθ (r), Sθ (w), is multiplied by a frequency filter function, such
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Figure 1.9: A diagrammatic representation of the OPT setup up for imaging whole
organisms. The specimen is placed within the index matched chamber that rotates
during image acquisition. The specimen is subjected to widefield illumination (yel-
low arrows) and transmitted light from the specimen (blue lines) is captured on the
camera imaging chip (CIC) through two lenses that maximise the depth of focus,
forming a projection. Each row of pixels within the projection corresponds to a
transverse (x-z) section of the imaged organism (red ellipse and line). These can
be observed over all acquired angles to reconstruct 2-D transverse images. Figure
adapted from Sharpe et al. (2002).
Level Movement Opercula Reaction to Stimuli
Light Anaesthesia
Equilibrium Loss Increase Only to substantial
Erratic Swimming
Deep Anaesthesia
None Decrease None
Medullary Collapse (death)
None Ceases None
Table 1.1: Definitions of the levels of anaesthesia experienced in the zebrafish, with
corresponding physical movement and reaction to external stimuli. Table adapted
from McFarland (1959) and Ross and Ross (2008).
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as the ramp filter |w|, and then the inverse transform is taken to produce the filtered sino-
gram. These sinograms are then back-projected at the acquisition angle to reconstruct the
corresponding (x− z) image I. The 3-D image can be produced by stacking the (x− z)
images for all r (Kak and Slaney, 1988; McGinty et al., 2008).
The filter is an essential aspect of the reconstructions that controls both unwanted blurring
and high intensity central regions that result when overlapping the reconstructed (x− z)
slices. A ramp filter is used to enhance the high frequencies and reduce the lower ones in
a linear manner, therefore enhancing contrasting features and minimising blurring. Sta-
tistical noise is often found as high frequency components in the Fourier domain and so
applying the Ramp filter over a Hanning window, H(w) = 1+ cos(piw/wn) where wn is
the Nyquist frequency, can further reduce aliasing (Chesler and Riederer, 1975).
A key principle of OPT is that parallel beam projection is assumed, defining projections
180◦ apart as identical. However, due to the inconsistent refractive index of the zebrafish
and resultant scattering this is not so. As a result projections are captured over 0 < θ < 2pi
to maximise the depth information acquired (McGinty et al., 2008).
1.5.2 Compressive Sensing
In many applications it is advantageous to acquire images in the minimal time possible.
This is the case when imaging zebrafish through OPT, whereby their viability upon recov-
ery is dramatically reduced under prolonged anaesthesia (Sun et al., 2009; Matthews and
Varga, 2012). In order to accurately reconstruct an OPT dataset using FBP the number of
angular projections obtained over 180◦ must be sampled at a rate equal to or better than
the Nyquist frequency along the circumference of the zebrafish (Kak and Slaney, 1988;
Phelps, 2006). However, acquiring a full dataset is time intensive and undersampling the
data would result in a degradation in image quality and an increase in aliasing.
CS has been successfully incorporated in applications similar to OPT, such as CT and MRI
reconstruction (Sidky and Pan, 2008; Sidky et al., 2009; Lustig et al., 2007; Chakraborty,
2008). It has also been used to successfully reconstruct high quality images from under-
sampled OPT datasets in zebrafish embryos (Correia et al., 2015). It can account for low
sampling and computationally reconstruct a high quality image from an incomplete set of
measured signals by exploiting redundancy. This is achieved through attempting to solve
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Figure 1.10: A schematic explaining the geometry and notation used in filtered back
projection (FBP) reconstruction of OPT images, Equation 1.1. The 2-D transverse
slice, I(x-z), of the 3-D specimen is shown, where the projections, P, are being cap-
tured for the polar coordinate r at different angles, θ . Figure adapted from Kak and
Slaney (1988).
40
CHAPTER 1. INTRODUCTION
the underdetermined linear problem;
Pθ (r) = KI + ε, (1.2)
under the constraint of sparsity, where the measured sinogram is comprised of the Radon
transformation, K, of the unknown fluorescence signal with the addition of noise, ε
(Donoho, 2006; Candès and Wakin, 2008). Sparsity is defined as having very few non-
zero components, therefore observing the image within a sparsifying domain would result
in little information. For example, Figure 1.11 shows a phantom image and its sparse rep-
resentation in the gradient domain, where only neighbouring pixels that differ in intensity
are represented. The original image has 32412 non-zero components and the gradient
domain has only 2949, therefore is sparse. Hence, the objective function most commonly
used for signal restoration can be minimised to recover I whilst exploiting this sparsity
through regularisation, where φ(I) is the regulariser and τ is the regularisation parameter:
f (I) = ||Pθ (r)−KI||22 + τφ(I). (1.3)
The first element in the objective function is a data fidelity term that measures the resid-
ual error between the acquired and estimated data through the l2 norm. The regularisation
terms are chosen to reflect prior knowledge of the images, where the regulariser is the
measure of sparsity and the parameter determines the degree of regularisation compared
to data fidelity.
(a) (b)
Figure 1.11: An example of sparse representation of an image, where a) is a phantom
in the image domain with 32412 non-zero components and b) is its sparse represen-
tation in the gradient domain with only 2949 non-zero components.
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The l0-norm is usually used to assess sparsity through computing the number of non-
zero entries. However, it is non-convex and therefore becomes computationally difficult
to minimise the objective function of Equation 1.3. The l1-norm can provide a good
approximation of the sparsest solution through calculating the sum of the coefficients and
it is convex, so is often used an alternative. However, it has been found that for many
images the TV-norm is more appropriate as a regulariser, where the total variation (TV)
of the images is minimised instead. The TV of the image is defined as;
φTV (I) =∑i
√
(DHI)2i +(DV I)
2
i , (1.4)
where DH and DV are the gradients of pixel i in the horizontal and vertical direction, re-
spectively, (Rudin et al., 1992; Candes et al., 2005). Due to OPT images being piece-wise
constant with sharp defining edges it is appropriate to assess sparsity of the gradient co-
efficients through TV, as they are compressible in this domain.
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Angiogenesis is found deregulated in many pathologies, including cancer where it is re-
quired for tumour progression and metastasis. Due to the absence of integrative organ
systems and true in vivo microenvironments it is increasingly accepted that biological
processes differ significantly when observed in vitro. Therefore, it is essential that in vivo
research of whole organisms is performed to complement in vitro investigation. Live,
global imaging of model organisms should achieve this, where longitudinal studies can
be performed to provide additional information and increased accuracy. Furthermore, it is
preferable to research tumour progression and angiogenesis within adult organisms. This
is due to the requirement of a mature immune system and fully formed vasculature, which
are not present within developing organisms, to accurately represent the human pathol-
ogy.
The overarching aim of the research project was to develop a quantitative, global imaging
platform that enables longitudinal studies of tumour progression and angiogenesis within
adult zebrafish. OPT imaging and the tumour angiogenesis zebrafish model, TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12), could provide this and enable mech-
anistic and drug development studies. However, system optimisation was required and
changes to the model organism could be desirable to better reflect the human disease.
These became my main research objectives, which were to:
• Reduce the OPT imaging acquisition time when imaging adult zebrafish with in-
ducible eGFP-tagged liver tumours and mCherry labelled vasculature
• Accurately quantify tumour progression and vascularisation from the resulting OPT
images
• Perform and optimise longitudinal imaging of tumour progression and vascularisa-
tion
• Perform mechanistic studies of tumour progression by developing novel zebrafish
models.
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Materials and Methods
2.1 Zebrafish
2.1.1 Husbandry and Breeding
All fish were kept in the Fish Facility at UCL in 28◦C system water on a photoperiod of
14 hours light followed by 10 hours dark. The system water comprises of Tropin Marin R©
marine salts added to reverse osmosis (RO) water to a conductivity of 420 MicroSiemens.
The products of fish metabolism and the addition of food increase the conductivity, which
is monitored to run between 420 and 520 MicroSiemens. The pH is automatically adjusted
to 7.0 through the addition of sodium bicarbonate. Fish were fed twice daily with a mix
of live brineshrimp, blended krill and Hikari protein pellets. When breeding, a male and
female fish of choice were placed within breeding tanks that contain a specialist insert to
separate the fish from the eggs laid. Embryos were collected and kept in system water
with 0.003% (w/v) methylene blue to prevent fungal infection, and were incubated at
28◦C. They enter the UCL Fish Facility nursery at 4 days post fertilisation (dpf) and
reach sexual maturity within 60 dpf.
2.1.2 Anaesthesia Preparations
Unless otherwise stated, tricaine methanesulfonate (MS-222) (Sigma) was used to anaes-
thetise zebrafish. 400 mg tricaine methanesulfonate powder was dissolved in 97.9 ml
deionised water with 2.1 ml 1M Tris and adjusted to pH 7. This was stored at -20◦C. For
embryos 1 ml was used per petri dish and for adults a 4.2% (168 parts per million (ppm))
solution within system water totalling 100 ml.
In some instances isoflurane (Abbott) was used as an anaesthetic. Isoflurane was dis-
solved in ethanol to create a 100,000 ppm stock solution and stored at 4◦C. The desired
amounts of anaesthetic were added to fish water immediately prior to use.
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2.1.3 Testing Anaesthesia
Zebrafish were placed into 100 ml of water containing the prescribed anaesthesia con-
centrations. Deep anaesthesia (Table 1.1) was determined by the loss of righting reflex
and response to external stimuli, through both tapping the bench and pinching the caudal
fin. Once deep anaesthesia was achieved the fish were placed into a fluorinated ethylene
propylene (FEP) tube used for OPT imaging containing the same anaesthetic solution.
Whilst in the tube the fish were closely monitored for movement, opercula movement and
response to external stimuli through tapping the bench. The external stimuli of tapping on
the bench is a greater stimulus than what would be experienced during OPT acquisition.
The fish were removed from the tube and placed in a recovery tank, when they either
awoke or as opercula movement ceased prior to encountering medullary collapse. Their
recovery was monitored and a Pasteur pipette was used to gently squirt oxygenated water
over the gills. Recovery was defined as the ability for the fish to swim once the righting
reflex had returned.
2.1.4 Transgenic and Mutant Lines
The tumour angiogenesis zebrafish model used throughout was the TraNac Tg(KDR:
mCherry:Fabp10-rtTA:TRE-eGFPKRASV 12). These fish are an inducible, eGFP labelled
genetic model of liver cancer that also present mCherry labelled vasculature. They also
remain transparent throughout all life stages. The line was generated through the breed-
ing of non-pigmented TraNac zebrafish (gift from Julian Lewis, Cancer Research In-
stitute), a double mutant for the mitfa/nacre and the mpv17/transparent genes, to both
Tg(KDR:mCherry) fish (gift from Steve Wilson, University College London) and Tg
(Fabp10-rtTA:TRE-eGFPKRASV 12) fish (gift from Zhiyuan Gong, National University of
Singapore). The resultant TraNac Tg(KDR:mCherry) and TraNac Tg(Fabp10-rtTA:TRE-
eGFPKRASV 12) were crossed to generate the line.
Other zebrafish lines used included wild-type (AB), the non-pigmented mutant line Casper
(roy-/roy-; nacre-/nacre- double mutant) gifted by Leonard Zon (Harvard Medical School)
and the transgenic line Tg (KDRmCherry:cmlc2GFP) gifted by Ian Zachary (UCL). The
Tg (KDRmCherry:cmlc2GFP) zebrafish were on a wild-type background with mCherry
and GFP labelled vasculature and cardiomyocytes, respectively.
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2.1.5 Embryonic Microinjection
Embryos were injected with 1 nl of solution at the one-cell stage of development, within
the first 15 minutes of fertilisation for the greatest efficiency of germ cell integration.
Glass capillary needles were loaded with the required solution before inserting into the
microinjector, where the liquid was then forced out through applying air pressure. The
volume injected was calibrated using a graticule. The needle was positioned in the blas-
todisc of the embryo for injection.
2.1.6 Fluorescent Zebrafish Larvae Selection
Embryos with fluorescent markers were selected under a widefield microscope from 2 dpf
under anaesthesia.
2.1.7 Tumour Expression
Tumour induction of zebrafish containing the Fabp10-rtTA:TREeGFPKRASV12 transgene
were performed through the addition of doxycycline (Sigma D-9891) to the fish water at
a concentration of 10 mg/L, unless otherwise stated. The eGFP signal was usually seen
at approximately 4 days post induction (dpi) when using 10 mg/L. Tumour reduction was
achievable through removing the doxycycline stimulant, which was used for zebrafish
larvae selection.
2.1.8 DNA Extraction
2.1.8.1 Single Embryo DNA Extraction
The HotSHOT method was used for single embryo DNA extraction. Individual embryos
were placed in separate wells of a 96 well plate with the excess water removed. 25 µl
of base lysis buffer (25 mM KOH, 0.2 mM EDTA) was added to the individual embryos
and the plate incubated at 95◦C for 30 minutes. Once cooled to room temperature 25 µl
of neutralisation solution (40 mM Tris-HCl at pH 5.0) was added to the wells and the
plate was centrifuged to pellet the remaining tissue. The concentration of extracted DNA
allowed for 1 µl of this solution to be used in subsequent polymerase chain reactions
(PCRs).
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2.1.8.2 Fin Clipping
DNA samples were acquired from adult zebrafish through fin clipping. The fish were
anaesthetised in 4.2% MS-222 until they lost the tail pinch response. At this point less
than 50% of the caudal fin was clipped using a sterile razor blade. The fish were trans-
ferred to a recovery tank, monitored to regain consciousness and then returned to storage
tanks in isolation. The fin clip was placed into 140 µl of DNA extraction buffer (made
with 50 µl 1 M Tris pH 8.0, 20 µl 0.5 M EDTA, 50 µl 20% Triton X-100 and 4.88 ml
nuclease free H2O) with 10 µl of 20 mg/ml Proteinase K. The reactions were then incu-
bated at 57◦C overnight in a waterbath followed by incubation for 10 minutes at 100◦C
before being centrifuged to pellet the remaining tissue. The concentration of extracted
DNA solution required 3 µl to be used in subsequent PCRs.
2.2 Molecular Biology
2.2.1 Materials
2.2.1.1 LB Broth
Luria Bertani (LB) broth medium was made through adding 20 g of LB Broth Base (In-
vitrogen) to 1 L of deionised water and autoclaving. Ampicillin antibiotic was added as a
selective agent once the broth had cooled to room temperature at a concentration of 100
µg/ml.
2.2.1.2 LB Agar Plates
LB agar medium was made through adding one LB Agar Tablet (Sigma-Aldrich) per 50
ml of deionised water and autoclaving. Once the solution had begun to cool ampicillin
antibiotic was added at a concentration 100 µg/ml before the medium was poured into
10 cm petri dishes (approximately 20ml per dish) and left to solidify through cooling to
room temperature. LB agar plates were stored at 4◦C.
2.2.2 Molecular Cloning
2.2.2.1 Bacterial Transformation
Bacterial transformation was performed through the heat shock protocol. Unless other-
wise stated the competent cells used were StellarTM (Clontech), which were were thawed
on ice. 4 µl of plasmid DNA was added to 50 µl of the cells. This was left on ice for 20
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minutes before performing heat shock at 42◦C for 45 seconds. The cells were then placed
on ice for a further 2 minutes before adding 250 µl of SOC media and were then left to
recover at 37◦C for 1 hour. The transformation can then be plated on LB agar plates with
the appropriate antibiotic and left at 37◦C overnight.
2.2.2.2 Expanding Bacterial Cultures
A single colony grown on a LB agar plate with the appropriate selective agent was isolated
and added to 5 ml volume of LB broth with the appropriate antibiotic. This was then
incubated for 16 hours at 37◦C, shaking at 300 rpm.
2.2.2.3 Plasmid Isolation and Purification
Plasmids were isolated from bacterial cultures using the QIAGEN QIAprep Spin Miniprep
Kit according to manufacturers instructions.
2.2.3 Polymerase Chain Reaction
All PCRs were performed with either Phusion R© High-Fidelity DNA Polymerase (New
England Biolabs) or Taq PCR Master Mix Kit (QIAGEN). Primer details, including se-
quences, annealing temperatures and the PCR enzyme used, are described in Table 2.1.
PCR with Phusion R© High-Fidelity DNA Polymerase:
Per 50 µl reaction:
10µl 5x Phusion HF Buffer
1µl 10 mM dNTPs
2.5µl 10 µM forward primer
2.5µl 10 µM reverse primer
1.5µl DMSO
0.5µl Phusion DNA Polymerase
3µl Extracted DNA
29µl Nuclease Free Water
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Cycling Conditions:
98◦C 30sec
98◦C 10sec
X◦C 30sec
35cycles72◦C 30sec
72◦C 10min
where X corresponds to the annealing temperature (Table 2.1).
PCR with Taq PCR Master Mix Kit:
Per 20 µl reaction:
10µl 2x Taq PCR Master Mix
0.5µl 100 µM forward primer
0.5µl 100 µM reverse primer
3µl Extracted DNA
6µl Nuclease Free Water
Cycling Conditions:
95◦C 10min
95◦C 30sec
X ◦C 30sec
30cycles72◦C 1m30sec
72◦C 10min
where X corresponds to the annealing temperature (Table 2.1).
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Gene of Interest Polymerase used Annealing Temperature Primer Sequence (5′→ 3′)
bcar1
Taq 60◦C Forward AGTCTCCAGACGAGTTGTCC
Reverse TGCCAACGAGAATCTTCA
ptenb
Taq 52◦C Forward TGTTGAGCTTTTGTTGGATGAA
Reverse CGATCAAACAGCCGCCTTAA
ptenb-LHS
Phusion 60◦C Forward GACCAATGCTGATGATGTTCCA
Reverse AACCGATATCACAGAACTGAAGT
ptenb-RHS
Phusion 58◦C Forward AAGGGAAGAACGGGTGTCAT
Reverse AGCCACCATCATTTGCAATCT
TREeGFPKRASV 12
Taq 59◦C Forward TATATCATGGCCGACAAGCA
Reverse GTGAGAGCGCTTTTGCCTAC
Table 2.1: Primer sequences and annealing temperatures used for PCRs and subsequent Sanger sequencing
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2.2.4 Gel Electrophoresis
1.6% agarose gels were made using molecular grade agarose powder (Bioline) and 1x
TAE Buffer (5PRIME), with the addition of 6 µl GelRed Nucleic Acid Gel Stain (Cam-
bridge Bioscience) per 100 ml. All gels were run at 110 V in 1x TAE Buffer.
2.3 Genome Editing
2.3.1 Determining the Target Region
Ensembl genome browser (http://www.ensembl.org) was used to analyse the
genes of interest within the zebrafish. The target region was determined and then primers
were designed to confirm the sequence within the zebrafish using Primer3 (http://
primer3.ut.ee) and UCSC In-Silico PCR (http://genome.ucsc.edu). PCR
was then performed to enable Sanger sequencing by Source Bioscience (UK). Primers
used can be found in Table 2.1.
2.3.2 TALENs
2.3.2.1 Design
The TALEN arms were created using the fast ligation-based automatable solid-phase
high-throughput (FLASH) protocol published by Reyon et al. (2012). The sequenced,
conserved DNA regions of interest were used to design TALENs using the online Zi-
FiT Targeter Software Version 4.2 (http://zifit.partners.org/ZiFiT/). The
output from this included a sequence of TALE repeats and FLASH-IDs, the latter being
a plasmid encoding one, two, three or four particular TALE repeats (detailed informa-
tion regarding DNA sequence is available in Supplementary Tables 1 and 2 of Reyon
et al. (2012)). Expansion of the desired FLASH plasmids (generously donated by Wilson
group (UCL)) was performed before use.
2.3.2.2 Construction
For more detailed methodology see Supplementary Document 1 in Reyon et al. (2012).
When purification and quantification are stated with respect to TALEN construction it
refers to using QIAGEN QIAquick PCR Purification Kit according to the manufacturers
instructions followed by the Nanodrop spectrophotometer, unless otherwise stated.
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The FLASH plasmid containing the initial TALE fragment required amplification and
5’- biotinylation through PCR. This was performed using Phusion DNA Polymerase with
the biotinylated forward primer (5’ - Biotin - TCTAGAGAAGACAAGAACCTGACC -
3’), and was subsequently digested with BsaI-HF for 15 minutes at 50 ◦C before purifica-
tion and quantification.
Each extension or termination FLASH plasmid was then prepared through a series of
digestions at 37◦C with BbsI, XbaI, BamHI-HF and SalI-HF for 2 hours, 5 minutes, 5
minutes and 5 minutes, respectively, to remove the backbone. This was followed by pu-
rification and quantification.
The FLASH units were then assembled through serial, solid-phase ligations and diges-
tions on streptavidin coated magnetic beads (Dynabeads, Life Technologies) using BsaI-
HF and T4 DNA ligase. They were then released from the beads through BbsI digestion.
The resulting DNA of TALE repeats was then purified once again before cloning into
the required JDS TALEN expression plasmid (gift from Wilson Group (UCL)) that had
been digested by BsmBI for 8 hours at 55◦C. The JDS plasmid used was dependent upon
the final base in the TALEN binding site, shown in Table 2.2. These plasmids were then
transformed into XL10-Gold Ultracompetent Cells through heat-shock and were left to
grow on an ampicillin LB agar plates. The colonies that grew were then verified through
colony PCR as follows:
Per 20µl reaction:
12.5µl QIAGEN Taq Polymerase mastermix
1µl 2µM forward primer (5’- GACGGTGGCTGTCAAATACCAAGATATG)
1µl 2µM reverse primer (5’- TCTCCTCCAGTTCACTTTTGACTAGTTGGG)
5µl colony sample
Cycling Conditions:
95◦C 10min
95◦C 30sec
62◦C 30sec
35cycles72◦C 2min40sec
72◦C 10min
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The PCR products were examined through gel electrophoresis, where positive samples
were expected to be 2.1 kb. Potential candidates were subsequently purified and se-
quenced by Source BioScience (Cambridge, UK).
JDS Plasmid Final Base of TALEN Target Site
JDS70 A
JDS71 C
JDS74 G
JDS78 T
Table 2.2: JDS TALEN expression plasmids used for cloning TALE repeats from
serial ligations. JDS plasmid used was dependent upon final base of TALEN binding
site.
2.3.2.3 Transcription
The positive colonies were cultured for expansion and the TALEN plasmids were then
isolated. The plasmids were linearised using PmeI (NEB) in CutSmart buffer at 37◦C
for one hour and subsequently purified using the QIAquick PCR Purification Kit. Tran-
scription was then performed using the T7 Polymerase mMESSAGE mMACHINETM kit
(Ambion) following manufacturers instructions and the TurboDNase step to remove the
residual DNA template was included. The TALEN mRNA required a polyA tail for im-
proved translational efficiency in vivo, which was achieved through the Poly(A) Tailing
Kit (Ambion) following manufacturer instructions. The resulting RNA was purified using
RNA Clean & ConcentratorTM-5 by Zymo Research and eluted in 25 µl of nuclease free
water, before being quantified by Nanodrop.
2.3.3 CRISPRs
2.3.3.1 Design
The online CRISPR design tool (http://crispr.mit.edu) developed by Hsu et al.
(2013) was used to generate possible guide RNAs (gRNAs) to target desired regions, of
which the highest scored sequences were chosen as they are most unlikely to have off-
target effects.
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2.3.3.2 Construction
The gRNAs were created through transcription from a synthesised double stranded DNA
(dsDNA). The dsDNA was created through annealing and extending two custom DNA
oligonucleotides, as previously shown in Gagnon et al. (2014). The gene specific forward
oligonucleotide consisted of the T7 promoter, the 20 nucleotide gRNA sequence identi-
fied and a complementary region to the reverse oligonucleotide that contained the Cas9
recruitment sequence. These oligonucleotides were synthesised by Eurofins Genomics
(Germany).
Forward oligonucleotide template:
5’-TAATACGACTCACTATAAGG-N20-GTTTTAGAGCTAGAAATAGCAAG-3’
Reverse oligonucleotide sequence:
5’- AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTA
TTTTAACTTGCTATTTCTAGCTCTAAAAC-3’
The annealing reaction was performed with 10 µM of each oligo in a 10 µl reaction
under the following conditions:
95◦C 5 min
95◦C→ 85◦C -2◦/sec
85◦C→ 25◦C -0.1◦/sec
4◦C Hold
This was then immediately followed by the extension phase, which ensured the entire
sequence was double stranded, through incubating at 12◦C for 20 minutes after the addi-
tion of the following reagents from NEB:
2.5µl dNTPs (10mM)
2µl 10x NEB Buffer 2
0.2µl 100x NEB BSA
0.5µl T4 NEB DNA polymerase
4.8µl Nuclease Free Water
The reaction was then purified using QIAGEN QIAquick PCR Purification Kit according
to the manufacturers instructions, verified through gel electrophoresis and subsequently
quantified using the Nanodrop.
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2.3.3.3 Transcription
CRISPR transcription was achieved through the NEB HiScribeTM T7 High Yield RNA
Synthesis kit, following manufacturers directions. The QIAGEN RNeasy Mini kit was
used to purify the RNA and remove remaining DNA template, where it was eluted in
30µl of nuclease free water. Concentration was then determined by Nanodrop.
2.3.3.4 Cas9 transcription
Cas9 mRNA was also required for CRISPR functioning. This was transcribed from a
plasmid generously donated by the Wilson group (UCL) using the T3 Polymerase mMES-
SAGE mMACHINETM, TurboDNase and Poly(A) Tailing kits (Ambion), all following
manufacturers instructions. The resulting RNA was purified through RNA Clean & Con-
centrator TM-5 by Zymo Research and quantified using the Nanodrop.
2.4 Genotyping
2.4.1 Sanger Sequencing
Sanger sequencing was performed by Source BioScience (Cambridge, UK) where PCR
products at a concentration of 1 ng/µl per 100bp were analysed using 3.2 pmol/µl of
supplied sequencing primers (as shown in Table 2.1).
2.4.2 Deep Sequencing
Primers surrounding the expected TALEN or CRISPR cleavage site were designed so
they produced approximately a 200bp amplicon, had a melting temperature of approxi-
mately 60◦C to 65◦C and had no secondary structure or primer dimers. The primers had
overhangs that were universal tags for the forward and reverse primers. This is schemati-
cally shown in Figure 2.1 and all MiSeq primers used and their corresponding annealing
temperatures are shown in Table 2.3. These primers were then used to amplify the DNA
region of interest through a PCR with Phusion R© High-Fidelity DNA Polymerase, as de-
scribed in Section 2.2.3. Gel electrophoresis was performed on the PCR products to con-
firm a single product and then the amplicons were cleaned using the QIAGEN QIAquick
PCR Purification Kit according to the manufacturers instructions. The resulting DNA was
quantified by the Nanodrop spectrophotometer and diluted to 15-25 ng/µl before being
passed to the Wilson Group (UCL) to perform deep sequencing using the Illumina MiSeq
based upon the protocol published within Gagnon et al. (2014).
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Figure 2.1: A schematic of the primer design for deep sequencing using the Illumina
MiSeq. Amplicon specific primers are designed with universal tags, where the blue
indicates the universal tag for the forward primer and the red for the reverse primer.
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Target MiSeq Primer Gene Specific Sequence (5′→ 3′) Annealing Temperature
ptenaL
MiSeq-Forward 1 ACGCAGCGCTAGTTTCTTGTTTA
68◦C
MiSeq-Reverse 1 TACTTACCGGACAACGTCATCAA
MiSeq-Forward 2 TCTTGCTTGTCTCTTCTCTCACA
66◦C
MiSeq-Reverse 2 TGTCTCACAGAATGGTGCAATAAAA
ptenaR
MiSeq-Forward 1 CAGCCGTGTCTAAAATAAAACTCAA
67◦C
MiSeq-Reverse 1 TACGTACGGAAGAAACAAGAACG
MiSeq-Forward 2 CTGAAGCCGCGCCACCG
72◦C
MiSeq-Reverse 2 CTTCGGGTTCATGCCGTTATCCTC
bcar1
MiSeq-Forward 1 ATGTGTTGGCAAAAGCCCTG
66◦C
MiSeq-Reverse 1 GCCAACGAGAATCTTCAGCC
Table 2.3: Primers used for Deep Sequencing with MiSeq to detect TALEN and CRISPR mediated genome editing. Annealing
temperatures shown were for PCR with Phusion R© High-Fidelity DNA Polymerase
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After sequencing the files were analysed using Geneious R9 (www.geneious.com,
Kearse et al. (2012)) to determine the insertions or deletions (indels) that had occurred.
2.4.3 HRMA
High resolution melting analysis (HRMA) was used to determine TALEN or CRISPR
mediated genome editing using DNA from single embryo extraction and the Precision
Melt Supermix kit (Bio-Rad). Initially multiple primers were designed for the target re-
gion and tested on control, uninjected DNA to identify those that elicited a single peak
melting profile. Those that functioned effectively are shown in Table 2.4. Once proven
these were used on the injected embryos. The HRMA reaction was performed according
to the manufacturers instructions below.
Per 10µl reaction:
5 µl 1x Precision Melt Supermix
1 µl 200 nM primer mix of forward and reverse primer
1 µl extracted DNA
3 µl Nuclease Free Water
PCR Cycling Conditions:
95◦C 2min
95◦C 10sec
60◦C 30sec
35cycles72◦C 30sec
High Resolution Melting Analysis:
95◦C 30sec
60◦C 1min
65◦C→ 95◦C 0.2◦/10sec
The HRMA reactions were performed on the BioRad CFX96 Touch R© machine and anal-
ysed using the Bio-Rad CFX Manager R© software, unless otherwise stated. Melting curves
of TALENs/CRISPRs injected samples were compared to uninjected controls.
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Gene of Interest HRMA Primer Sequence (5′→ 3′)
bcar1
Forward 1 CCCTCTATTTTGAGTTACACTCTTC
Reverse 1 GTTGGTTCGCTAACTGCTGTA
Forward 2 AGTCTCCAGACGAGTTGTCC
Reverse 2 TGCCAACGAGAATCTTCA
ptena-L
Forward 1 TTTAATAAGACGCAGCGCTAG
Reverse 1 GCCCATGGCAATGATGTTAGG
Forward 2 CACTATAGCTTTACTTGCTCTAGCC
Reverse 2 TCAACCGGGACCTTACTTTCTGT
Forward 3 CTTGCTCTAGCCAGTAGCATTGT
Reverse 3 ATTTGAGTAATCAACCGGGACCT
ptena-R
Forward 1 AGAACCAGGGATAAAAAGGTACAAT
Reverse 1 ATGGAAGTGCAATTGAGCTGTG
Forward 2 GGTGTATGGTTGTGCTGATA
Reverse 2 CATTAATGCAAAACGAGCTA
Forward 3 GGGTGTGTTGCTTCACATGA
Reverse 3 GATATCTTTGCCTATCGTCG
ptena
Forward 1 ATGAGAACCATGTGGCTGCC
Reverse 1 GCGATGCAGCAGATAGGCAC
Forward 2 GATGAGAACCATGTGGCTG
Reverse 2 CGATGCAGCAGATAGGCACA
Table 2.4: Primers used for High Resolution Melt Analysis to detect TALEN and CRISPR mediated genome editing.
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2.4.4 Poly Peak Parser
The online tool Poly Peak Parser (http://yosttools.genetics.utah.edu/
PolyPeakParser/) developed by Hill et al. (2014) was used to determine indels
within DNA sequences from the chromatogram data received from Sanger sequencing
from PCR samples. The chromatogram is compared to a provided reference sequence,
from which the alternate sequence, if present, can be deduced and indels can then be
identified. In all cases the signal ratio cut off was 0.33.
2.5 Histopathology and Immunohistochemistry
2.5.1 Sample Preparation
Liver tissue was dissected from euthanised zebrafish and fixed in 10% formalin (Fischer
Scientific, P/0840/53), before being dehydrated in graded ethanols, paraffin embedded
and sagittal sectioned at 5 µm. Formalin-fixed, paraffin-embedded (FFPE) sections were
then mounted onto Superfrost Plus R© slides (Thermo Scientific).
2.5.2 Staining
For immunohistochemistry (IHC) the slides were de-waxed with xylene treatment fol-
lowed by rehydration in graded ethanols of decreasing concentration. Antigen retrieval
was performed through either 10 mg/ml Pronase enzymatic digestion for 15 minutes or
through boiling in citrate buffer (2.94 g Trisodium citrate dehydrate, 5.4 ml 1M HCl in 1 L
dH2O) for 10 minutes. Sections were subsequently blocked in 3% hydrogen peroxide for
15 minutes, Avidin and Biotin (Vectastain) for 15 minutes and 10% serum matching the
secondary antibody host species for at least an hour. Primary antibody incubation was for
8 hours in a humidified chamber at 4◦C. Slides were incubated with secondary antibody
for an hour and then incubated with Avidin-Biotin complex (ABC) solution (Vectastain)
for 30 minutes. DAB (3,3’-Diaminobenzidine) solution (SIGMAFAST) was then applied
until optimum levels of staining occurred. Haematoxylin (Sigma-Aldrich) was used as a
counterstain and the slides were subsequently dehydrated and mounted onto glass cover-
slips, before being digitally imaged using a NanoZoomer 2.0-HT (Hamamatsu, UK). All
primary antibodies used are listed within Table 2.5.
Immunohistochemistry (IHC) for validation of CS-OPT quantification after antibody op-
timisation and all Hematoxylin and Eosin (H&E) stains were performed by IQPath (In-
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stitute of Neurology, UCL). Staining was performed using the Ventana Discovery XT
instrument, using the Ventana DAB Map detection kit (760-124). Heat mediated epi-
tope demasking was performed on the Ventana instruments, using a citrate based buffer
(Ventana Ribo CC, 760-107). Anti-mCherry (Novus Biologicals, 1C51) primary anti-
body incubation was for 8 hours using a 1:100 dilution. Rabbit anti-Mouse (Dako E0354)
secondary antibody incubation was for 32 minutes, using a 1:200 dilution. Slides were
haematoxylin counterstained. Digital images of the stained sections were generated using
a Leica SCN400F at x40 magnification.
2.6 Immunohistochemistry Quantification
Immunohistochemistry quantification was achieved through collaboration with Sebastian
Brandner (Institute of Neurology, UCL). Analysis of the digital IHC images was per-
formed at x20 magnification. Manually selected regions of interest (ROI) corresponding
to segmented vasculature in the CS-OPT data were analysed using Definiens Developer
XD v2.4.2 (Munich, Germany). Initial identification of the tissue, background and ves-
sels within these ROI was performed by Dr. Matthew Ellis (Institute of Neurology, UCL)
based on the level of blue and brown staining, calculated from the RGB image using the
HSD model (van Der Laak et al., 2000). The combined level of brown and blue stain-
ing was used to identify the tissue and background; background ≤ 0.5 > Tissue (value
range 0-3 a.u.). The threshold used to identify vessels (Th_V) was calculated using per-
centiles decreasing from 99 in increments of 1, searching for a change in value greater
than 0.01au; a percentile of 99 describes the threshold that separates the lowest stained
99% of tissue from the highest 1%. A lower threshold (Th_L) was then calculated at
Th_V-4. Following identification of all areas with brown staining greater than Th_V, any
object with blue staining equal to or greater than the level of brown staining was removed.
The remaining brown areas were then grown into surrounding pixels with brown staining
greater than Th_L. Vessel lumen were then incorporated and vessel diameters calculated.
Percent tumour vascularisation was based on the vessel stain plus lumen for the area of
tissue plus enclosed background.
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Primary Antibody Host Source Secondary Antibody Host Source
vWF Rabbit Dako Biotinylated anti- rabbit IgG Goat Dako
CD31 Rat BD Biosciences Biotinylated anti- rat IgG Goat Vector Labs
eNOS Mouse BD Biosciences Biotinylated anti- mouse IgG Goat Dako
ERG Rabbit Abcam Biotinylated anti- rabbit IgG Goat Dako
mCherry Mouse Novus Biologicals Biotinylated anti- mouse IgG Horse Dako
Table 2.5: Details of Primary and Secondary Antibodies used for Immunohistochemistry staining
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2.7 Widefield Microscopy
Zebrafish were deeply anaesthetised (Table 1.1) in system water containing 4.2% MS-222,
unless otherwise stated, prior to imaging. Widefield imaging was performed on a OLYM-
PUS MVX10 fluorescent microscope using a OLYMPUS U-HGLGPS light source at 561
nm and 488 nm for mCherry and eGFP excitation, respectively. The exposure time for
both mCherry and eGFP channels was 175 ms, with additional images with 25 ms or 10
ms for particularly intense eGFP signals. Images were captured on a OLYMPUS XM10
CCD camera and were 1376 x 1038 pixels, where each pixel was 20.48 µm2.
For quantification of tumour progression the eGFP signal area was calculated using Im-
ageJ (http://imagej.nih.gov). A threshold was applied to segment the eGFP
tumour region and then the area could be extracted.
2.8 Optical Projection Tomography
2.8.1 Instrumentation
Instrumentation was performed by the Photonics Group at Imperial College London. The
angularly multiplexed (Chen et al., 2013) two channel OPT instrument represented in Fig-
ure 2.2 was designed to accommodate juvenile and adult zebrafish up to 5 cm in length
and 1 cm in diameter and provide a field of view of 33.8 x 28.5 mm. In each channel
the optical imaging system provided a magnification of 0.49x with images acquired using
sCMOS cameras (Zyla 5.5 sCMOS, Andor Technology Ltd) with an imaging sensor of
16.6 x 14.0 mm with 2560 x 2160 pixels of 6.5 µm. The effective numerical aperture
(NA) of each imaging arm was adjusted using the adjustable iris in the back focal plane
of the “objective” lenses L1 to provide a depth of field of 2.5 mm with a diffraction lim-
ited point spread function of 18-22 µm depending on the wavelength. This is close to the
Nyquist limit of 26 µm determined by the system magnification and the pixel size of the
camera. One imaging arm was focused to 1.25 mm and the other to 3.75 mm from the
axis of rotation. These imaging arms were optimised using WinLens (www.winlens.de)
for minimum aberrations and field curvature across the field of view.
For imaging zebrafish larvae a single armed system was used comprising of a 200 mm
focal length tube lens (ITL200, Thorlabs Inc), a sCMOS camera and a Nikon objective
(N4X-PF) providing a magnification of 4x, Figure 2.3. The NA of the system was 0.04
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and the depth of field was 0.6 mm.
2.8.2 Acquisition
For imaging, fish were deeply anaesthetised (Table 1.1) in system water containing 4.2%
MS-222, unless otherwise stated, and transferred into a clear FEP tube with a refractive
index of 1.3 (EW-06406-12, Cole Parmer Instrument Co Ltd) with care taken to minimise
any bubbles within the tube. For juvenile and adult zebrafish the FEP tubing was 9.5
mm internal diameter (11 mm outside diameter) and for larvae (< 30 dpf) it was 794 µm
internal diameter (1.58 mm outside diameter). These tubes were then sealed with a plug
and mounted under a rotation stepper motor (T-NM17A200, Zaber Technologies Inc.) set
to run using a sufficiently low level of acceleration to prevent ‘slipping’ of the fish within
the tube. Typically, the acceleration used was 10 microsteps/s2 for a motor with 12800
microsteps/revolution (T-NM17A200), corresponding to an angular acceleration of 1.6
deg/s2. The tube was suspended in a custom-built imaging chamber of octagonal cross-
section filled with water to provide index matching of the tube and with glass windows
normal to the imaging and excitation axes. This chamber allowed for the sample to be
illuminated from multiple directions simultaneously in order to improve uniformity of
fluorescence excitation. Samples were illuminated at 561 nm for mCherry excitation and
488 nm for eGFP excitation.
Because adult zebrafish typically present an aspect ratio > 4:1 (i.e. > 4 cm length and
1 cm diameter), it is possible to more efficiently utilise this excitation light by dividing
it into three sub-beams with similar aspect ratio to the fish. The OPT image projection
data was acquired by the two sCMOS cameras running in parallel interfaced with sepa-
rate computers and the acquisition process was controlled by custom software written in
LabVIEW (National Instruments) by Dr. Sunil Kumar (Imperial College London) such
that one computer was slaved to the other, which also controlled the rotation stage motor,
and the projection images were acquired synchronously.
2.8.3 Data Management
Following the data acquisition, each series of angular projections was manipulated com-
putationally to ensure that the rotation axis was centred in the adjusted dataset and the
two multiplexed camera datasets were then co-registered using a calibration process in-
corporating magnification, translation and rotation with rigid body transforms. The co-
registered angular projections were then saved as OME-TIFF files on an OMERO (Allan
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Figure 2.2: Schematic of dual projection channel multispectral OPT system used for
imaging juvenile and adult zebrafish.
Figure 2.3: Schematic of the OPT system for imaging zebrafish larvae, mounted in a
horizontal manner using a single sCMOS camera. Figure taken from Correia et al.
(2015).
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et al., 2012) server to enable sharing of these large datasets with remote access across the
internet. This angular projection dataset requires much less storage capacity than the 3-D
reconstructed image stacks. The projection data can subsequently be downloaded and the
3-D image stacks reconstructed on demand. Figure A.1 presents an overview of the data
workflow.
2.8.4 Reconstruction
2.8.4.1 Filtered Back Projection
OPT datasets comprising co-registered sets of angular projections from each sCMOS
camera saved as OME-TIFF files could be directly reconstructed using Filtered Back Pro-
jection (FBP) via a MATLAB (The MathWorks Inc) programme written in-house using
the standard iradon library function, Equation 1.1. The iradon function was performed
using the Hann filter (ramp filter multiplied over the Hann window). FBP reconstruction
ideally requires several 100 angular projections to reconstruct 3-D images without loss of
information using the imaging system reported here. When implemented on a personal
computer with a graphics processing unit (NVIDIA Tesla K40 GPU), this typically takes
a few minutes for a data set with 200 projections that reconstructs to a z-stack of 2000
image planes.
2.8.4.2 Compressive Sensing
For compressive sensing (CS) reconstruction an adapted version of the TwIST algorithm
by Bioucas-Dias and Figueiredo (2007) is used, which is available as a MATLAB code
from http://www.lx.it.pt/~bioucas/TwIST/TwIST.htm. All parameters
we defaulted as in Bioucas-Dias and Figueiredo (2007), unless otherwise mentioned or
optimised.
2.8.4.3 Similarity Measures
Structural similarity index measure (SSIM) is used to determine the correlation between
two images, g and h, rather than traditional methods like mean squared error (MSE) where
the result isn’t seen to concur with the visual quality of the perceived image. SSIM com-
pares the luminance, contrast and structure of two images, through the equation;
SSIM(g,h) =
(2µgµh + c1)(2σgh + c2)
(µ2g +µ2h + c1)(σ2g +σ
2
h + c2)
(2.1)
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where µg,µh,σg,σh and σgh are the means, standard deviations and covariances for the
images and c1 and c2 are regularisation constants. There is a built-in Matlab function,
ssim, that calculates this using default values for regularisation constants, based upon
the work in Wang et al. (2004). It provides an output value between -1 and 1, where 1
represents identical images. The images were converted and scaled to 8-bit grayscale with
a dynamic range of 0-255, for optimal performance with this measure.
2.8.5 Segmentation
A percentile threshold based upon the cumulative frequency graph was applied to both
tumour and vasculature reconstructions. A median filter was applied over a neighborhood
of 5 pixels to the vasculature, before using a multiscale Hessian-based method in MAT-
LAB for vessel enhancement (Frangi et al., 2006; Correia et al., 2015). This determines
the “vesselness”, i.e. the likelihood of each voxel belonging to a vessel, by analysing lo-
cal image structure through a Hessian matrix (H), a square matrix of second order partial
derivatives for a given voxel (I):
H(I) =
∣∣∣∣∣∣∣∣
d2I
dx2
d2I
dxdy
d2I
dxdz
d2I
dydx
d2I
dy2
d2I
dydz
d2I
dzdx
d2I
dzdy
d2I
dz2
∣∣∣∣∣∣∣∣ .
Subsequently, the "vesselness" (likelihood of belonging to a vessel) can be resolved through
calculating the Hessian eigenvalues (λ ), which represent intensity variations for particu-
lar directions (eigenvectors). The three eigenvalues are ordered by magnitude, therefore
|λ1| ≤ |λ2| ≤ |λ3|. If the voxel has one eigenvalue of approximately 0 and the other two
similarly large and negative it is likely a vessel. This is as it is presumed there will be
little or no intensity change along the direction of the vessel but will be in the other di-
rections, whilst incorporating prior knowledge that vessels are bright structures on a dark
background.
The assessment of these eigenvalues is based upon a series of probabilities. Firstly, the
following two ratios:
RA =
|λ2|
|λ3| RB =
|λ1|√|λ2λ3| , (2.2)
that determine the relative relationships between each eigenvalue. If the voxel belongs to
a vessel you would expect a value close to 1 for RA and a low value for RB. Furthermore,
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background noise can be eliminated through the expression:
S =
√
∑
j≤D
λ 2j , (2.3)
as low values would indicate no secondary structure, where D is the image dimension.
These are all applied within the following expression to determine the likeliness that the
voxel analysed belongs to a vessel:
V (s) =
0, if λ2 > 0 or λ3> 0(1− exp(−R2A2α2 ))exp(−R2B2β 2 )(1− exp(−S22c2 )), (2.4)
where α,β and c are chosen to determine the contribution of each element and were used
as previously described in Correia et al. (2015). Importantly, the vesselness is observed
over a range of scales, V (s), to identify different sized vessels. This range is determined
based upon the variation of expected vessel diameters and implemented in calculating the
Hessian matrix. In line with Correia et al. (2015) a scale of 5 was used.
2.8.6 Skeletonisation
Following Hessian- based analysis the vasculature was subjected to a threshold before
being imported into the Amira (FEI) software package. In Amira a 3-D median filter with
a neighbourhood of 6 was used before applying the auto-skeleton tool with no threshold,
10 iterations and “smooth” and “attach to data” coefficients of 0.5 and 0.25, respectively.
2.8.7 Quantification and Visualisation
The tumour volume was quantified through extracting the number of non-zero voxels
in the image within MATLAB. For the vasculature vessel length, volume, diameter and
branching were analysed for the tumour region from the resultant skeleton within Amira.
Vessels with diameter smaller than 26 µm were excluded from the analysis. For visualisa-
tion the final CS-OPT images are presented with the skeletonised and dilated vasculature
to present a binary image with appropriate vessel diameters.
2.9 Statistical Analysis
Statistical analysis of data was performed using InStat (GraphPad) and a 95% significance
level was used for all tests. The Kolmogorov and Smirnov test was used to test for Gaus-
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sian distributions within the sample datasets and the Bartlett test was used to confirm that
the datasets for comparison had equal standard deviations (SDs).
For comparing datasets proven to have a Gaussian distribution and equal SDs one-way
ANOVA followed by the Student Newman Keuls test was used. If datasets for compari-
son were proven to differ from a Gaussian distribution or have significantly different SDs
then the non-parametric ANOVA Kruskal-Wallis test was applied, followed by the Dunn’s
multiple comparison test.
When analysing rates of change linear regression analysis can be performed through
Prism (GraphPad) if the linear function suitably fits the data, which is when r2 > 0.95.
The slopes of each fitted linear regression line are then compared through a two tail un-
paired t test, where P<0.05 was considered significantly different.
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3.1 Introduction
As described in Section 1.4.3, optical projection tomography (OPT) is a 3-D fluorescence
microscopy technique that can provide whole-body mesoscopic imaging of live, transpar-
ent organisms such as zebrafish embryos (McGinty et al., 2011; Andrews et al., 2016).
When researching biological processes and pathologies such as cancer progression and
tumour angiogenesis the use of embryos has considerable limitations. This is due to their
immature body systems, including the vasculature and immune system. Adult zebrafish
are usually pigmented, however the mutant zebrafish described in Section 1.3.1 are
non-pigmented throughout their lifespan and are sufficiently transparent to permit optical
readouts (White et al., 2008; Heilmann et al., 2015). Therefore OPT has the potential to
globally image live, adult zebrafish.
It is important for live, in vivo imaging that the acquisition period is minimal. The
acquisition period required to obtain a sufficient number of projections for FBP recon-
struction of both the tumour and vasculature channels would be greater than 15 minutes.
During image acquisition the organisms require anaesthesia to prevent movement and
stress. However, prolonged periods of anaesthesia cause respiratory and cardiac failure,
as well as increased mortality rates (Sun et al., 2009; Matthews and Varga, 2012).
Furthermore, shorter acquisition periods would result in lower light doses, subsequently
reducing phototoxicity and the chance of fluorescent protein photobleaching. Reducing
the number of projections during imaging would reduce the acquisition period, however
the image quality would be degraded when reconstructing using the conventional filtered
back projection (FBP) algorithm (as described in Section 1.5.1).
It has been shown in Correia et al. (2015) that incorporating compressive sensing
(CS) iterative algorithms (as described in Section 1.5.2) can reconstruct 3-dimensional
(3-D) images of zebrafish embryos with fewer angular projections, whilst retaining the
image quality for quantitative analysis. The CS algorithm two-step iterative shrink-
age/thresholding (TwIST) was used, which had been shown to efficiently converge to
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minimise an objective function in the form of that in Equation 1.3 (Bioucas-Dias and
Figueiredo, 2007). This approach can be used with various denoising problems and has
been shown to work competently with total variation (TV) regularisation (Bioucas-Dias
and Figueiredo, 2007). Using TwIST and TV regularisation as few as 50 projections
could be used for image reconstruction opposed to the densely sampled dataset required
for conventional FBP (Correia et al., 2015). Therefore the acquisition time for embryo
imaging would be significantly reduced.
For these reasons I wanted to incorporate CS iterative algorithms into OPT recon-
struction of adult zebrafish with inducible eGFP-tagged liver tumours and mCherry
labelled vasculature. This would enable minimisation of the acquisition period whilst
maintaining the image quality. Consequently readouts of tumour progression and
angiogenesis could be achieved from live adult zebrafish.
3.2 Experimental Summary
To investigate whether CS reconstruction using the TwIST algorithm could be incorpo-
rated an adult (81 dpf) TraNac Tg(KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV 12) ze-
brafish, as described in Section 1.3.2.2, was induced with 10 mg/L of doxycycline for
3 weeks. I performed OPT imaging of the zebrafish with Dr. Sunil Kumar (Photon-
ics Group, Imperial College London), where 512 angular projections were acquired. I
then reconstructed the oversampled 512 projection dataset with FBP to provide a "ground
truth" reference image, as described in Section 2.8.4.1. This dataset was also under-
sampled to produce datasets of 160, 120, 80, 70, 64, 50, 40, 30 and 20 evenly spaced
projections, for which CS reconstruction was applied and investigated through the TwIST
algorithm, described in Section 2.8.4.2. Following CS reconstruction I segmented both
tumour and vasculature images as described within Section 2.8.5 and I skeletonised the
vasculature as described in 2.8.6. The similarity between reconstructions and the refer-
ence images was quantified using the structural similarity index measure (SSIM), Section
2.8.4.3.
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3.3 Results
3.3.1 Algorithm parameters
Within the CS TwIST algorithm there are two key parameters that require optimisation.
These are the number of TV minimisation iterations (TVit), to minimise Equation 1.4,
and the regularisation parameter, which controls the level of TV regularisation within the
main algorithm (τ in Equation 1.3). It is important to determine the optimal parameters
that will result in a high quality reconstruction, which preserves detail and minimises the
loss of information, within a reasonable amount of time.
Previously 64 projections were sufficient for 3-D CS reconstruction of an OPT im-
aged TraNac Tg(KDR:mCherry) zebrafish embryo, producing high vascular detail for
quantitative analysis (Correia et al., 2015). Therefore, the undersampled 64 projection
dataset of the adult zebrafish was used to optimise TVit and τ . As the image would only
improve with the number of TVit the highest value used in Correia et al. (2015), 40, was
firstly used to optimise τ through assessing the SSIM value when compared to the 512
FBP reference image. Once the value for τ had been established optimisation of TVit
was performed to determine the lowest number of iterations required without introducing
noise.
Cross-sectional x− z reconstructions of the vasculature channel can be seen in Fig-
ure 3.1. The FBP reconstructions for the reference 512 projection dataset and the
undersampled 64 projection dataset are shown within Figure 3.1a, where the white
arrowheads highlight the level of noise that results when the sample rate of projections
is lower than the Nyquist limit. Within the 512 FBP reference image key vascular detail
to be retained during CS reconstruction can be observed, including the lateral cutaneous
vessel (LCV) and unidentified vessels (UI). Figure 3.1b shows the same cross-sectional
reconstruction with 64 projections using CS reconstruction with varying values of
τ , when TVit set to 40. As expected, increasing the value of τ caused an increased
smoothing through denoising. The level of smoothing required would remove noise but
retain important vasculature detail evident in the reference image. When using τ of 0.001
streak artefacts are present within the reconstruction, which are absent at higher tested
values. Values of τ ≥ 0.008 show a loss of contrast within the zebrafish cross-section and
a loss in key vasculature detail. This is reflected within the SSIM values, shown in the
top right hand corners within Figure 3.1b, where individual reconstructions are compared
to the 512 FBP reference image. The SSIM value is largest when τ = 0.004 with a
72
CHAPTER 3. REDUCING OPT ACQUISITION TIME
value of 0.9594. Therefore τ = 0.004 was considered optimal and was used to determine
the lowest value of TVit , Figure 3.1c. All reconstructions resulted in high SSIM values
greater than 0.95, where only small increases occurred with higher values of TVit . No
discernible differences were seen between reconstructions using TVit ≥ 10 and above,
however reconstructing with the lower value of TVit = 5 noise and streak artefacts were
introduced, as indicated by the white arrows in Figure 3.1c. Therefore, the optimal values
for vasculature reconstruction were τ = 0.004 and TVit = 10, where reconstruction took
754 ms for this cross-section.
Optimisation was performed on the tumour channel reconstructions using the same
tested values for τ and TVit , Figure 3.2. Once again Figure 3.2a shows the FBP
reconstructions for the reference 512 projection dataset and the noisy undersampled 64
projection dataset. The 512 FBP image shows the known lobed structure of the liver,
where the right lobe (RL), central lobe (CL) and left lobe (LL) are annotated. However,
some scatter artefacts are also seen despite utilising the oversampled dataset (white
arrowhead). Figure 3.2b shows reconstructions with various τ when TVit was set to
40. A value of τ =0.015 was considered optimal due to having the highest SSIM value.
Once again this reflected the images as τ =0.004 had a reduced background compared to
τ =0.008 and maintained detail lost in τ =0.02. When reconstructing with τ set to 0.015
a value of 25 for TVit was optimal, as the streaks were reduced and further iterations
did not introduce discernible differences or significantly increase the SSIM value, Figure
3.2c. Reconstructions of this tumour cross-section with the optimised parameters took
942 ms.
The reconstructions completed in Figures 3.1 and 3.2 had the maximum number of TwIST
iterations (MaxiterA) within the main algorithm set to a value of 10. This was to ensure
the reconstructions were not too time consuming. To confirm that 10 iterations were an
adequate number to allow convergence the same vasculature and tumour cross-sections
were reconstructed using the default value of MaxiterA = 1000 for comparison. In both
cases there were no differences between the two images, Figure A.2. Therefore we can
accept that a value of 10 for MaxiterA is adequate to enable convergence of both the
vasculature and tumour channels when using the optimised τ and TVit values.
3.3.2 Analysing the number of projections
Once the algorithm parameters were optimised CS reconstruction using TwIST could be
applied to the evenly spaced undersampled datasets consisting of 120, 80, 70, 64, 50, 40,
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(a)
(b)
(c)
Figure 3.1: Optimising the TwIST parameters τ and TVit for the vascula-
ture channel (561nm) using cross-sectional reconstructions of an adult TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12) zebrafish. Images are repre-
sented as heat maps, where red indicates high fluorescence intensity and blue low.
(a) shows the FBP reconstructions with the over sampled 512 projections, acting as a
reference image, and the under sampled 64 projections (as indicated in the top right
hand corner of the images). Key vascular features have been annotated including the
lateral cutaneous vessels (LCV) and unidentified vessels (UI). (b) shows optimisation
of τ when the value of TVit is set to the high value of 40 and (c) shows optimisation of
TVit with the optimised value of τ = 0.004, when reconstructing the undersampled
64 projections using the TwIST algorithm. SSIM values of the images compared to
the reference 512 FBP image are shown in the top right hand corner in (b) and (c).
Arrows indicate scatter artefacts. Scale bar 1 mm.
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(a)
(b)
(c)
Figure 3.2: Optimising the TwIST parameters τ and TVit for the tumour
channel (488nm) using cross-sectional reconstructions of an adult TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish. Images are repre-
sented as heat maps, where red indicates high fluorescence intensity and blue low.
(a) shows the FBP reconstructions with the over sampled 512 projections, acting as a
reference image, and the under sampled 64 projections (as indicated in the top right
hand corner of the images). The lobed structure of the zebrafish liver can be seen,
where the right lobe (RL), central lobe (CL) and left lobe (LL) have been annotated.
(b) shows optimisation of τ when the value of TVit is set to the high value of 40 and
(c) shows optimisation of TVit with the optimised value of τ = 0.015, when recon-
structing the undersampled 64 projections using the TwIST algorithm. SSIM values
of the images compared to the reference 512 FBP image are shown in the top right
hand corner in (b) and (c). Arrows indicate scatter artefacts. Scale bar 1 mm.
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30 and 20 projections. Therefore, the trade-off between the reconstructed image quality
and number of angular projections acquired could be investigated in order to reduce the
acquisition time of OPT.
Initially the same 2-dimensional cross-sections for the vasculature and tumour
channels as previously used for parameter optimisation were analysed and compared
to the corresponding 512 FBP reference reconstructions. As expected it was clear that
the fewer projections used the greater the streaking artefacts and the CS reconstructions
with the greatest number of projections were the most similar to the reference images,
Figure 3.3. Discernible differences were seen with 30 projections or fewer for the
vasculature images and with 20 projections for the tumour images, where blocky effects
were strongly depicted. Although streak artefacts and noise were seen within the other
reconstructions with various projection numbers it was unclear as to whether these
could influence the final processed images and subsequent conclusions. Therefore it was
important to quantify this in the context of a processed 3-D reconstruction of the tumour
burdened zebrafish to determine the level of undersampling achievable for our purposes.
The 3-D CS reconstructions of the undersampled datasets were segmented and the tumour
regions were analysed. The quantification SSIM was used to determine the fidelity of
the reconstructions to the full 512 projection FBP reconstruction reference image. The
relationship between the SSIM and the number of projections differed slightly between
the tumour and the vasculature channels, Figure 3.4. The SSIM for the tumour channel
was consistently higher, which was to be expected considering the detail was less
intricate. It is also a simple, smooth relationship where the SSIM always increased with
projection number. This was unlike the vasculature where particular reconstructions had
slightly greater similarity to the reference image than those reconstructed with a greater
projection number. For example, 70 projections yielded a greater SSIM of 0.8599 than
80 projections with 0.8562. It is possible this was a result of selecting evenly spaced
projections when undersampling, where different projections were incorporated in the
different undersampled reconstructions. Particular projection angles could have captured
greater vascular detail than others to produce this effect, which wouldn’t be seen within
the tumour channel due to being a more consistent, larger entity.
The SSIM as a function of projection number did not plateau to unity, Figure 3.4.
This is a result of both artefacts being present within the reference images and denoising
loosing the finer image details. Both reference cross-sectional images within Figure
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(a)
(b)
Figure 3.3: Cross-sectional reconstructions of an adult TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) using FBP for 512 projec-
tions (512 FBP) as a reference image or the TwIST algorithm with a different
number of angular projections (as indicated in the top right hand corner) for (a) the
vasculature channel and (b) the tumour channel. Images are represented as heat
maps. Arrowheads indicate scatter artefacts. Scale bar 1 mm.
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Figure 3.4: Quantitative analysis of fidelity for TwIST reconstructed images from
undersampled datasets to the reference 512 FBP image. The SSIM is used as a func-
tion of the number of angular projections for tumour and vasculature channels.
3.3 have artefacts, as indicated by the white arrowheads. As a consequence of CS
reconstruction the artefacts are removed during image denoising, therefore the images
will never be identical. Denoising smooths the images in order to reduce the artefacts
within the images, which results in finer details being lost that are unable to be recovered,
independent of projection number. Due to the vasculature channel comprising of finer
detail, compared to the tumour channel, this is more heavily affected, which is likely why
the SSIM plateau occurs at a lower SSIM.
Despite the difference in SSIM values both channels plateaued at approximately
60 projections, Figure 3.4. This was seen to be in accordance to the cross-sectional
reconstructions of Figure 3.3, where upon closer inspection the introduction of streak
artefacts did progressively increase when fewer than 64 projections were used. For these
reasons it was believed that reconstructing 64 projections with the TwIST algorithm
would be the minimal number of projections sufficient to provide a true representation of
the reference image. The tumour region reconstruction for the reference image and 64
projection CS reconstruction can be seen in Figure 3.5. The images are highly similar
and have SSIM values of 0.8695 and 0.9503 for the vasculature and the tumour channels,
respectively. Therefore it could be accepted that this level of undersampling is adequate
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to provide a true representation of the tumour region.
To further highlight the capabilities of CS reconstruction recovering the loss of informa-
tion when using only 64 projections, the fluorescence intensity images for the whole adult
tumour burdened zebrafish were analysed, Figure 3.6. The reference FBP reconstruction
with the full 512 projections is shown in Figure 3.6a. It is evident how this image is de-
graded when only 64 projections are used to reconstruct with FBP in Figure 3.6b. When
utilising the TwIST algorithm in CS reconstruction for the same 64 projections the loss of
information due to noise in the image was minimised, Figure 3.6c. Following reconstruc-
tion, the 3-D image stacks were segmented and skeletonised to produce binary images of
the vasculature. Figure 3.6d shows the “vesselness” of this 3-D dataset visualised after
the Hessian-based analysis and Figure 3.6e shows the “final” segmented image following
skeletonisation and dilation of the vasculature. Rendered 3-D images of these correspond-
ing figures are shown in Video 1. Therefore, acquiring as few as 64 projections using OPT
was sufficient for whole organism imaging when using CS reconstruction, which would
reduce the acquisition time to less than 3.5 minutes.
3.4 Discussion
It was important to reduce the acquisition time of OPT when performing live, in vivo
imaging to reduce both the anaesthesia period and light dose experienced by adult
zebrafish. This has been achieved through applying the CS algorithm TwIST, which was
previously used to reconstruct a zebrafish embryo from undersampled datasets (Correia
et al., 2015). As a result far fewer projections can be acquired and the undersampled
dataset can be reconstructed to an adequate quality where there is a minimal loss of
information.
In order to reconstruct using the TwIST algorithm optimisation of key parameters
was required. Firstly the optimal level of denoising was determined to ensure artefacts
were removed but detail was retained. This was achieved through optimising the regular-
isation parameter τ to be 0.004 and 0.015 for the vasculature and tumour reconstructions,
respectively. It was beneficial to find the minimal number of TV minimisation iterations
during denoising where no reduction in image quality was seen, as this is a computa-
tionally time intensive element. For the vasculature and tumour channels, respectively, I
found 10 and 25 iterations sufficient taking 754 ms and 942 ms. Furthermore, 10 TwIST
iterations were confirmed sufficient for algorithm convergence. OPT projections of adult
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Figure 3.5: 3-D reconstructions of adult TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TRE- eGFPKRASV12) zebrafish after tumour induction using FBP and CS. (a)
An individual OPT projection fluorescence intensity image of the tumour excited at
488 nm. (b,c) Reconstructions of the tumour and vasculature (post segmentation) in
the region indicated by dotted lines using (b) FBP with 512 Projections and (c) CS
with 64 projections respectively.
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Figure 3.6: Reconstructed OPT images of adult TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TRE- eGFPKRASV12) zebrafish expressing liver specific eGFP-labelled tumour
and mCherry-labelled vasculature showing maximum intensity projections of eGFP
(green) and mCherry (red) fluorescence. (a) and (b) show FBP reconstructed images
computed with 512 and 64 projections respectively, (c) shows the corresponding im-
age reconstructed from 64 projections using the CS-OPT approach, (d) shows the
“vesselness” of the same reconstruction and (e) shows the “final” segmented image
of the vasculature. Scale bar = 2.5 mm. See Video 1 for corresponding 3-D anima-
tions.
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fish are approximately 2000 pixels along the y-axis. As a result TwIST reconstruction of
the whole adult, tumour burdened zebrafish with these optimised parameters would be
performed in under 30 mins per channel, which is an acceptable computational time.
Consequently, I analysed TwIST reconstruction with undersampled datasets to in-
vestigate image quality and number of angular projections through assessing both
cross-sectional and 3-D reconstructions. The cross-sectional images highlighted the
finer detail that would not be seen through 3-D reconstruction. It is clear that the fewer
projections used to reconstruct the greater the block effects in the images. This is as TV
regularisation tends to lead to blocky effects, known as the staircasing effect (Chan et al.,
2005). The quantification SSIM was used to further determine where the undersampling
limit lies through analysing the correlation between the undersampled and reference 3-D
images. This measure accounts for luminance, contrast and structure of the image and
results in a value that concurs with the visual quality of the perceived image, opposed
to traditional measures such as mean squared error (MSE) (Wang et al., 2004). The
SSIM and image quality both fall when using less than 60 projections, which is seen
to a greater extent in the vasculature reconstructions. The sudden decline in SSIM
value is likely due to a loss of the finer vasculature detail within the images, where it
becomes more difficult to distinguish them from the residual noise once a certain level of
undersampling is encountered. As a result denoising does not work efficiently at these
levels with our chosen, optimised parameters. The decline does not occur as strongly
within the tumour channel. The tumour fluorescence signal is a simple structure in
comparison to the vasculature, consisting of a single solid element. Consequently, the
tumour signals would be sparser than the vasculature within the compressible gradient
domain used for denoising. As a result they would be less prone to image degradation
with a greater degree of undersampling. For these reasons 64 projections were chosen
for CS reconstruction using the TwIST algorithm with the chosen parameters. I proved
this was sufficient for a true representation of the reference image through providing
SSIM values greater than 0.85 in the tumour region for each channel and highlighted
its capabilities for the entire fish. Therefore, the total number of angular projections
required for compressive sensing optical projection tomography (CS-OPT) would be
reduced 8-fold compared to the reference FBP image. Subsequently the imaging pe-
riod would be reduced to less than 3.5 minutes and drastically improve zebrafish viability.
Reducing the acquisition time to such a degree provides the opportunity for further
imaging avenues as well as improving zebrafish viability. For example, additional
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fluorophores or Förster Resonance Energy Transfer (FRET) biosensors could be incor-
porated into the zebrafish tumour model and imaged using CS-OPT. FRET biosensors
are devices that enable physiological interactions to be determined, indicating specific
cellular physiology, through providing a readout based upon the proximity of two or more
fluorophores (Clegg, 1995; Kiyokawa et al., 2006). FRET interactions can be measured
through Fluorescence Lifetime Imaging Microscopy (FLIM), where the fluorescence
lifetime of one of the fluorophores is measured to provide ratiometric, robust readouts.
We have previously shown the ability to quantitatively image FRET biosensor activity
within live zebrafish embryos using FLIM-OPT (McGinty et al., 2011; Andrews et al.,
2016). It is possible that the additional time resulting from CS-OPT could enable FLIM
imaging within the whole, live adult organism. However, greater image detail may be
required to detect this.
The CS-OPT system is not limited to a minimal number of 64 projections and if
required the number of projections could be further reduced. Greater regularisation and
further optimisation of the parameters τ , TVit and MaxiterA, could help maintain the
desired image quality at the expense of reconstruction time. However, the image quality
would be limited, due to missing information with a reduced projection number. It is also
possible that different sets of projections could result in better reconstructions. This is a
property that could explain the relationship between the number of angular projections
and the SSIM value within the vasculature channel. Throughout the performed experi-
ments the undersampled datasets consisted of evenly spaced projections throughout the
entire 360◦ of the zebrafish. It is possible that particular projections could have captured
greater vasculature detail. Therefore, it is plausible that the acquired projections could be
chosen dependent upon the area of interest. For example, if tumour physiology alone was
of interest it may be beneficial to have a greater proportion of the projections acquired at
angles on the side of the zebrafish encompassing the tumour.
Decreasing acquisition time through utilising compressive sensing will always re-
sult in a loss of information that cannot be recovered. Therefore, other methods could be
considered. Additional arms could be implemented within the OPT imaging instrumen-
tation, which would enable multiple images to be captured simultaneously. However,
this may be impractical due to spatial availability and would increase the cost of the
system. Another option would be to increase in the imaging speed of the OPT system.
During acquisition the imaging chamber containing the zebrafish is rotated to enable
multiple images to be captured at different angles. The rotational speed of the chamber
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could be increased, however the rotational pull would increase and this would result
in the zebrafish moving within the imaging chamber during acquisition, subsequently
introducing motion artefacts into the reconstructions. A possible option to overcome
this would be to mount the zebrafish within the imaging tube and prevent any possible
movement. Previous studies using OPT imaging have embedded samples within agarose
to prevent this issue, however the samples were sacrificed prior to imaging (Sharpe et al.,
2002; Sharpe, 2003; McGinty et al., 2011; Correia et al., 2015). To enable live adult
zebrafish imaging this is not a feasible option, crucially as the gills are essential for
oxygen uptake and ionoregulation and agarose would prevent these from functioning
(Rombough, 2002). It is possible that, with substantial research to ensure health is not
affected, one part of the zebrafish could be embedded within agarose to hold it in place,
such as the tail fin. In practice mounting the fish prior to imaging and then removing the
agarose afterwards are likely to be timely procedures and consequently the anaesthesia
period required may be increased rather than reduced. A further possibility would be to
adjust the water within the imaging capsule so that it is more viscous, therefore reducing
the rotational pull. There are no known agents that can be used with live zebrafish
and so if this were to be implemented it is once again critical that extensive research is
performed to ensure the chemical agent used is not toxic and does not affect the imaging
performance.
Using CS reconstruction for OPT imaging of an adult zebrafish is a novel applica-
tion and zebrafish differ significantly between embryonic and adult lifeforms. One of
the most crucial differences is the difference in their optical properties, where there
is increased light scatter within the adult organism. This is a result of their internal
pigmented organs, increased size and the remaining chromatophore development.
Furthermore, the embryonic physiology is significantly different to the fully developed
adult organism. The previous implementation of CS reconstruction of the zebrafish
embryo in Correia et al. (2015) also used mCherry labelled vasculature. As shown within
Figure 1.6 the vasculature is far more complex within the adult organism. With these
significant physiological differences it was unknown as to whether undersampling would
result in a too greater loss of information for recovery through CS reconstruction and if it
did not to what extent it could be achieved.
Through optimisation of the parameters of the TwIST algorithm and the number of
projections used for reconstruction I have shown that this CS-OPT approach using the
TwIST algorithm is attractive for in vivo imaging. I have shown that 64 projections
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of both vasculature and tumour fluorescence are sufficient when using CS-OPT. This
reduction in the number of projections is 8-fold compared to our reference image and
5-fold compared to the previous 360 projections used in McGinty et al. (2008, 2011).
Consequently, the acquisition time is reduced to less than 3.5 minutes and the zebrafish
receive lower light doses and are anaesthetised for reduced periods of time. This increases
their viability and reduces their chances of respiratory and cardiac failure (Sun et al.,
2009; Matthews and Varga, 2012). Therefore, CS-OPT can enable the use of longitudinal
studies of tumour progression and angiogenesis within adult organisms with improved
accuracy through live, whole organism, 3-D imaging.
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Quantitative Analysis of Tumorigenesis and Angiogenesis
using CS-OPT
4.1 Introduction
Deregulation of angiogenesis results in many pathologies, particularly cancer where it is
crucial for tumour progression and provides a possible route for metastasis. Therefore,
this is a potential therapeutic target and understanding the underlying physiology and
mechanisms in vivo is of interest.
The developed compressive sensing optical projection tomography (CS-OPT) plat-
form described in Chapter 3 is capable of globally imaging fluorescent reporters of
vascularisation and tumour growth in live adult zebrafish. It has the potential for
longitudinal applications to study physiological and pathophysiological events. When
studying tumorigenesis and angiogenesis it is desirable to achieve quantitative readouts
as well as qualitative 3-dimensional (3-D) images. Quantifications enable accurate
analysis and statistical testing to understand relationships and confirm hypotheses. This
is crucial when determining drug efficacy and for performing mechanistical studies on
gene function.
The tumour angiogenesis zebrafish model TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12), described in Section 1.3.2.2, has an inducible, eGFP
tagged liver tumour and a mCherry labelled vasculature. Consequently this model
zebrafish provides fluorescent readouts of both tumour progression and regression, with
the corresponding vasculature changes. Therefore, using the novel CS-OPT platform in
combination with this model could enable 3-D quantifications of tumour progression and
angiogenesis within a whole, adult organism.
During tumour growth and progression angiogenesis is stimulated through both
hypoxic and non-hypoxic mechanisms, as described in Section 1.2.2. Additional modes
of angiogenesis are used within the context of cancer and the resulting tumour vasculature
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differs from physiological vessels, as mentioned in Section 1.2.3. Quantitative measures
of angiogenesis previously used within other angiogenic assays (Section 1.1.4) such as
vessel number, branching, length, diameter and density could be analysed from CS-OPT
images.
It is important to determine that the extracted CS-OPT quantifications are accu-
rate for future studies and they truly represent the biological processes occurring in
vivo within the model zebrafish. Using histopathology the inducible liver specific
eGFPKRASV12 driven tumour model has previously been shown to produce liver
hyperplasia that progresses to hepatocellular carcinoma (HCC) with inducer treatment
and tumour shrinkage upon inducer withdrawal (Nguyen et al., 2012). Therefore,
histopathological analysis can be performed to confirm tumour growth and progression.
However, in order to validate the extracted angiogenic measures a well established
technique is required for comparison, such as immunohistochemistry (IHC). From
corresponding 2-dimensional (2-D) sections IHC can be used to specifically stain for the
tumour vasculature. Comparing the two analyses will provide validation.
Within this Chapter I analyse the overall performance of the CS-OPT system with
regards to image quality and the zebrafish model organism. I have extracted quantifica-
tions that can be used for measuring tumour progression and vascularisation, which I have
also confirmed and validated using histopathology and IHC. Therefore, I demonstrate
that the CS-OPT platform would be suitable for both mechanistic and drug development
studies.
4.2 Experimental Summary
I performed all CS-OPT imaging with Dr. Paul Frankel and Dr. Sunil Kumar (Photonics
Group, Imperial College London). Acquired images were then reconstructed using the
TwIST algorithm, segmented, skeletonised and analysed by myself. For methods details
see Section 2.8.
In initial preliminary studies 8 adult (122 days post fertilisation (dpf)) TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish (Section 1.3.2.2) were
treated for 1 week with 10 mg/L of doxycycline. These were then imaged using CS-OPT
to determine the performance of the platform. 5 female and 3 male zebrafish were used.
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Once the requirements for optimal CS-OPT imaging of adult tumour burdened ze-
brafish were determined from the preliminary study an in vivo cross-sectional study
of tumour and vasculature development was performed. Adult (145 dpf) TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish were housed within fish
water comprising of 68 mg/L of Tropic Marin R© Sea Salts dissolved in deionised water
with the addition of 10 mg/L doxycycline. Images were acquired after 1, 2 and 3 weeks
of treatment and after a 4th week where the doxycycline had been withdrawn. Each
group contained at least 8 zebrafish and CS-OPT was performed with the acquisition of
64 projections.
MATLAB was used for segmentation, tumour quantification and vasculature skele-
tonisation. Amira (FEI) was also used for vasculature skeletonisation, subsequent
quantification and all image visualisation. For tumour quantifications n ≥ 8 and for
vasculature quantifications n ≥ 5 for each study group. To confirm tumour progression
and validate CS-OPT derived quantifications the zebrafish were sacrificed after imaging
and the tumours were removed, formalin-fixed, paraffin-embedded (FFPE) and subjected
to histological analysis (Section 2.5). Hematoxylin and Eosin (H&E) staining of n ≥
6 FFPE tumour tissues for each study group was performed by IQPath (Institute of
Neurology, UCL) and used to confirm what was previously reported by Nguyen et al.
(2012). IHC was performed on n ≥ 3 FFPE tumour tissues for each group using the
antibodies within Table 2.5. I optimised IHC staining and subsequent IHC stains were
performed by IQPath (Institute of Neurology, UCL). The resultant stained slides were
quantified by myself and Dr. Matthew Ellis (Institute of Neurology, UCL) as described
in Section 2.6.
4.3 Results
4.3.1 Preliminary acquisitions of adult zebrafish
In initial studies TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish
were imaged using CS-OPT to ascertain the performance of the platform with regards to
image quality. The fish were immersed in 0.75x MS-222 solution for 2 minutes prior to
imaging, when they were then immersed in 1x MS-222 solution. During the acquisitions
this was altered to 2 minutes prior to acquisition in 1x MS-222 due to the fish recovering
from anaesthesia and moving within the imaging chamber. Despite this alteration the
zebrafish were still seen to move over the acquisition period, either through incomplete
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anaesthesia, slipping within the imaging capsule or being affected by the speed of
rotation whilst capturing the projections. Any movement within acquisition results in
inaccurate image reconstructions, rendering the projection set useless. The fluorinated
ethylene propylene (FEP) tubing was altered so that the base of the tube was angled. This
restricted zebrafish placement within the tubing and prevented rotational movement and
slippage during image acquisition.
When observing the acquired projections key requirements were determined. Firstly,
strong auto fluorescent signals were observed in the gut of fed zebrafish when excited
at both 488nm and 561nm, Figure 4.1a. Different food sources were trialled, including
the sole use of brine shrimp or hikari protein pellets, but none reduced the fluorescence
signal observed. Only when the zebrafish had been starved 24 hours prior to imaging was
this problem rectified, Figure 4.1a.
It was also clear that the individual eggs within the female zebrafish were visible
at both excitation wavelengths, as highlighted with the red arrow in Figure 4.1b. The
eggs are visible within the non-pigmented female zebrafish by eye (Figure 1.5) and
therefore have a different refractive index to the rest of the body, FEP tubing and water.
This would lead to an increase of scattering. The fluorescence signal within this region
of the fish appears greater than in the males, this also indicates the eggs have a level of
auto-fluorescence.
Zebrafish with homozygous KDR:mCherry vasculature, KDR:mCherry+/+ , have a
more intense fluorescence signal compared to the heterozygotes, KDR:mCherry+/- ,
Figure 4.1c. Due to the increased signal intensity of the vessels the KDR:mCherry+/+
zebrafish would be faster to image and reconstructions would have better accuracy and
detail. Therefore, for future OPT imaging male, KDR:mCherry+/+ zebrafish, that have
been starved for 24 hours prior to acquisition, will be used.
4.3.2 Quantifying tumour growth and vascularisation with CS-OPT
Analysis of tumour progression and angiogenesis with CS-OPT was determined through
an in vivo cross-sectional study. The groups imaged after 1, 2 and 3 weeks of doxycycline
induction showed tumour progression and the final group of 3 weeks induction followed
by one week of no inducer showed the tumour regression known of this model, Figure 4.2
and Video 2. Qualitative changes in tumour vasculature are also observed, where there is
a greater tumour coverage and an increased amount of branching after 3 weeks of tumour
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Figure 4.1: Fluorescent properties of adult TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TRE- eGFPKRASV12) zebrafish excited at 561nm. (a) Individual OPT pro-
jections of fed and starved zebrafish indicating auto fluorescence in the gut of fed
zebrafish. (b) Individual OPT projections of female and male zebrafish indicating
light scattering in abdomen due to eggs within the female (indicated by arrow). (c)
Widefield fluorescence microscopy images of heterozygous (KDR:mCherry(+/-)) and
homozygous (KDR:mCherry(+/+)) zebrafish.
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induction, which is subsequently lost upon tumour regression, Figure 4.2c and Video 3.
The vasculature extending up to ∼1.7 mm into the fish has been reconstructed, as seen
within in Figure 4.3 and Video 4 where the vasculature colocalised with the tumour is
coloured orange.
To quantify tumorigenesis the tumour volume was calculated for all fish within each of
the study groups. I calculated the number of non-zero voxels within the tumour channel
image after reconstruction and segmentation. A significant increase in tumour volume
was observed between 1 and 3 weeks of tumour induction, as well as a significant
decrease between 3 weeks treatment and the 1 week of inducer removal, Figure 4.4.
A degree of variability was observed within each study group due to genetic variation
between the individual zebrafish.
In order to determine angiogenic measures skeletonisation of the segmented vasculature
was required to extract information for analysis. Skeletonisation and the subsequent anal-
ysis was initially performed using modified versions of the MATLAB functions Skele-
ton3D and Skel2Graph3D written by Philip Kollmannsberger (available on the MATLAB
file exchange (urlhttp://uk.mathworks.com/matlabcentral/fileexchange/authors/382138)
(Kerschnitzki et al., 2013). The skeletonisation functioned used an iterative thinning
approach, whereby the boundary points of the object are repeatedly removed until only
single connected voxels remain. Skel2Graph3D was used to produce an adjacency
matrix of all the branch points of this skeleton and the distance between them. The
skeleton produced mapped well to the segmented vasculature, Figure A.3a, however
Skel2Graph3D did not accurately depict the correct vessels and branch points as some
regions lacked connection and others had incorrect nodes, Figure A.3b. To create a
cleaner skeleton iterations of Graph2Skel3D (also written by Philip Kollmannsberger)
were performed along with Skel2Graph3D. The stopping criteria for these iterations was
when all branch points identified had greater than 2 emanating branches, therefore only
true branches were depicted. This worked well for a subregion of vasculature shown
in Figure A.3c, where the resulting image mimicked the original image in Figure A.3a.
However, when analysing the entire tumour region the algorithm did not complete, even
when left to compute for several days. Due to its time intensive nature this approach was
not suitable for vasculature analysis.
The software package Amira (FEI) was subsequently used to skeletonise and extract
quantifications of vascular properties from the CS-OPT images. Once the segmented
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Figure 4.2: Representative CS-OPT reconstructions of the eGFP-labelled tumour
and mCherry-labelled vasculature in adult TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TRE- eGFPKRASV12) zebrafish. Data was acquired following 10 mg/L doxy-
cycline treatment at 145 dpf after one, two and three weeks of treatment and after
three weeks of doxycycline treatment plus a further week with no treatment. (a)
shows whole zebrafish (scale bar = 5 mm); (b) the tumour alone and (c) with the
segmented tumour vasculature (scale bar = 2 mm). See Videos 2 and 3 for corre-
sponding 3-D animations.
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Figure 4.3: Representative CS-OPT reconstructions of eGFP-labelled tumour
and the colocalised mCherry-labelled vasculature in adult (145 dpf) TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish. Data has been ac-
quired following doxycycline treatment after (a) one, (b) two, (c) three weeks of
treatment and (d) after three weeks of doxycycline treatment plus a further week
with no treatment. (e) and (f) are representative cross-sections showing tumour and
vasculature from the reconstructed volume shown in (c) indicated by dotted lines 1
and 2 respectively. Red indicates vasculature ‘outside’ the tumour, orange indicates
vascular ‘inside’ the tumour and green is the tumour. Scale bar 2 mm. See Video 4
for fly-through animations corresponding to the images in (a)-(d).
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Figure 4.4: CS-OPT quantifications of tumour volume from the in vivo cross-
sectional study using adult (145 dpf) TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish. Data was acquired following doxycycline treatment after
one, two and three weeks of treatment and after three weeks of doxycycline treat-
ment plus a further week with no treatment. Graph plots the corresponding varia-
tion of the mean tumour volume, for which n≥8 at each condition and the error bars
represent the standard error of the mean (SEM). **p<0.01 as indicated by lines.
CS-OPT images were imported into Amira a 3-D median filter with a neighbourhood
of 6 was applied to remove residual noise, Figures A.4a and A.4b. The auto-skeleton
tool was then applied to produce a skeleton using no threshold, 10 iterations and
“smooth” and “attach to data” coefficients of 0.5 and 0.25, respectively. From this
skeleton the location, length, diameter and branching information for every individual
vessel can be extracted. The resultant skeletons clearly mapped to the CS-OPT images
well and with the chosen parameters there were no incorrect nodes or connections,
Figure A.4c. Expanding the extracted skeleton to correspond to the calculated diameter
for each voxel of the vessel shows its accuracy, Figure A.4d. The time taken for these
processes to be accurately completed for the entire adult zebrafish was within 15 minutes.
Key markers of angiogenesis include vessel branching, length, diameter and per-
cent tissue vascularisation. I analysed these for the tumour region of 5 CS-OPT images
from each group of the in vivo cross-sectional study. Any vessels with a diameter or
length less than 26µm, the known resolution of the CS-OPT platform, were excluded
as noise. The mean angiogenic branching and percent tumour vascularisation for the
tumour region, Figures 4.5a and 4.5b respectively, showed a significant increase during
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the tumour progression period from 1 week to 3 weeks of treatment with doxycycline.
Both also had a significant reduction during tumour regression once the inducer was
removed. No significant differences were seen in mean vessel length or diameter, Figures
4.5c and d. Once again variability was observed for all angiogenic markers between
individual fish within each of the study groups due to genetic variation.
4.3.3 Validating CS-OPT quantifications
It is important to determine that the quantifications drawn from CS-OPT truly represent
the physiology of both the tumour and the vasculature. Therefore, validation with
previously established techniques was required.
To assess tumour progression FFPE tissue sections from each of the study groups
were analysed in collaboration with pathologist Professor Sebastian Brandner (Institute
of Neurology, UCL) using H&E staining, Figure 4.6. The tumours are seen to be pro-
gressing from a hyperplastic liver, where there has been an increase in cell proliferation,
towards a HCC phenotype. This is characterised by densely packed cells with high
nuclear to cytoplasmic ratio, prominent nucleoli, reduced area of glycogen and lipid
storage, increased mitosis and rosette like structures surrounding dilated bile canaliculi,
Figure 4.6c. The samples taken after removing the inducer show a proportion of shrunken
cells with intense eosinophilic cytoplasm and dense purple nuclear staining indicating
chromatin condensation, which are features indicative of apoptosis, Figure 4.6d. This
confirms what has been previously described for this eGFPKRASV12 driven tumour
model within the zebrafish by Nguyen et al. (2012).
For analysing the vasculature within the zebrafish liver tumours IHC was performed,
however specific staining of zebrafish endothelial cells had not previously been possible.
Numerous different endothelial markers (vWF, eNOS, CD31 and ERG) were trialled
with different antigen retrieval techniques. This was without success as non-specific
staining was seen in all cases, as summarised and shown within Table 4.1 and Figure A.5.
Through discussions with Roberto Mayor (UCL) an mCherry antibody was identified
that had been used previously and did not cross-react with the eGFP fluorophore, which
is highly similar in protein structure to mCherry with a Protein BLAST E-value of 9e-20
(https://blast.ncbi.nlm.nih.gov/Blast.cgi). When using citrate buffer
antigen retrieval and the mCherry antibody at 1:200 concentration specific staining of the
zebrafish endothelial cells within the tumour was achieved. There was no background or
cross reaction with the eGFP fluorophore within the zebrafish liver tumour, Figure 4.7.
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Figure 4.5: CS-OPT quantifications of vascular properties from the in vivo cross-
sectional study using adult (145 dpf) TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish. Data was acquired following doxycycline treatment after
one, two and three weeks and also after three weeks of doxycycline treatment plus
a further week with no treatment. Graphs plot the (a) mean number of tumour
vessel branch points, (b) percent tumour vascularisation (proportion of vasculature
volume within tumour volume), (c) mean tumour vessel length and (d) mean tumour
vessel diameter, for which n≥5 at each condition and the error bars represent the
standard error of the mean (SEM). *p<0.05, **p<0.01 as indicated by lines.
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Figure 4.6: Induction and progression of HCC in adult (145 dpf) TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish from the in vivo cross-
sectional study. Images of H&E stained representative tumour sections following tu-
mour induction for (a) one week, (b) two weeks, (c) three weeks and (d) three weeks
of tumour induction plus a further week after removal of inducer treatment. White
arrowheads highlight the cells with high nuclear to cytoplasmic ratio and prominent
nuclei, grey arrows mitotic cells and white arrows rosette like structures with dilated
bile canaliculi, all features of HCC. Black arrowheads indicate apoptotic cells that
are shrunken with intense eosinophilic staining and condensed chromatin and black
arrows indicate glycogen and lipid storage. Each group n=6-8. Scale bars 100 µm.
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Antibody Antigen Retrieval Tissue Sample Outcome
vWF
Pronase Healthy Liver Low level of non-specific staining
Citrate Buffer Healthy Liver High level of non-specific staining
eNOS
Pronase Healthy Liver Low level of non-specific staining
Citrate Buffer Healthy Liver Intermediate level of non-specific
staining
CD31
Pronase Liver Tumour Low level of non-specific staining
Citrate Buffer Liver Tumour Low level of non-specific staining
ERG
Pronase Liver Tumour Low level of non-specific staining
Citrate Buffer Liver Tumour Low level of non-specific staining
Table 4.1: Summary of trialled antibodies for endothelial cell markers to detect vas-
cularisation within zebrafish liver tissue sections. All sections were from TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish, either when unin-
duced (healthy liver) or after 3 weeks of tumour induction with 10 mg/L doxycycline.
Staining was performed at 1:100 antibody concentration.
Furthermore, the evidence of complete endothelial cell staining highlights the thorough
expression of the KDR:mCherry transgene.
Once IHC with the mCherry antibody had been established it was used to stain FFPE
tissue sections from numerous fish within each of the in vivo study groups. The resultant
IHC stained sections could then be quantified. Regions of the mCherry stained liver
tumour sections that correspond to the segmented vasculature in the CS-OPT data (as
highlighted in Figure 4.3e and f) were selected for analysis. Due to the IHC data being
2-D and the CS-OPT data 3-D the quantification percent tumour vascularisation was
analysed to enable comparison between datasets for validation.
The brown stained vessels were identified from the blue stained background of the
tissue and surrounding slide area. The vessel lumen were incorporated into the identified
areas to correspond to the CS-OPT signal and the vessel diameters were calculated. As
previously mentioned the CS-OPT resolution limit is 26 µm and it is also well known
that during the IHC process tissue and vessel morphology is likely to change, for example
with collapsed vessels and tissue shrinkage. Furthermore, as IHC is a 2-D approach the
vessels may be observed in different orientations and this must be considered. For these
reasons vessels with a diameter lower than 5 µm or lower than 10 µm with a width/length
ratio over 3 were excluded from the analysis. Based upon zebrafish physiology the upper
vessel diameter limit analysis was 100 µm.
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The percent tumour vascularisation was calculated through the vessel area detected
within the selected tissue region of interest, for all of the in vivo cross-sectional study
groups. It was seen to significantly increase during 1 to 3 weeks of tumour induction
and also significantly reduce during tumour regression upon removal of the doxycycline
inducer, Figure 4.8. Both the level and trend of vascularisation seen with IHC mimic the
quantifications extracted from CS-OPT in Figure 4.5b. Therefore, the IHC quantifications
validate the information extracted from CS-OPT images.
4.4 Discussion
4.4.1 Requirements of imaging adult zebrafish with CS-OPT
To acquire accurate images for subsequent analysis it was crucial to determine the
performance of the CS-OPT platform when imaging whole, adult zebrafish. It was
clear that the zebrafish gut was fluorescent when feeding had occurred within 24 hours
of imaging. Several different foods were trialled to prevent this, but none resolved
the problem. This issue could be a result of the food substances themselves, as they
often contain nutrients and compounds to enhance fish colour (including shrimp and
krill), or alternatively it could be elements of the zebrafish digestive system involved in
metabolism. I have shown that depriving the zebrafish from food for 24 hours allows for
emptying of the gut. Importantly, this did not impact the viability of the zebrafish.
The female zebrafish anatomy caused both vasculature and tumour signals to be
inaccurate and unreliable, due to the eggs causing both auto-fluorescence and refraction.
Such a finding restricts CS-OPT analysis to male zebrafish only. It is important to note
that sexual dimorphism is present within the zebrafish liver, with respect to histology,
sensitivity to sex hormone perturbation, regulatory networks and subsequent functions,
(Zheng et al., 2013). This requirement is not a significant concern as single sexes are
used for many studies, including the use of three previous zebrafish liver cancer models
(Zheng et al., 2014) and mammalian models of physiology and pharmacology where
there is a male bias, for example (Beery and Zucker, 2011).
It was apparent that fish homozygous for the KDR:mCherry transgene were advan-
tageous for CS-OPT analysis due to their increased signal intensity. This would enable
faster acquisition times and finer vascular detail to be detected. Homozygosity of
zebrafish can be easily determined through out-crossing to a wild type fish and observing
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Figure 4.7: Immunohistochemical staining of tumour vasculature using the
mCherry antibody. Representative images show staining of vessels (brown) from
three week induced adult (145 dpf) TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish from the in vivo cross-sectional study. Scale bar 50 µm.
Figure 4.8: Validating CS-OPT vascular quantifications from the in vivo cross-
sectional study through IHC quantification. Graph shows analysis of percent vessel
coverage performed over regions of interest on mCherry stained sections from (145
dpf) TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish. Data
follows doxycycline treatment after one, two and three weeks and after three weeks
of doxycycline treatment plus a further week with no treatment. Each group (n=3)
and error bars represent the SEM. *p<0.05, **p<0.01 as indicated by lines.
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fluorescence within 100% of offspring.
Movement of the zebrafish during acquisition poses a crucial problem, due to in-
troducing artefacts in the reconstructions and rendering them unreliable. The anaesthesia
protocol was altered to prevent the fish from gaining consciousness and moving, where
1x cold MS-222 was used throughout, with no impact on the viability of recovery.
However, incomplete deep anaesthesia was still observed.
The movement of the rotating chamber within the CS-OPT apparatus results in the
zebrafish slipping or slightly rotating within the FEP tubing overtime. The apparatus
was modified so that the zebrafish were more restricted within the FEP tubing during
acquisition to limit the chance of movement. This restriction could be further improved
through using smaller FEP tubing or by using an index-matched material to hold the fish
in place, such as agarose or beads. In order to apply either of these additional options
substantial research would be required to ensure the health and viability of the zebrafish
are not impacted, whilst ensuring the clarity of subsequent reconstructions remains.
4.4.2 Accurate quantifications for studying tumour progression and
angiogenesis with CS-OPT
Quantitative analysis alongside qualitative information is beneficial when studying bio-
logical processes. The developed CS-OPT platform can provide 3-D whole organism
images of live adult zebrafish, however its ability to provide accurate quantifications was
unknown. Within this chapter I have quantified tumour growth and vascularisation within
adult zebrafish using CS-OPT. I confirmed tumour growth with what has previously been
reported by Nguyen et al. (2012) and have validated the vasculature measures with IHC
to ensure the true biology is accurately represented. As a result these can be used as
measures of tumour progression and angiogenesis.
4.4.2.1 Quantifications of tumour progression
It was previously reported that this zebrafish model driven by inducible, liver specific
expression of eGFP tagged oncogenic krasV12 recapitulated the genetic and molecular
hallmarks of human HCC (Nguyen et al., 2011). The eGFP fluorescence was also shown
to correspond to tumour volume, which increased during tumour progression (Nguyen
et al., 2012). These traits were replicated in the in vivo cross-sectional study with CS-OPT
imaging. During the 3 weeks of inducer treatment histopathology revealed an increase in
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densely packed cells with high nucleocytoplasmic ratio and rounded, prominent nuclei
indicative of HCC. CS-OPT analysis also clearly showed a significant increase in tumour
volume. Furthermore, tumours are known to regress upon removal of the inducer within
this oncogene driven model zebrafish (Nguyen et al., 2012). This was also observed
with CS-OPT imaging and analysis where a significant reduction in tumour volume was
quantified and the histopathology of the regression group indicated signs of apoptosis
causing the reduction in tissue size. Therefore, the CS-OPT quantifications of tumour
progression and regression were confirmed.
4.4.2.2 Methods of extracting measures of angiogenesis from CS-OPT images
It was of interest to analyse tumour vascularisation and I initially encountered difficulties
when trying to extract quantifications from the segmented CS-OPT 3-D images using
MATLAB (MathWorks). This was overcome through using the software Amira (FEI).
Amira successfully detected the vessels and branch points from the identified skeleton
within a reasonable time frame and the the subsequent quantifications were proven
to be accurate when mapped to the original image. Despite the MATLAB process
described working effectively for small tumour subregions, it did not complete the entire
tumour vasculature over a period of several days. This indicates that the process itself
is correct and able to extract the information desired, but was not efficient. The images
in Amira are filtered before the skeleton is extracted. The lack of this step in MAT-
LAB may play a part in the extended computational time, however this was not seen to
affect the subregion that was successfully analysed, so is unlikely to be the primary cause.
The iterations performed in attempt to clean the initial extracted skeleton had the
stopping criteria of all branch points having greater than two protruding vessels, which
was chosen as a vessel would only be branching if this were true. The stopping criteria
could be relaxed, however this would lead to inaccuracies within quantifications. Not
only would the number of vessels and their corresponding lengths be incorrect, but other
properties reliant on these would also be affected, for example the mean vessel diameter.
Due to these reasons, and the time required to address them, it was not beneficial to
pursue this further when it became apparent Amira was efficient and accurate for the
required purposes. Furthermore, it is possible to export the Amira skeleton into a format
that is compatible with MATLAB. As a result using Amira will not limit any possible
future analysis that requires in-house written codes.
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4.4.2.3 Quantifications of angiogenesis
Angiogenesis is a key requirement of tumour progression and is usually quantified
through assessing vessel length, vessel diameter, vessel branching and the vascular
density (Staton et al., 2009). These measures were analysed for CS-OPT images from the
in vivo cross-sectional study after vessels with an average length or diameter less than 26
µm were excluded. These vessels were removed as they had values lower than the known
resolution of the CS-OPT platform, and therefore cannot be definitively proven to be
vessels rather than noise. As a result the initial angiogenic sprouts may not be included
in quantifications.
It is known that as tumours increase in size they become centrally oxygen deprived, as
the central cells exceed the oxygen diffusion distance from the established vasculature
(Thomlinson and Gray, 1955; Maxwell et al., 2001). Furthermore the tumour model
zebrafish used is driven by the over expression of a constitutively active form of Ras,
krasV 12. Both Ras signalling and hypoxia drive the expression and activity of HIF-1,
the transcription factor that independently regulates VEGF and other genes involved in
driving angiogenesis, Figure 1.2 (Pugh and Ratcliffe, 2003; Semenza, 2002). Therefore,
the tumours being analysed, which are increasing in volume through the expression of
oncogenic kras, should show an increased level of angiogenesis. The CS-OPT analysis
revealed significant increases in both mean tumour vessel branching and percent tumour
vascularisation during tumour progression and the vasculature appeared more aberrant
and chaotic within the 3-D images. This is what would be expected if angiogenesis were
occurring as described in Section 1.2.3 (McMahon et al., 2001; Semela and Dufour,
2004; Vakoc et al., 2009). These properties also decreased upon tumour regression.
VEGF expression through hypoxic and non-hypoxic mechanisms is known to inhibit
apoptosis, Figures 1.1 and 1.3. Therefore, when oncogenic Ras is no longer expressed
and the tumours begin to regress endothelial apoptosis could be initiated. No significant
differences were apparent in mean vessel length or mean vessel diameter within the
CS-OPT images, which is what has previously been reported during tumour progression
(Vakoc et al., 2009).
In attempt to validate the CS-OPT vascular quantifications the well established
technique IHC was performed and, to the best of my knowledge, this is the first report
of specific endothelial cell staining within the zebrafish. The mCherry antibody used did
not produce any background staining or cross-react with the eGFP fluorophore expressed
within the liver tumours. Therefore IHC can be used to accurately quantify the vascular
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properties. As previously discussed the current limitation of CS-OPT is the ability to
image the vasculature up to 1.7 mm into the zebrafish. For unbiased comparison the
regions corresponding to the CS-OPT imaging capability were analysed from the IHC
stains. Comparative analysis of percent tumour vascularisation was used for validation,
as IHC is a 2-D technique and CS-OPT provided 3-D quantifications. The result showed
that CS-OPT was truthfully representing the physiological changes occurring during
tumour progression and regression.
4.4.3 TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-eGFPKRASV12)
zebrafish as a model for HCC
As previously described in Section 1.3.2.2, the TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) zebrafish used are an adaptation of the previously developed
and studied HCC model zebrafish by Nguyen et al. (2011, 2012). Through histopatho-
logical and transcriptomic analyses these zebrafish were shown to progress from a
hyperplasia liver to a neoplastic, malignant HCC phenotype (Nguyen et al., 2011). It
would be of interest to confirm that the progression being observed within the afore-
mentioned studies was in agreement with the previous research and the observations
were not purely hyperplasia. In order to so several approaches could be considered to
determine the molecular hallmarks and gene signatures of the tumour samples. This
could include quantitative PCR of genes and immunohistochemical staining or western
blot analysis of proteins that are known to change in expression between hyperpla-
sia and neoplasia. For example, the reduction in expression of gene tp53 or the loss
of the protein E-cadherin, which were both previously identified by Nguyen et al. (2011).
No metastases were observed using CS-OPT, however malignancy and metastasis
were not studied by other means. The HCC model has previously been shown to be
malignant, where tumour cells were found in surrounding vessels and nearby tissues
(Nguyen et al., 2011). It would be of interest to determine whether the tumours within the
performed research were malignant but too few cells had metastasised for detection using
CS-OPT. This could easily be analysed through histological analysis of key surrounding
tissues and vessels, either using H&E staining or immunostaining for GFP expression.
It is unknown whether tumour growth, vascularisation and regression are depen-
dent purely on oncogene expression within this zebrafish model or whether hypoxia is
a contributing factor. The commercial chemical Hypoxyprobe has previously been used
to detect hypoxia within adult zebrafish both in vitro and in vivo (Jopling et al., 2012).
104
CHAPTER 4. QUANTITATIVE ANALYSIS OF TUMORIGENESIS AND
ANGIOGENESIS USING CS-OPT
The Hypoxyprobe contains Pimonidazole that, at a low oxygen tension, can bind to
thiol groups and therefore enable subsequent analyses, such as immunohistochemistry,
to detect hypoxia. Incorporating this chemical into studies can provide additional
information into the mechanisms involved within the zebrafish tumour model used, the
similarity to the human pathology and the reliability of further studies.
One addition to the performed research that could enhance the qualitative and quantitative
information achieved would be to include a data point prior to tumour induction. CS-OPT
imaging was performed on Day 0 to confirm that the eGFPkrasV 12 expression was not
leaky and a vasculature baseline was achieved. However, due to the healthy liver lacking
fluorescence no liver volume can be extracted and subsequently the vascularisation
of the healthy liver is also unknown. This information could be provided through the
addition of a further fluorophore, that does not interfere with eGFP or mCherry, that is
specifically expressed in the zebrafish liver. For example, infrared fluorescent protein
(iRFP) expression downstream of the liver specific fabp10 promoter. Consequently,
the fate of healthy liver vasculature could be monitored within longitudinal studies and
provide both a greater understanding of the tumorigenic and angiogenic processes and
improved quantifications for mechanistic and drug development studies.
4.4.4 CS-OPT mesoscopic imaging capability
CS-OPT 3-D reconstructions of the tumour burdened zebrafish from the in vivo cross-
sectional study clearly showed qualitative changes in tumour volume and vascularisation.
These can be used to study tumour progression and angiogenesis. The complete eGFP
tagged liver specific tumour spanning the entire width of the fish (∼1 cm) has been
successfully reconstructed, highlighting the ability of the CS-OPT platform to image
whole adult zebrafish at the mesoscopic level. The vasculature has only been recon-
structed up to 1.7 mm in depth within the tumour, which accounts for approximately a
third of the tumour vasculature. The resolution of the CS-OPT images is 26 µm. As
a result the CS-OPT imaging platform successfully bridges the ‘mesoscopic imaging
gap’ and enables in vivo brightfield and fluorescence imaging of whole adult zebrafish.
Additionally, this capability is achievable at a cost comparable to a widefield microscope.
Therefore, the platform is advantageous to other imaging techniques that are described in
Section 1.4.
CS-OPT does not account for scattering or aberrations of the emitted fluorescence
and so the imaging performance is reduced towards the centre of adult zebrafish. Thus
105
CHAPTER 4. QUANTITATIVE ANALYSIS OF TUMORIGENESIS AND
ANGIOGENESIS USING CS-OPT
the ability of the CS-OPT image reconstruction and subsequent image segmentation
can vary throughout individual fish due to variations in their optical properties. This
property is seen in the tumour vasculature, and not the tumour itself, due to its finer
structure. While this instrument does already provide a useful platform for studying
cancer progression and the corresponding angiogenic changes, its capabilities and
vascular penetration depth could be improved.
Previous in vivo studies of tumour progression and corresponding vascularisation
within zebrafish were studied qualitatively through observing the fluorescence levels
and 2-D coverage. Quantitative measures were only provided with regards to tumour
progression using histopathological, transcriptomic and protein analysis (Li et al., 2012;
Nguyen et al., 2012; Li et al., 2013; Sun et al., 2015). This is also true of other adult
model organisms, where quantitative analysis usually required sacrifice for subsequent
processing. The CS-OPT quantifications are advantageous as they provide 3-D measures
of tumour volume and the corresponding vascular properties in vivo within adult
organisms. The additional dimension can enable greater information and consequently
provide improved accuracy as the entire physiology can be analysed. As a result robust
quantitative measurements of tumour progression, regression and angiogenesis can
be detected and analysed with greater accuracy, with the added benefit of potential
longitudinal imaging. This highlights the capability of CS-OPT imaging as a platform
for both mechanistic and drug development studies.
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Longitudinal Imaging with CS-OPT
5.1 Introduction
The developed compressive sensing optical projection tomography (CS-OPT) platform
facilitates 3-D mesoscopic fluorescence imaging of live, transparent zebrafish with the
ability for quantitative analysis. Within Chapter 4 I have highlighted this capability
through utilising the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12)
zebrafish model (as described in Section 1.3.2.2) to quantify tumour volume and vascu-
larisation. Coupled with benefits of low phototoxicity and quick acquisition times, as
shown in Chapter 3, CS-OPT has the potential to be a powerful modality for longitudinal
studies of tumorigenesis and angiogenesis, with respect to both mechanistic and drug
development studies.
To achieve longitudinal imaging it is necessary that the CS-OPT platform is mini-
mally invasive so that repetitive imaging will not impact on the viability of the zebrafish.
It is also important that zebrafish reach a deep level of anaesthesia, where they have no
response to external stimuli (Table 1.1), for prolonged periods of time without resulting in
detrimental or lethal side effects (McFarland, 1959; Ross and Ross, 2008). This is due to
the 3-D reconstruction algorithms being reliant upon motionless specimens and any slight
movement during acquisition introduces errors in the reconstructed images and resulting
quantifications (Correia et al., 2015; Kak and Slaney, 1988; Sharpe et al., 2002). CS-OPT
imaging of adult tumour burdened fish requires approximately 3.5 minutes to acquire
signals for both the tumour and vasculature. When including specimen positioning on
the CS-OPT system this translates to an average time of approximately 10 minutes of
required deep anaesthesia.
The anaesthetic regime widely used by the zebrafish community is 4.2% (168 parts per
million (ppm)) MS-222 (tricaine methanesulfonate), based upon its reliability and con-
sistency compared to other agents (Westerfield, 2000; Collymore et al., 2014). However,
with prolonged exposure zebrafish experience respiratory and cardiac failure leading to
higher mortality rates (Matthews and Varga, 2012; Sun et al., 2009). I had noticed on
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multiple occasions that TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12)
fish require longer exposure to MS-222 to reach deep anaesthesia than wild-type (AB)
zebrafish. Furthermore, these fish are unable to maintain deep anaesthesia for prolonged
periods of time and are seen to moving during image acquisition, as previously mentioned
in Section 4.3.1. It has been reported that a combination of MS-222 with isoflurane
reduces cardiac failure and prolongs time under deep anaesthesia before reaching
respiratory arrest and medullary collapse (Huang et al., 2010). The recovery period when
using the combined anaesthesia is also reduced when compared to MS-222 alone.
The TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) model zebrafish
expresses krasV 12 within hepatocytes in a dosage dependent manner as described in
Section 1.3.2.2 (Nguyen et al., 2012). Therefore, it is crucial to determine the optimal
inducer concentration to achieve desired tumour onset and growth rates prior to longitu-
dinal studies of tumorigenic and angiogenic progression. This it particularly true for drug
development studies, whereby the optimal point to administer the therapeutic agent needs
to be considered. Previously a concentration of 10 mg/L has been used, as in Chapters
3 and 4, but it is not known whether this dose is optimal or how tumour progression is
affected after 3 weeks of treatment. The affect of adult zebrafish age on tumour onset and
progression is also unknown. Therefore, this is another variable that needs to be better
understood for accuracy in future studies.
Within this Chapter I address these points. I have performed longitudinal imaging
of an individual zebrafish over a period of 5 months and analysed vasculature progression
and remodelling in the context of development. I have also optimised a regime combining
doses of MS-222 and isoflurane to repeatedly enable deep anaesthesia for prolonged
periods of time and have analysed the effect of inducer concentration and zebrafish age
on tumour onset and progression.
5.2 Experimental Summary
To demonstrate that CS-OPT is a minimally invasive imaging technique a single TraNac
Tg (KDR:mCherry) zebrafish has been repeatedly imaged from 2 weeks post fertilisation
(wpf) to 26 wpf as described in Section 2.8. Imaging was performed on the single arm
OPT platform, as shown in Figure 2.3, whilst the fish was less than 5 wpf due to the
organism size. After this point, during the juvenile and adult life stage, imaging was
performed using the dual projection channel multispectral OPT system, as shown in
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Figure 1.9.
Optimisation of anaesthesia for CS-OPT imaging of TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) involved using both MS-222 alone and in combination
with Isoflurane. Fish lines used were Wild-Type (AB), TraNac, Casper, TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) and Tg (KDRmCherry:cmlc2GFP),
described in Sections 1.3.1 and 2.1.4. All fish used were between 6-9 months. Fish
were anaesthetised with prescribed concentration and deep anaesthesia was determined
as described in Table 1.1. All fish were continuously monitored whilst anaesthetised as
described within Section 2.1.3. The external stimuli was tapping on the bench, which is
a greater stimulus than that experienced during CS-OPT acqusition. The time taken for
each fish to reach and to maintain deep anaesthesia were recorded, as well as the recovery
time. For repetitive anaesthesia experiments the fish were anaesthetised once a week for
a period of 4 weeks. Statistical analysis was performed as described in Section 2.9.
For the optimisation of doxycycline concentration studies were performed on TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) at ages 425 days post fertilisation
(dpf) and 150 dpf, which are termed old and young, respectively. For each doxycycline
concentration n≥4. The required dose of doxycycline was added to the system water
directly from within UCL fish facility, which is described in Section 2.1.1. Fish were
kept in isolation, where they were fed and subsequently given fresh doxycycline water
every other day. Imaging and quantification of tumour progression was performed twice
a week using the widefield fluorescence microscope described in Section 2.7, where the
fish were deeply anaesthetised (Table 1.1) prior to imaging.
5.3 Results
5.3.1 Demonstrating the minimally invasive nature of CS-OPT
To emphasise the minimally invasive nature of the CS-OPT platform an individual ze-
brafish with a red fluorescent vasculature was longitudinally imaged. Imaging began dur-
ing the larval lifestage at 2 wpf and continued fortnightly through to adulthood at 12 wpf,
with an additional final imaging session at 26 wpf. A subset of these have been recon-
structed and are shown in Figure 5.1. The zebrafish recovered from all imaging sessions
and its viability was not affected. Furthermore this zebrafish was able to breed and pro-
duce healthy, fertilised offspring after imaging was complete.
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Qualitative changes are apparent when observing the zebrafish vasculature develop, Fig-
ure 5.1 and Video 5. Dramatic changes occur between 4 and 8 wpf as a result of the
zebrafish size and vascular network developing and becoming increasingly dense. At 4
wpf some of the primitive embryonic vessels can clearly be seen, such as the intersegmen-
tal vessels, Figure 5.1. However, the dorsal aorta and posterior cardinal vein that are also
obvious within zebrafish embryo images, Figure 1.6a, are hidden by further vessels that
have developed. Smaller, finer vessels are depicted within the 4 wpf image, compared
to the other images within Figure 5.1. This is due to both the higher magnification of
the single axis OPT imaging system and zebrafish larvae itself. The larvae has reduced
scatter as a result of its smaller size and greater transparency, where key organ systems
and remaining pigmentation cells are still developing within the fish. From 8 wpf greater
vascular detail can be observed and key vessels such as the lateral cutaneous artery (insert
box within Figure 5.1) can be depicted. As the zebrafish continues to grow the density
and complexity of the vasculature increases, where a greater degree of branching can be
seen. The gaps in the vasculature apparent within the 8 wpf image are gradually filled
through 12 wpf and up to 26 wpf, Figure 5.1 .
Quantitative analysis of developmental angiogenesis can be drawn from these longitudi-
nal images. To demonstrate this ability the lateral cutaneous artery (insert boxes within
Figure 5.1) has been analysed, Table 5.1. Due to the use of a different OPT imaging
system for zebrafish larvae, analysis has been performed from 8 wpf onwards. As
previously demonstrated within Section 4.3.2, Amira was used to extract the information
required after image segmentation in MATLAB. The image was skeletonised so the
remaining voxels represented the centre of each vessel and had a value corresponding to
the diameter of the vessel at that point. From this skeleton the lateral cutaneous artery
was selected and analysed. The key angiogenic characteristics of vessel length, mean
vessel diameter and number of branches emanating were extracted from Amira for the
8, 12 and 24 wpf images shown in Figure 5.1. Vessel length was the total number of
voxels within the skeleton for the particular vessel, the mean vessel diameter was the
average of the voxel values within the vessel and the number of branches was calculated
as the number of voxels that had three non-zero adjoining voxels. It is clear that each of
these traits increases overtime and plateaus towards 26 wpf, as you would expect as the
organism is growing and maturing towards a fully developed adult, Table 5.1.
Once again movement was seen from the zebrafish during image acquisition. Con-
sequently, these datasets were not of use and particular time points were lost as CS
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Figure 5.1: Reconstructed CS-OPT images from a longitudinal study of an individ-
ual TraNac Tg (KDR:mCherry) zebrafish repeatedly imaged at 4, 8, 12 and 26 weeks
post fertilisation (wpf). Insert boxes define the vascular region containing the lateral
cutaneous artery and Table 5.1 summarises the vascular quantification of this vessel.
Scale bar = 2 mm. See Video 5 for corresponding 3-D animations.
8 wpf 12 wpf 24 wpf
Length (mm) 7.09 11.00 16.01
Mean Diameter (µm) 159.82 253.22 265.24
Number of Branchpoints 36 57 65
Table 5.1: Vascular quantification of the lateral cutaneous artery in a TraNac Tg
(KDR:mCherry) zebrafish longitudinally imaged using CS-OPT at 8,12 and 26 weeks
post fertilisation (wpf).
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reconstruction is reliant upon motionless specimens. The 2 wpf time point experienced
significant motion, which was a result of their small size causing slipping and rotational
movement within the FEP imaging tubing during acquisition. Movement within other
time points during image acquisition was a result of a lack of maintained deep anaes-
thesia, where zebrafish exhibited traits of light anaesthesia such as response to external
stimuli (Table 1.1).
5.3.2 Optimising the anaesthetic regime
5.3.2.1 Anaesthetising TraNac zebrafish using MS-222
As I had previously observed TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFP
KRASV12) fish require longer exposure to MS-222 to reach deep anaesthesia than
wild-type (AB) zebrafish it was beneficial to clarify and elucidate this phenomenon. To
do so the time to reach deep anaesthesia using 168 ppm MS-222 (4.2%) in these fish was
compared to other zebrafish genotypes. The genotypes used for comparison included
wild-type (AB), another double transgenic line (Tg (KDRmCherry:cmlc2GFP)) and two
non-pigmented zebrafish lines, Casper and TraNac. As described in Section 1.3.1, Casper
zebrafish are identical in appearance to TraNac and share the loss of functional nacre,
however they lack both functional copies of the gene roy opposed to transparent (tra).
The time taken to reach deep anaesthesia in the wild-type (AB) fish was not sig-
nificantly different to that of the Tg (KDRmCherry:cmlc2GFP) or Casper lines,
however a significant increase was seen in the TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) and the TraNac zebrafish, Figure 5.2. There was also
a significantly larger variation within the TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) and the TraNac groups when compared to the pigmented
lines, where P<0.001 using the Bartlett method. Therefore, it can be determined that
these differences in response to MS-222 were not due to the expression of fluorescent
transgenes or the non-pigmented phenotype, but a result of the TraNac genotype and
likely as a result of loss of the tra gene.
Fish, of all genotypes, were also found to respond to external stimuli. Therefore,
despite the use of 168 ppm MS-222 allowing deep anaesthesia to initially be reached, it
was not maintained.
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Figure 5.2: Analysis of the time to reach deep anaesthesia within different zebrafish
lines using 168 ppm MS-222. The groups of zebrafish tested were as described in
Section 5.2. Within each group n=5 and the error bars represent the standard error
of the mean (SEM). **p< 0.01 and N.S. indicates not significant.
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5.3.2.2 Using combined doses of MS-222 and Isoflurane to improve deep anaesthe-
sia
Based upon a previously reported study by Huang et al. (2010) TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish were anaesthetised with
combined doses of MS-222 and isoflurane, in the hope to achieve and maintain longer
periods of deep anaesthesia, Figure 5.3. In line with Huang et al. (2010) I began with
equal anaesthetic concentrations as low as 50/50 ppm (MS-222/isoflurane), however all
fish exhibited only light anaesthesia (Table 1.1) after 15 minutes of exposure. A dose
escalation was then performed with equal amounts of each anaesthetic. The minimum
concentration of MS-222 and isoflurane required for 100% of fish to reach deep anaes-
thesia within 15 minutes was found to be 150/150 ppm. However, despite reaching deep
anaesthesia 75% of fish maintained in 150/150 ppm awoke within 5 minutes of treatment,
Figure 5.3a. Using a dose of 165/165 ppm resulted in all fish staying under anaesthesia,
yet 60% were seen to respond to external stimuli suggesting a state of light anaesthesia
(Table 1.1). This was significantly improved when using doses of 170/170 or 175/175
ppm, where greater than 80% of fish were maintained under deep anaesthesia with no
response to external stimuli, Figure 5.3a.
To determine whether longer periods of deep anaesthesia could be achieved and
maintained the amount of isoflurane with a constant 175 ppm MS-222 was varied. It
was reasoned that MS-222 doses higher than 175 ppm would be detrimental to zebrafish
due to a concentration of 200 ppm being routinely used as an overdose for zebrafish
euthanasia (Matthews and Varga, 2012). Using a dose of 175/200 ppm had little effect
on the time under deep anaesthesia compared to 175/175 ppm, while the combination of
175/250 started to trend towards a reduced time. Using a regime of 175 ppm MS-222
alone resulted in a reduced time under deep anaesthesia, with a corresponding increase
in response to external stimuli as had previously observed for 168 ppm MS-222, Figure
5.3b. Importantly, no significant differences in recovery time were observed using the
combined regimes described Figure 5.3b when compared to MS-222 alone, Table 5.2.
5.3.2.3 Repeatedly using combined doses of MS-222 and Isoflurane
To implement longitudinal studies repeated anaesthesia is necessary. For CS-OPT anal-
ysis one imaging session per week is sufficient to see significant changes in tumour pro-
gression and vascularisation (Chapter 4). Based on results from Figure 5.3b, groups of
TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) fish were subjected to the
combined doses of 175/175 ppm or 175/200 ppm of isoflurane with MS-222, once a week
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(a) (b)
Figure 5.3: Analysing time under deep anaesthesia using combinations of MS-222
and isoflurane (MS-222 ppm/isoflurane ppm) on TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TRE- eGFPKRASV12) zebrafish. Equal doses of the anaesthetics (a) and vari-
ations of isoflurane concentration with 175ppm of MS-222 (b) were analysed. The
data presented for each group is the mean with error bars representing the stan-
dard error of the mean (SEM), where n ≥ 4 for each group. Solid white bars rep-
resent > 50% of fish awakening, hatched bars represent > 50% fish experiencing
light anaesthesia and solid black bars represent > 80% of fish remaining under deep
anaesthesia.
Anaesthetic Regime
MS-222/ Isoflurane (ppm)
Recovery Time
(Mean (sec) ± SEM)
175/0 121 ± 9.3
175/175 99 ± 13.2
175/200 155 ± 7.1
175/250 202 ± 27.7
Table 5.2: The recovery time of TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish after anaesthesia with regimes varying in isoflurane con-
centration (ppm) with 175 ppm of MS-222. The data presented is the mean recovery
time (s) and error bars represent the standard error of the mean (SEM), where n ≥
4 for each group.
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for four weeks, Figure 5.4. The time under deep anaesthesia varied over the four week
study when using a dose of 175/200, which was not seen when using 175/175 ppm, Fig-
ure 5.4. Therefore it was determined that the 175/175 ppm combined anaesthetic regime
would be optimal for motionless 3-D image acquisition during longitudinal studies. Im-
portantly, repeated exposure to these combined doses of MS-222 and isoflurane did not
impact the health, fitness or viability of the zebrafish. All fish experienced rapid recover-
ies, did not have reduced viability or appear under any stress, Table 5.3.
5.3.2.4 Reducing the time to reach deep anaesthesia in TraNac zebrafish using both
MS-222 and Isoflurane
The combined 175/175 ppm of MS-222 and isoflurane doses were tested on Wild-Type
(AB), TraNac and TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) fish.
This was to determine whether the time to reach deep anaesthesia compared to standard
MS-222 alone in different genetic backgrounds was affected, Figure 5.5.
All fish were found to reach deep anaesthesia in less than 3 minutes. TraNac and
TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) fish have a reduction in
both the time taken to reach deep anaesthesia and the variation between individual fish
(P<0.01 using Bartlett method) when using the 175/175 ppm combined regime compared
to standard MS-222 used in Figure 5.2. A significant difference is still observed between
the Wild-Type (AB) group and the TraNac fish, indicating a similar role effect as
observed in Figure 5.2, Figure 5.5.
5.3.3 Optimising doxycycline treatment for tumour onset and pro-
gression
It is important to determine the optimal doxycycline concentration within the zebrafish
tumour model prior to mechanistic and drug development studies. Furthermore, it is
of interest to ascertain whether the models dose dependency is variable with age. Both
old and young zebrafish were initially treated with low concentrations of doxycycline, 1
mg/L and 2 mg/L, and monitored over two weeks. Tumours did not develop in any of the
fish at either concentration, highlighted with the higher dose in Figure 5.6.
Subsequently higher doses of doxycycline were required and 5 mg/L was anal-
ysed. All young zebrafish developed tumours over the 22 day period analysed, compared
to only 75% of old fish. Of the fish that did develop tumours during the course of the
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Figure 5.4: Time under deep anaesthesia with repeated use of MS-222 and isoflu-
rane combinations 175/175 and 175/200 (MS-222 ppm/isoflurane ppm) on TraNac
Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish. Each anaesthetic
regime was tested over 4 weeks. The data presented for each group is the mean with
error bars representing the standard error of the mean (SEM), where n≥ 3 for each
group. The horizontal dotted line at 10 minutes represents the average time required
for CS-OPT image acquisition.
Anaesthetic Regime Recovery Time
MS-222/ Isoflurane (ppm) (Mean (sec) ± SEM)
Week 1 Week 2 Week 3 Week 4
175/175 155 ± 7 149 ± 22 137 ± 18 113 ± 15
175/200 202 ± 45 117 ± 24 132 ± 28 123 ± 28
Table 5.3: The recovery time after anaesthesia with repeated use of combined MS-
222 and isoflurane concentrations 175/175 and 175/200 (MS-222 ppm/isoflurane
ppm) on TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish.
The data presented is the mean recovery time (s) and error bars represent the stan-
dard error of the mean (SEM), where n ≥ 3 for each group.
117
CHAPTER 5. LONGITUDINAL IMAGING WITH CS-OPT
Figure 5.5: Analysis of the time to reach deep anaesthesia within different zebrafish
lines using 175 ppm of both MS-222 and isoflurane. Within each group n=5 and the
error bars represent the standard error of the mean (SEM). **p<0.01.
study differences were apparent with respect to age for both tumour onset and tumour
progression, Figure 5.7. Tumours were apparent at 4 days post induction (dpi) in young
zebrafish, but were not seen until imaging at 9 dpi in the older fish. Furthermore, the
tumour area was consistently larger in younger fish and so the tumour progression
was more advanced, Figure 5.7b. Linear regression analysis was performed on the
quantifications shown in Figure 5.7b. When fitting linear functions to each of these
datasets the the r2 values were both greater than 0.95 and the tumour growth rate was
significantly higher in younger fish when compared to old, at 2.085 ± 0.176 opposed to
1.187 ± 0.1086.
Induction of the young fish was continued with 5 mg/L in an attempt to understand the
dynamics of the tumour progression and to identify the optimal point for therapeutic
administration during drug development studies. The rate of tumour growth began to
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Figure 5.6: Representative TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish from a cohort of 4 zebrafish per group induced with
2mg/L doxycycline. Widefield images of Old (425 dpf) and Young (150 dpf)
zebrafish are shown at Day 0 and Day 14, as indicated in the top left of each image.
plateau after the initial 22 days of tumour induction, but surprisingly tumours were seen
to regress after imaging on 26 dpi, as seen between 26 and 33 dpi in Figure 5.8. The
inducer concentration of 5 mg/L did not appear to be sufficient to maintain tumours of
this size. It was hypothesised that this was through too few reverse tetracycline-dependent
transactivator (rtTA) proteins being able to bind to tetracycline response element (TRE)
sequences within the hepatocytes and drive oncogene expression. With this in mind the
inducer dose was raised to 7.5 mg/L after imaging on 33 dpi and the tumours began
increasing in size again, Figure 5.8. After 44 dpi the same phenomena occurred once
more with a dramatic drop in tumour size being observed at 47 dpi and so at this point
the dose was escalated further to 10 mg/L, Figure 5.8.
Once again, the increase in doxycycline concentration temporarily resulted in tu-
mour growth, before regression occurred after 51 dpi, Figure 5.8. This concentration had
been used in previous studies, as shown in Chapters 3 and 4, and larger tumours had been
seen, for example the representative fish after 3 weeks of tumour induction within Figure
4.2. Therefore, this finding was unusual. Using 10 mg/L of doxycycline a colour change
was observed within the zebrafish water over the 48 hours used before a fresh water
change. Doxycycline is known to be light sensitive and degrade overtime to give a yellow
colour, but with a light/ dark cycle of 14/10 hours (as described in Section 2.1.1) a water
change is only required every other day (personal communication with Zhiyuan Gong,
The National University of Singapore). However, the colour change observed was to a
shade of red. Upon this observation a water study was performed to determine whether
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(a)
(b)
Figure 5.7: Longitudinal widefield imaging of Old (425 dpf) and Young (150 dpf)
TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish induced
with 5 mg/L doxycycline for 22 days. Images show an eGFP labelled tumour and
mCherry labelled vasculature. a) shows widefield images for a representative ze-
brafish from each group at selected time points, as indicated in the top left of each
image. b) is the corresponding quantitative analysis of tumour area from all tumour
burdened zebrafish within each group (n ≥ 3). The graph plots the mean tumour
area and error bars represent the standard error of the mean (SEM).
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the system water or the lighting within the room being used was causing an unusual
degradation of doxycycline and reducing its potency. System water from the UCL fish
facility and Tropic Marin R© water made from 68mg/L of Tropic Marin R© Sea Salt with
deionised water were used with 10 mg/L doxycycline water. Fish tanks containing 100
mls of each water type were placed in two different rooms within the UCL fish facility,
including the room the longitudinal study was being performed in. After 24 hours the
system water had changed colour to the red shade in both locations, but the Tropic
Marin R© water had not. Therefore, 10 mg/L Tropic Marin R© doxycycline water was then
used after imaging on Day 58. This water change resulted in tumour growth at a similar
rate to previous points within the study prior to regression, Figure 5.8b. The pH was
tested for both waters and they were not significantly different, the system water was
7.01 and the Tropic Marin R© water was 7.38.
5.4 Discussion
5.4.1 CS-OPT is a minimally invasive platform for longitudinal
imaging
Longitudinal studies of tumour progression and the accompanying vascular changes
would be beneficial to provide additional temporal information and improved accuracy
when compared to cross-sectional studies (Ntziachristos et al., 2005). Furthermore the
number of animals required for research would be reduced. There are limited imaging
modalities capable of live mesoscopic imaging, which is desirable for in vivo studies of
model organisms. CS-OPT achieves accurate quantitative mesoscopic imaging of whole
organisms, as shown in Chapter 4, and the zebrafish simply require anaesthetising to
satisfy the requirement of motionless imaging. The rapid acquisition time also minimises
light dose and anaesthesia time experienced by the zebrafish. Therefore, CS-OPT has the
potential to be a powerful platform for quantitative longitudinal studies if the viability of
the imaged zebrafish is not affected through repeated imaging sessions.
Through longitudinal imaging of vascular progression and remodelling in the context
of development the minimally invasive nature of this platform has been demonstrated.
Repetitive imaging of individual zebrafish occurred every fortnight from 2 wpf up until
12 wpf, which spans the larvae, juvenile and adult life stages, with an additional imaging
session at 26 wpf. The recovery and fitness of the zebrafish were not affected. 3-D
quantitative imaging of whole organisms was achievable throughout the longitudinal
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(a)
(b)
Figure 5.8: A longitudinal study to understand the relationship between dose depen-
dency and tumour progression within TraNac Tg (KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV12) zebrafish at 150 dpf. Doxycycline concentration was initially 5 mg/L,
before being increased to 7.5 mg/L and 10 mg/L after imaging on Day 33 and Day
47, respectively. a) shows widefield images of a representative zebrafish with the
mCherry fluorescent vasculature and eGFP fluorescent tumour at selected time
points, as indicated in the top left of each image. Doxycycline concentration is indi-
cated on the left of each row. b) is the corresponding quantitative analysis plotting
mean tumour area from all tumour burdened zebrafish throughout the study, for
which n=4, and error bars represent the standard error of the mean (SEM). Bars in-
dicate the doxycycline concentration used and when Tropic Marin R© (T.M) was used
in place of system water.
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study without the need for invasive procedures such as chronic transparent window
preparation. Therefore, CS-OPT provides advantages compared to other techniques
frequently used such as 2-D imaging with widefield microscopy, surface imaging with
confocal microscopy and the invasive nature of intravital imaging (Jain et al., 2002;
Huisken and Stainier, 2009; Conway et al., 2014).
Quantitative analysis revealed the rate of angiogenesis and vascular growth for the
lateral cutaneous artery was reducing during the 24 week study. It is important to note
that there was greater detail and resolution of vasculature obtainable from the larvae
fish at 2 wpf and 4 wpf, where primitive embryonic vessels could still be seen (Isogai
et al., 2001). This is a result of both the organism physical features, such as size and
transparency, and the use of a different, higher magnification imaging system. For these
reasons these datasets were omitted from quantitative analysis of the lateral cutaneous
artery. To minimise the noise sensitivity within the quantitative analysis filters were ap-
plied both before and after segmentation in MATLAB and before skeletonisation within
Amira. However, this will not completely eliminate artefacts within the subsequent
skeletons or quantifications. As I have previously discussed within Chapter 3, it is well
known that the adult zebrafish is prone to light scatter, and therefore limits the depth of
penetration achievable. Due to this physical constraint it is also likely that level of image
noise would be greater towards the centre of the organism. Performing longitudinal
studies of individual zebrafish would enable clarification between artefact and true signal
within the reconstructions, as the noise should differ within repeated imaging sessions.
For CS-OPT to be accurately used within longitudinal studies it is crucial that the
system is calibrated prior to use. This is to ensure that drift of the system does not
influence subsequent quantifications when directly comparing individual organisms over
time. There are two crucial operations involved in doing so, these are aligning the two
imaging arms used within the multiplex system and registering them both with respect
to each other. In order to do so an L-shaped bent needed positioned outside the axis of
rotation is imaged by the system at 0◦ and 180◦. The system is perfectly aligned if the
mirror image of the 180◦ projection exactly overlaps that of the 0◦ projection. If perfect
alignment cannot be achieved and an exact alignment is possible with a lateral translation
only, then it is sufficient. Once the individual arms have been aligned the data from each
can be combined and registered with respect to each other, which is currently a manual
process performed by eye.
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As previously mentioned CS-OPT imaging requires motionless specimens, other-
wise reconstructions contain artefacts resulting in inaccurate or useless images (Kak and
Slaney, 1988; Sharpe et al., 2002). Within the longitudinal study of vascular development
movement was once again seen, with significant motion experienced in the 2 wpf imaging
session. The zebrafish larvae experienced movement as a result of the imaging chambers
rotational pull during acquisition. Previous 3-D imaging studies of small specimens, such
as zebrafish embryos, have achieved immobilisation through embedding the specimens
in low melt agarose (McGinty et al., 2011; Correia et al., 2015; Andrews et al., 2016).
As I discussed within Section 4.4.1 the use of agarose or other materials to hold the fish
within the imaging apparatus would require substantial research due to the increased
complexity of the zebrafish larvae compared to the embryo. For example, gill function
could be affected, which is essential for ionoregulation and oxygen uptake in zebrafish
from 7 dpf (Rombough, 2002). Movement was also seen due to zebrafish responding to
external stimuli, which was previously observed in Section 4.3.1. As defined in Table 1.1
deep anaesthesia results in no response to external stimuli, and despite initially reaching
deep anaesthesia this is not maintained during imaging. This further highlights the need
of an optimised anaesthetic regime for motionless 3-D imaging.
5.4.2 An optimised anaesthetic regime for motionless 3-D image ac-
quisition
TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish have been re-
peatedly anaesthetised using a combined dose of MS-222 and isoflurane to quickly reach
and maintain a deep level of anaesthesia for extended periods of time. This overcomes the
shortfalls encountered when using MS-222 alone for 3-D imaging of live, non-pigmented
adult zebrafish.
It is known that using MS-222 alone for prolonged anaesthesia zebrafish are sus-
ceptible to both respiratory and cardiac failure (Sun et al., 2009; Matthews and Varga,
2012). It has previously been reported (Huang et al., 2010) that a combined dose of 65
ppm of both MS-222 and isoflurane in adult wild type zebrafish is optimal to improve
the time under deep anaesthesia without impacting upon survival. The results presented
here show that this dose was not sufficient to induce deep anaesthesia in either wild type
zebrafish or in the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) fish
within 15 minutes. Using a combination of both MS-222 and isoflurane did improve
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anaesthesia, however the minimal dose required for deep anaesthesia to be reached was
150 ppm of both MS-222 and isoflurane.
The combination of isoflurane with MS-222 improves the maintenance of deep
anaesthesia within TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) ze-
brafish at doses higher than 170 ppm of each anaesthetic. This was determined through
the response to an external stimulus greater than that experienced during CS-OPT image
acquisition. Achieving this is an important advancement for imaging live zebrafish,
whereby accurate images and quantifications are dependent upon completely motionless
animals during acquisition. Furthermore, there was an increase in the time under deep
anaesthesia before loss of opercula movement was observed, where the 175/175 ppm
dose was optimal. The extended time under deep anaesthesia could open up additional
avenues for imaging. Spatial and temporal readouts of protein activity have previously
been achieved using Förster Resonance Energy Transfer (FRET) biosensors through
Fluorescence Lifetime Imaging Microscopy (FLIM) OPT in zebrafish embryos (McGinty
et al., 2011; Andrews et al., 2016). Providing a greater period of deep anaesthesia
could enable FLIM OPT in live adult zebrafish, providing additional information in
physiological and pathophysiological contexts. Importantly this anaesthetic regime can
be repeated, and does not affect the viability of the adult zebrafish. Again a combined
dose of 175/175 ppm of each anaesthetic was shown to be optimal, where it consistently
achieved an average time under deep anaesthesia of greater than 10 minutes with lit-
tle variation throughout. This highlights its potential use for longitudinal imaging studies.
It was also apparent that both TraNac and TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) fish require prolonged exposure to MS-222 to reach deep
anaesthesia compared to Wild-Type (AB) zebrafish. This difference is not seen in
Casper or other double transgenic fish suggesting a role for the tra gene in regulating
the MS-222 response. The mutation present in the tra gene results in a truncated
form of the mitochondrial protein mpv17, which leads to a reduction in iridophores,
as discussed in Section 1.3.1. It has previously been proposed that the loss of mpv17
function could result in alterations in metabolism so it is possible that this could account
for the differences in response to MS-222 (Krauss et al., 2013). It would be of great
interest to further investigate this. The combined use of 175 ppm of both MS-222
and isoflurane reduces the time to reach deep anaesthesia and does not increase the
recovery period when anaesthetising the TraNac and TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) fish. Therefore the zebrafish will experience less stress as a
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result. However, it is important to note a difference in time to reach deep anaesthesia is
still observed when compared to the wild-type (AB) fish. Due to differences between
zebrafish lines there may be a need to perform additional adjustments to the 175/175
ppm anaesthetic regime. However, it is clear that using a combination of MS-222 and
isoflurane is superior to the widely used 4.2% (168ppm) MS-222 regime.
Thus incorporating the combined anaesthetic dose of 175 ppm of both MS-222
and isoflurane can provide prolonged periods of deep anaesthesia required for 3-D imag-
ing of adult non-pigmented zebrafish, without impacting upon recovery. Additionally,
the ability to perform repeated treatments will significantly improve the accuracy and
information achievable from imaging live adult zebrafish in longitudinal studies.
5.4.3 Investigating dose dependency within the tumour angiogenesis
zebrafish model
For longitudinal studies of tumour progression and vascularisation using the tumour an-
giogenesis zebrafish model TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12)
it is important to understand the relationship between the inducer, doxycycline, and the
tumour growth rate. This is especially the case for drug development studies, where opti-
mal points of tumour progression should be identified for administering therapeutics. It
would also be of benefit when planning mechanistic studies, where inducer concentration
could be chosen to complement the predicted effect and provide sufficient time to observe
differences. For example, if the study is hypothesised to increase tumour progression it
may be desirable to reduce the rate for quantifications and comparisons to be drawn.
It is known that the hepatocellular carcinoma (HCC) model is dependent on the
dose of doxycycline, whereby lower inducer concentrations reduce the frequency of
tumour onset and the rate of progression (Nguyen et al., 2012). This has been seen
within the performed longitudinal studies. A doxycycline concentration of 2 mg/L or
lower was not adequate to induce tumour development within 14 dpi but with 5 mg/L
doxycycline tumours were visible as early as 4 dpi in some individuals and in all by 9 dpi.
Prior to this longitudinal study it was unknown whether age affected tumour pro-
gression and initiation. It appears that older zebrafish have a reduced incidence of tumour
growth, a delayed onset and a reduced growth rate compared to the younger fish. It is
possible that the transgene is not being expressed as highly within older organisms or
defensive protective mechanisms are involved. Further investigation would be required
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to understand the cause of this observed reduction in tumorigenesis. However, it is clear
that the model organism age should be considered within future studies.
Within this study continued treatment of doxycycline surprisingly caused tumour
regression, even with a dose escalation up to the previously used concentration of 10
mg/L. It became clear that this is a result of using system water, as the use of Tropic
Marin R© Sea Salts dissolved in deionised water resulted in tumour growth when the
doxycycline concentration was not altered from 10 mg/L. The pH of the two water types
was not significantly different and system water (as described in Section 2.1.1) is also
made from Tropic Marin R© Sea Salts. Therefore it can be speculated that doxycycline
degradation is caused by an additional component within the circulating system water,
such as zebrafish waste products, pheromones or microorganisms. Future experiments
using the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish model
will use Tropic Marin R© water. Consequently, optimisation is still required prior to
initiating longitudinal studies as this longitudinal study of doxycycline dose was not
performed within Tropic Marin R© water.
The degradation of doxycycline has highlighted an important issue regarding com-
pound stability. For future drug development studies the therapeutic stability within the
zebrafish water would need to be determined, as if the therapeutic was degraded it could
significantly impact upon efficacy.
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Mechanistic Studies of Tumour Progression and
Vascularisation
6.1 Introduction
As shown within Chapter 4 the developed CS-OPT imaging modality is capable of
whole organism, quantitative imaging of tumour progression and vascularisation using
the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) zebrafish model (as
described in Section 1.3.2.2). Coupled with its ability for longitudinal imaging, as shown
in Chapter 5, CS-OPT can be a powerful platform for researching key proteins and
biological interactions of interest through mechanistic studies.
The tumours within the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12)
zebrafish model are driven through an overexpression of oncogenic krasV 12 and reca-
pitulate human hepatocellular carcinoma (HCC) (Nguyen et al., 2011). However, this
krasV 12 driven model only achieves local metastasis. p53 is a tumour suppressor (seen in
Figure 1.3) found frequently mutated or deleted in many cancers including HCC and it
has been shown that its absence is critical for metastasis in a HCC mouse model (Lewis
et al., 2005). It was recently shown that the metastatic potential was not increased when
the zebrafish tumour model lacked functional p53, but there was an increase in tumour
onset (Nguyen et al., 2011). As previously described (Section 1.2.2) several studies
have shown that an increase in activity of the Ras pathway coupled with a decrease in
PTEN expression results in more aggressive and metastatic tumours (Dankort et al.,
2009; Nogueira et al., 2010; Wang et al., 2012). Furthermore, PTEN is highly mutated
and deleted within human HCC, where a reduced PTEN expression correlates with the
progression of the disease and an increase in metastasis (Dong-Dong et al., 2003; Hu
et al., 2003). Therefore, it is of interest to determine whether a reduced PTEN expression
within the zebrafish would increase the metastatic potential of the tumours and as a result
better reflect the human pathology.
Due to the well known gene duplication events that commonly occur in the ze-
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brafish genome there are two homologs to human PTEN within the zebrafish (Taylor
et al., 2003). These are ptena on Chromosome 17 and ptenb on Chromosome 12. Both
are highly similar to the human form and contain a N-terminal phosphatase domain
and a C2 domain that targets the protein to the cell membrane (Faucherre et al., 2008).
These lipid phosphatases are essential for development, as double knockouts of both
ptena and ptenb (ptena-/- ptenb-/-) are lethal (Faucherre et al., 2008). They exhibit
hypervascularisation and enhanced angiogenesis throughout the zebrafish, as well as
a significantly increased level of the zebrafish homolog for VEGF, vegfaa (Faucherre
et al., 2008; Choorapoikayil et al., 2013). Haploinsufficient zebrafish, ptena+/- ptenb-/- or
ptena-/- ptenb+/-, develop normally but are prone to hemangiosarcomas with an increased
vegfaa expression in the vascularised tissue connected to the eye bulb (Choorapoikayil
et al., 2013). Also, Faucherre et al. (2008) reported that after 18 months ptenb-/-
zebrafish had a 33% incidence rate of spontaneous eye tumours with an increased Akt
phosphorylation, despite functional ptena expression. Tumours were not observed in WT
or ptena-/- zebrafish.
It is of importance to understand the downstream signalling pathways required for
tumour progression. Many groups, including our lab, have previously shown an
important role for the protein p130Cas within tumorigenesis (Barrett et al., 2013).
p130Cas is an adapter protein known to associate with multiple proteins through its
phosphorylation sites and various interaction domains. These include a Src-homology
3 (SH3) domain, substrate domain and C-terminal domain, as shown within Figure 6.1.
It is triggered through numerous receptor tyrosine kinases (RTKs) increasing p130Cas
tyrosine phosphorylation, which is mediated by Src kinase. This results in the formation
of signalling complexes that are required for several key cellular functions including cell
cycle progression, cell survival, migration and invasion, Figure 6.1 (Barrett et al., 2013).
Deregulation and overexpression of p130Cas is found in many cancers, where its
presence is often correlated with the advancement of the disease (Barrett et al., 2013).
This is true of HCC, where greater p130Cas expressing tumours have reduced expression
of adhesion molecules, increased metastasis and worse prognosis (Guo et al., 2008).
Silencing p130Cas expression has found to block tumour growth and progression in
lung, breast and ovarian cancer (Cabodi et al., 2010; Nick et al., 2011). Therefore it
is a potential therapeutic target. p130Cas is also involved in endothelial cell migration
and proliferation, whereby the pro angiogenic factor VEGF is known to induce its
phosphorylation (Barrett et al., 2013). Its loss of function during development is lethal
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Figure 6.1: The structure and signalling pathways of adapter protein p130Cas. The
protein consists of a N-terminal SH3 domain, a proline-rich domain, a substrate do-
main, a serine-rich domain and a C-terminal domain. Upstream regulation occurs
through receptor tyrosine kinase phosphorylation mediated through Src kinase, in-
dicated by the yellow ‘P’ symbols on the protein. Signalling complexes can then be
formed that drive cell cycle progression, invasion, migration and survival. Figure
from Barrett et al. (2013).
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within mice, where the embryos have an underdeveloped cardiovascular system with
dilated blood vessels and impaired integrity (Honda et al., 1998). This supports its critical
role for developmental angiogenesis. However, the role of the zebrafish homolog bcar1
has yet to be determined within tumour progression or angiogenesis.
For these reasons mechanistic studies relating to ptena, ptenb and bcar1 are of interest
within the tumour angiogenesis zebrafish model TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12). A non-functional mutant of ptenb was available from the
Zebrafish International Resource Center (ZIRC) (zebrafish.org). This mutant,
ptenbhu1435 henceforth referred to as ptenb-, was created by Faucherre et al. (2008) and
has a single point mutation from C to A within exon 3 that translates to a premature
stop codon at position 65. This subsequently produces a non-functional protein as it is
truncated before the catalytic site of the phosphatase domain, Figure 6.2. There were
no bcar1 or ptena non-functional mutants available at the start of the project. However
the genome editing techniques transcription activator-like effector nucleases (TALENs)
and clustered regularly interspaced short palindromic repeats (CRISPRs), as described in
Section 1.3.3, could be used.
Due to the embryonic lethality of ptena-/- ptenb-/- zebrafish an inducible knock out
would be advantageous to produce a complete loss of ptena and ptenb within the adult
tumour burdened zebrafish. TALENs and CRISPRs have recently been used for targeted
knock-in gene editing, as described within Section 1.3.3 (Bedell et al., 2012; Chang
et al., 2013; Auer and Del Bene, 2014). Therefore it is possible that genes of interest
can be genetically modified through the insertion of LoxP sites within intronic regions
surrounding a key exon of interest. The resulting mutant gene will produce a functional
protein until Cre recombinase is present, causing a recombination event that removes the
entire crucial exon, resulting in a loss of function mutation.
Within this Chapter I have performed a preliminary longitudinal mechanistic
study of the available ptenb- mutant within the TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) zebrafish line using widefield microscopy. I also describe
efforts towards creating ptena and bcar1 non-functional mutant lines as well as a ptena
inducible knock out line that could subsequently be used in combination with the ptenb-
mutant. Development of these mutant lines will lead to using the CS-OPT imaging
platform for mechanistic studies to provide novel insights into tumour progression and
vascularisation through longitudinal, 3-D quantifications.
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6.2 Experimental Summary
To verify zebrafish genotype DNA extraction was performed using the methods stated
in Section 2.1.8 and DNA amplification was performed through polymerase chain reac-
tions (PCRs) as described in Section 2.2.3 with the primers and conditions listed in Table
2.1. When fluorescent screening was not possible (as described in Section 2.1.6) pres-
ence of the eGFPKRASV12 transgene was determined through amplicon detection by gel
electrophoresis, Section 2.2.4. The forward primer for the eGFPKRASV 12 transgene lies
within the eGFP region of the construct and the reverse within the zebrafish KRASV 12
sequence. Therefore, PCR reactions will only amplify the transgenic DNA, and not the
wild type zebrafish RAS within the fish. Sanger sequencing, deep sequencing or high
resolution melting analysis (HRMA) was performed using the primers stated in Tables
2.3 and 2.4 and the Poly Peak Parser software was used to identify specific insertions or
deletions (indels), all described within Section 2.4. Unless otherwise stated, 3 uninjected
controls and 22 injected samples were used for each HRMA. The ptenb loss of function
mutant genotype was identified from the sequencing chromatograms, as shown in Figure
6.3.
For longitudinal mechanistic studies of ptenb the zebrafish line TraNac:ptenb Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12) was generated and genotyped. The
zebrafish used were 174 days post fertilisation (dpf) and for each genotype examined
n=8. The inducer concentration at the start of the study was 5 mg/L of doxycycline,
which was added directly to system water from UCL fish facility. Fish were kept in
isolation, where they were fed and subsequently given fresh doxycycline water every
other day. Imaging of tumour progression was performed twice a week using the
widefield fluorescence microscope described in Section 2.7. At the end of the study
the zebrafish were euthanised with an overdose of anaesthesia resulting in medullary
collapse (Table 1.1). Fin clips were taken for genotyping and the tumours were dissected
and either fixed in 10% formalin (Fischer Scientific, P/0840/53) or were snap frozen in
liquid nitrogen for subsequent protein or RNA analysis.
In an attempt to create new loss of function and inducible knock-out mutants the
gene editing tools TALENs and CRISPRs were designed and created as described in
Section 2.3. All TALEN arms were microinjected into single cell embryos at 300
ng/µl and CRISPR gRNAs at 70 ng/µl with 150 ng/µl of Cas9 nuclease. The concept
for producing an inducible knockout was devised by Leo Valdivia Alvarez (Wilson
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Figure 6.2: Schematic of the ptenb- mutant created by Faucherre et al. (2008), show-
ing the structural domains, exon organisation and site of the point mutation within
exon 3, where tyrosine 65 (Y) changes to a stop codon (*) before the catalytic P loop.
Figure from Faucherre et al. (2008).
Figure 6.3: Sequencing chromatograms of the different ptenb- genotypes. Figure
shows the wild type ptenb (ptenb+/+), the heterozygous(ptenb+/-) and the homozygous
(ptenb-/-) loss of function mutant. The red arrow indicates the position of the C>A
point mutation in the non-functional mutant gene.
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Group, UCL). The approach used either TALENs or CRISPRs to target intronic regions
surrounding a key exon of interest, rather than the conventional exonic regions. The
aim was then to incorporate LoxP sites in a head to tail orientation through homology
directed repair (HDR) of the TALEN or CRISPR mediated double strand break (DSB).
This would occur by co-injecting synthetic DNA containing a modified LoxP (mLoxP)
site, shown to function in zebrafish by (Hans et al., 2009), surrounded by complementary
sequence to the DSB site, Figure 6.4. For TALEN mediated insertion the synthetic DNA
is a single stranded oligonucleotide that corresponds to that published by Bedell et al.
(2012). This oligonucleotide has 27 bases of sequence homology to the TALEN left arm
recognition sequence and the start of the spacer region, the mLoxP sequence, and then
27 bases of homology to DNA 10bp downstream from the TALEN right arm recognition
site. The TALEN specific synthetic DNA is microinjected at a concentration of 50 ng/µl.
For CRISPR mediated insertion the synthetic DNA is based upon the design by Chang
et al. (2013), where insertion of the mLoxP sequence is targeted to 3bp from the end of
the gRNA target site. The synthetic DNA has the mLoxP sequence surrounded by 25bp
of sequence homology upstream and 20bp homology downstream of the target region
and is microinjected at 75 ng/µl.
Figure 6.4: The novel genome editing approach using TALENs or CRISPRs to cre-
ate inducible knockout zebrafish models. TALENs and CRISPRs are targeted to
intronic regions surrounding a key exon. Upon eliciting a DSB the aim is to incor-
porate a mLoxP site through homology directed repair. Synthetic DNA containing
a mLoxP site surrounded by donor templates of complementary sequence to the
TALEN or CRISPR target site is coinjected with TALENs or CRISPRs. Includes
figures from Auer and Del Bene (2014).
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6.3 Results
6.3.1 Studying the ptenb loss of function mutant
6.3.1.1 Generating the line
The ptenb loss of function line was imported from ZIRC and fish were genotyped
when they reached adulthood to identify heterozygotes, ptenb+/-. These were subse-
quently bred with the tumour angiogenesis line, TraNac Tg(KDR: mCherry:Fabp10-rtTA:
TRE-eGFPKRASV 12). Embryos were selected for KDR:mCherry and eGFPKRASV 12
transgenes and for ptenb+/- once they reached adulthood. The identified zebrafish
were heterozygous for all of the following genes and trangenes; transparent, nacre,
KDR:mCherry, eGFPKRASV 12 and the ptenb loss of function mutant. Therefore, these
were incrossed, and selected for fluorescence once more. When this generation reached
adulthood the zebrafish had one of four pigmentation phenotypes due to different tra and
nacre genotypes. They were either wild type, lacking melanocytes, lacking iridophores
or lacking both, the TraNac phenotype, as shown within Figures 1.4 and 1.5. To generate
a transparent line the TraNac phenotype fish with either the ptenb+/- or ptenb-/- genotype
were incrossed and the clutch of embryos screened for fluorescence again. The resulting
adult fish were transparent with a mCherry labelled vasculature, an inducible, liver spe-
cific cancer tagged with eGFP and had different ptenb genotypes. From this generation the
ptenb+/- and ptenb-/- genotyped zebrafish were incrossed and once again the embryos were
selected for fluorescence. The identified ptenb+/- zebrafish from this generation, which
were confirmed to be homozygous for KDRmCherry and eGFPKRASV 12, became the es-
tablished line TraNac:ptenb+/-Tg(KDR: mCherry:Fabp10-rtTA:TRE-eGFPKRASV 12). In-
crosses of this line provided ptenb+/+, ptenb+/- and ptenb-/- zebrafish for studies of ptenb
function within tumour progression.
6.3.1.2 Longitudinal mechanistic study of ptenb during tumorigenesis
An initial widefield fluorescence study of ptenb within tumour progression was performed
prior to CS-OPT studies using the TraNac:ptenb:Tg(KDR:mCherry:Fabp10-rtTA:TRE-
eGFPKRASV 12) zebrafish. Homozygous and heterozygous ptenb mutant zebrafish were
used alongside a ptenb wild type (ptenb+/+) control. All zebrafish used were genotyped
offspring of the aforementioned established line with the ptenb+/- genotype.
The study began using an inducer concentration of 5 mg/L. After 4 days post in-
duction (dpi) tumours were visible within the ptenb+/- and ptenb+/+ zebrafish, which
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had increased by 8 dpi, Figure 6.5. Conversely, no tumours were seen in any of the 8
ptenb-/- zebrafish, Figure 6.5. Due to this unexpected finding the inducer concentration
was raised to 7.5 mg/L for all of the groups, in an attempt to see tumour onset within the
ptenb-/- zebrafish. The ptenb+/- and ptenb+/+ tumours continued to progress and increase
in size. Not until 18 dpi were tumours observed within ptenb-/- group and this was only
in 25% of the zebrafish, Figure 6.5b. Therefore, there was a significant delay (p<0.01) in
tumour onset and progression when zebrafish had no functional copies of ptenb.
Metastasis was not observed in any of the zebrafish. However, non-functional ptenb
heterozygous expression had a contrasting effect to the homozygous loss of function
phenotype, where a trend towards greater tumour progression compared to wild type
was seen, Figure 6.5. It is important to note that the ptenb+/- zebrafish with the
largest tumour at 15 dpi, 57.03 mm2, died prior to imaging on 18 dpi. Therefore,
it is likely that the quantifications for 18 dpi are negatively skewed in comparison
to other time points, but despite this the trend was still apparent. The next largest
tumour within the ptenb+/- group died at 19 dpi, where the last recorded tumour area
at 18 dpi was 131.84 mm2. No wild type controls were this heavily tumour burdened,
the largest being 53.14 mm2, and 100% of the group survived. This again indicates
the increased tumour progression experienced within the heterozygous group. As a
result of losing the two largest samples within one group the study was terminated and
the zebrafish were sacrificed for further studies to understand the underlying phenomena.
Due to the striking ptenb-/- phenotype it was important to confirm the genotype of
these zebrafish, with respect to both ptenb and eGFPKRASV 12. Sequencing verified
all eight of the zebrafish were homozygous for the ptenb non-functional mutant and
PCR proved the eGFPKRASV 12 transgene was also present within all fish, Figure A.6.
Therefore, the genotype was verified and did not contribute to this unexpected result.
6.3.2 Creating a ptena loss of function mutant
The zebrafish ptena gene was studied to determine the gRNA target site for disrupting
gene function through CRISPR mediated gene editing. Exon 2 was chosen as it is the first
exon present within all splicing variants, excluding the polymerase binding site, and it is
upstream of the catalytic site of the phosphatase domain. This target is also in line with
the non-functional ptena mutant reported by Faucherre et al. (2008). Two gRNA’s were
designed to target this exon as shown in Table 6.1.
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(a)
(b)
Figure 6.5: Longitudinal mechanistic study of ptenb during tumorigenesis us-
ing TraNac:ptenb Tg (KDR:mCherry:Fabp10-rtTA:TRE- eGFPKRASV12) zebrafish,
where homozygous (ptenb-/-) and heterozygous (ptenb+/-) expression of the non-
functional ptenb mutant zebrafish were studied alongside a ptenb wild type control
(ptenb+/+). Zebrafish (174 dpf) were initially induced with 5 mg/L of doxycycline,
which was raised to 7.5 mg/L after imaging on day 8. a) shows widefield images for
a representative zebrafish with an eGFP labelled tumour and an mCherry labelled
vasculature from each group at selected time points, indicated in the top left of each
image. b) is the corresponding quantitative analysis of tumour area for all fish within
the study (n ≥ 7). The graph plots the mean tumour area and error bars represent
the standard error of the mean (SEM). **p<0.01 when using the Kruskal-Wallis test.
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gRNA gRNA Sequence (5′→ 3′) Strand HRMA Primers
ptena-1 AAGGCAGGCAAAGGTCG-
CAC
Coding ptena Forward 1 & Reverse 1
ptena-2 TCTGCGAGGATCTCGACCAG Coding ptena Forward 2 & Reverse 2
Table 6.1: Designed CRISPR gRNAs for zebrafish ptena exon 2. Information in-
cludes the gRNA DNA sequence, the strand of DNA being targeted and the primers
(described in Table 2.4) used for testing for CRISPR function through High Resolu-
tion Melt Analysis (HRMA).
Initially oligonucleotides were designed as described in Gagnon et al. (2014) to create the
gRNA. Therefore the forward oligonucleotide template was ATTTAGGTGACACTATA-
N20- GTTTTAGAGCTAGAAATAGCAAG, where the N20 corresponded to the gRNA
sequence shown in Table 6.1. In all cases the dsDNA was successfully created, however
subsequent transcription reactions failed to produce any RNA in contrast to successful
positive controls. Upon further research it was discovered that the T7 RNA polymerase
promoter stated and used by Gagnon et al. (2014) was 3 bases (AGG) shorter than
recommended elsewhere. The forward oligonucleotide template was modified to include
the additional 3 bases, ATTTAGGTGACACTATAAGG-N20- GTTTTAGAGCTA-
GAAATAGCAAG. This alteration rectified the encountered problem and transcriptions
yielded approximately 9 µg of each gRNA.
Unfortunately neither of the ptena exon 2 gRNAs introduced indels within the tar-
geted DNA region, as shown by the clean melting peaks within Figure A.7.
6.3.3 Creating an inducible knockout of ptena
6.3.3.1 Determining the target region of ptena
Due to possessing ptenb- zebrafish an inducible knock out of the zebrafish ptena gene
would be attempted, which could be used upon the ptenb deficient background. Once
again exon 2 was chosen for the aforementioned reasons.
It was essential to verify the DNA sequence of the intronic regions surrounding
exon 2, to ensure the gene editing tools targeted a region with no single nucleotide
polymorphisms (SNPs) that could affect the efficiency. Fin clips from 10 zebrafish were
amplified and sequenced using primers ptena-LHS and ptena-RHS from Table 2.1.
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6.3.3.2 Using TALENs to produce a ptena inducible knockout
Based upon the confirmed intronic sequence a TALEN pair was designed for each side of
ptena exon 2, termed ptenaL and ptenaR, where each TALEN arm is referred to as either
left or right. This is shown in Table 6.2, where the left and right arm binding sites, TALE
repeat sequences and corresponding HRMA primers are presented. Full DNA sequences
of each TALE subunit are available in Supplementary Table 1 of Reyon et al. (2012).
A low efficiency was observed when analysing TALEN construction through colony
PCR. Gel electrophoresis revealed DNA bands that were clearly a variation of distinct
sizes ranging from 0.5 to 2.1kb, Figure A.8. This indicated that the serial ligation
reactions involved in the FLASH high throughput assembly of the TALEN had only been
successful in a subset of reactions within each repetition. Therefore, the likelihood of
a positive colony being produced was reduced. However, two possible candidates were
identified for ptenaL-right and one for ptenaL-left, as indicated by the asterisks in Figure
A.8. Sequencing confirmed these colonies were positive, therefore establishing a TALEN
pair for ptenaL. It is important to note that for both identified TALEN arms over 100
colonies were screened for two attempts using the FLASH protocol. A positive colony
for ptenaR-left of ptenaR-right during the two FLASH attempts could not be identified.
To prevent wasting additional time and resources the construction of the designed ptenaR
TALEN was outsourced to Genetic Service, Inc (Boston, USA). Interestingly, they
encountered similar problems and were never able to create the TALEN.
The ptenaL TALEN created was verified through microinjection followed by HRMA
using the tested primers stated within Table 6.2, Figure 6.6. The uninjected controls in
Figure 6.6a show clean, single peak melt curves compared to the TALEN injections in
Figure 6.6b, which have a shifted, noisy left tail. As a result it can be concluded that the
ptenaL TALEN is functioning to elicit a DSB and indels are occurring during the DNA
repair process as desired.
To test whether the TALEN mediated knock-in strategy would work synthetic sin-
gle stranded DNA (ssDNA) containing the mLoxP site was designed and created for the
ptenaL TALEN, as shown Figure 6.7. Co-injection of the TALEN and synthetic DNA
was attempted on 3 occasions but LoxP insertion was never observed when genotyping
with deep sequencing.
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TALEN DNA Target Sequence (5’→ 3’) TALE repeats left arm TALE repeats right arm HRMA Primers
ptenaL TTTTGCTTAATGTTAACC
TGGTGTACAGTGCACA
TTAAAGAAAAAGATCATA
TAL/010/015/020/024/
027/015/020/021/
026/015/019/025/
030/011/016/022
TAL/010/011/016/021
/029/011/016/021/
026/011/019/021/
030/012/016/025
ptena-L Forward
1 & Reverse 1
ptenaR TGTTTTAATGGATTACAC
ATGTTTGAACTAGTATT
TGTCCAATACCACACAGC
TAL/009/015/020/025/
030/011/016/025/
029/014/016/025/
030/011/017/021
TAL/009/015/017/022/
026/011/020/021/
027/012/016/022/
026/012/016/024
ptena-R Forward
1 & Reverse 1
Table 6.2: Designed TALENs to target and cleave either side of ptena exon 2. The TALEN DNA target sequence is shown in the
following order; left arm, spacer region (underlined), right arm. Also presented are the TALE repeats for each arm, for DNA
sequences of TALE repeats see Supplementary Table 1 of Reyon et al. (2012), and primers (described in Table 2.4) used for testing
for TALEN function through High Resolution Melt Analysis (HRMA).
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Figure 6.6: HRMA validating the functional activity of TALEN ptenaL using
primers ptena-L Forward 1 and Reverse 1. Single cell embyros were injected with
300 ng/µl of both ptenaL-left and ptenaL-right TALEN arms. (a) shows the unin-
jected controls and (b) the TALEN injected samples.
Figure 6.7: Synthetic single stranded DNA designed and created for TALEN ptenaL
(described in Table 6.2) containing the mLoxP sequence. The synthetic DNA con-
tains 27 bases of sequence homology, blue, surrounding the mLoxP sequence, red.
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6.3.3.3 Using CRISPRs to produce a ptena inducible knockout
Initially four possible CRISPRs were designed and constructed for the right hand side
of ptena exon 2 and only two for the left, due to already possessing a functioning gene
editing tool for that side. The details of these are shown in Table 6.3. Their function
was analysed by microinjection and HRMA using the tested primers stated within Table
6.3. HRMA of each of the six CRISPRs produced clean, single peaks that mimicked
the uninjected controls and therefore they had failed to function and elicit gene editing,
Figure A.9.
Due to having no success 8 further gRNAs were designed and created, 2 of which
were for ptenaL and 6 for ptenaR, Table 6.4. Once again there was a greater effort
towards creating a functional CRISPR for the right hand side of ptena exon 2. For ptenaR
intronic regions further downstream than previous attempts were targeted incase an
unknown factor, such as secondary structure, was inhibiting CRISPR function. Synthetic
DNA fragments containing the mLoxP sequence to be inserted by HDR at each gRNA
target site were also designed, Figure 6.8. Therefore these could be co-injected with
the gRNA and Cas9, enabling both verification of CRISPR function and mLoxP site
insertion simultaneously through deep sequencing.
gRNA Sequences 5’→ 3’ Strand HRMA Primers
ptenaL-1 ACAATGCTACTGGCTAGAGC Non-coding ptena-L Forward 2 &
Reverse 2
ptenaL-2 GTGCACAGAAAGTAAGGTCC Coding ptena-L Forward 3 &
Reverse 3
ptenaR-1 TCGTCATTCTATTTTCAAAC Coding ptena-R Forward 2 &
Reverse 2
ptenaR-2 TAGTATTGTGTATCGACGAT Coding ptena-R Forward 3 &
Reverse 3
ptenaR-3 ATCGTCTTTAAAATCGTCAC Non-coding ptena-R Forward 3 &
Reverse 3
ptenaR-4 GAAAAAAAGGACTGGGTGTA Coding ptena-R Forward 4 &
Reverse 4
Table 6.3: Designed CRISPR gRNAs to target and cleave either side of zebrafish
ptena exon 2. Information includes the gRNA DNA sequence, the strand of DNA
being targeted and the primers (described in Table 2.4) used for testing for CRISPR
function through High Resolution Melt Analysis (HRMA).
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gRNA Sequences 5’→ 3’ Strand MiSeq Primers
ptenaL-3
CCCCGGTTGATTACTC Coding ptena-L MiSeq
AAATT Forward 2 & Reverse 2
ptenaL-4
CCCAAATTTGAGTAAT Non-coding ptena-L MiSeq
CAA Forward 2 & Reverse 2
ptenaR-5
ACATGACTGTTTCTAT Non-coding ptena-R MiSeq
GCGGTGG Forward 1 & Reverse 1
ptenaR-6
ACTGTTTCTATGCGGT Non-coding ptena-R MiSeq
GGCGCGG Forward 1 & Reverse 1
ptenaR-7
CTATGCGGTGGCGCGG Non-coding ptena-R MiSeq
CTTCAGG Forward 1 & Reverse 1
ptenaR-8
CGCATTAAGGTCCAAA Non-coding ptena-R MiSeq
CAGGAGG Forward 2 & Reverse 2
ptenaR-9
ATTAAGGTCCAAACA Non-coding ptena-R MiSeq
GGAGGCGG Forward 2 & Reverse 2
ptenaR-10
TCCTCCATCCGCCTCC Coding ptena-R MiSeq
TGTTTGG Forward 2 & Reverse 2
Table 6.4: Additional designed CRISPR gRNAs to target and cleave either side of
zebrafish ptena exon 2. Information includes the gRNA DNA sequence, the strand
of DNA being targeted and the primers (described in Table 2.3) used for testing for
CRISPR function through deep sequencing with MiSeq.
Figure 6.8: Synthetic single stranded DNA containing the mLoxP sequence for each
additional CRISPR described in Table 6.4. Each piece of DNA contains 25 bases
of sequence homology upstream and 20 bases downstream, blue, of the mLoxP se-
quence, red. The mLoxP sequence is designed to insert 3bp from the end of the
gRNA target site, which is underlined in each case.
143
CHAPTER 6. MECHANISTIC STUDIES OF TUMOUR PROGRESSION AND
VASCULARISATION
Deep sequencing revealed that all of the designed CRISPRs had failed to elicit a DSB and
therefore neither indels or the mLoxP site were incorporated, Figure A.10. Unfortunately
there was inadequate time to pursue this project further.
6.3.4 Creating a bcar1 loss of function mutant
6.3.4.1 Using CRISPRs for bcar1 gene editing
The zebrafish bcar1 gene was studied to determine the target site for gene disruption.
There are two splicing variants within zebrafish and exon 1, which consists of only 4
amino acids, differs. Both variants have exon 2 and so this was targeted. Two CRISPRs
were designed and created as shown in Table 6.5. The HRMA of injected samples
clearly showed bcar1-1 failed to produce indels within the target sequence due to single,
clean peaks mimicking the uninjected controls being produced, Figure 6.9. However, the
bcar1-2 melt peak has a slightly disrupted left tail where a few small double peaks were
observed, Figure 6.9c. This HRMA was promising, but not conclusive.
PCR amplification was performed on the bcar1-2 injections followed by Sanger
sequencing, using the bcar1 primers within Table 2.1, to determine whether insertions
and deletions were occurring. Sequencing was performed with the reverse primer, Table
2.1, due to having greater quality and reliability. Therefore, if indels had occurred at
the gRNA target site there would be a single clean sequence downstream of this point
and several sequences overlapping, with a shorter peak height, upstream. This was the
case, as shown in Figure A.11, where 3bp from the end of the gRNA target site there is a
change from a single sequence to multiple. Therefore bcar1-2 has successfully elicited a
DSB and subsequently indels had been incorporated through DNA repair.
gRNA gRNA Sequence (5′→ 3′) Strand HRMA Primers
bcar1-1 GCCGGCCATGCAGC-
GAACAGAGCC
Non-coding bcar1 Forward 2 & Reverse 2
bcar1-2 GTGCTGGAGCGGGA-
CACGCA
Coding bcar1 Forward 2 & Reverse 2
Table 6.5: Designed CRISPR gRNAs for zebrafish bcar1 exon 2. Information in-
cludes the gRNA DNA sequence, the strand of DNA being targeted and the primers
(described in Table 2.4) used for testing for CRISPR function through High Resolu-
tion Melt Analysis (HRMA).
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Figure 6.9: HRMA validating the functional activity of the bcar1 CRISPRs using
primers bcar1 Forward 1 and Reverse 1. Single cell embyros were injected with 70
ng/µl with 150 ng/µl of Cas9. (a) shows the uninjected controls and (b) the bcar1-1
CRISPR injected samples and (c) the bcar1-2 CRISPR injected samples. (c) indi-
cates function of bcar1-2 due to small double peaks being observed compared to the
single, clean peaks as observed in (a) and (b).
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The remaining injected embryos were raised to adulthood, where they were screened
for germline transmission through outcrossing to wild type and performing HRMA once
more. Only ten zebrafish were screened, as within these three positive fish were identified
through disrupted melt peaks, which are referred to as bcar1-2-Fish1, bcar1-2-Fish2 and
bcar1-2-Fish3, Figure 6.10. At this point deep sequencing was performed upon a clutch
of 10 embryos per outcross to determine whether any of the mutations being transmitted
were of use. This step could help to save time if the mutations present within the embryos
did not disrupt gene function, rather than determining this after waiting for the zebrafish
to develop and screening adults. Deep sequencing found that bcar1-2-Fish1 produced <
5% of reads with frame-shift mutations, Figure 6.11, where most indels created in-frame
mutations of 3bp or 9bp that did not result in a premature stop codon, Figure A.12. As a
result this fish, and its offspring, were of no use. Conversely, bcar1-2-Fish2 and bcar1-2-
Fish3 both produced frame-shift mutations at the gRNA target site, as shown in Figures
6.11 and A.12. A frame shift of either one or two bases produces a premature stop codon
within exon 2, so both of these germline transmitting zebrafish were of use. In an attempt
to save time these fish were then also outcrossed to the tumour angiogenesis zebrafish
line, TraNac Tg(KDR: mCherry:Fabp10-rtTA:TRE-eGFPKRASV 12). Therefore, identifi-
cation of founders within these offspring would reduce the number of additional crosses
to establish the line, where a non-pigmented background with homozygous expression of
both fluorescent transgenes is required.
Once the offspring from the bcar1-2-Fish2 and bcar1-2-Fish3 outcrosses reached adult-
hood genotyping was required to identify founder fish with bcar1 loss of function muta-
tions. From this the bcar1 mutant lines could be established. Initially 40 of the wild-type
background zebrafish were screened, where only two fish were found to have a frame-shift
mutation. These fish were of opposite sex and had the same mutation consisting of a 1bp
deletion and a 3bp insertion. This mutation is shown within Figure 6.12, as well as the
amino acid sequence for both wild type bcar1 and the bcar1 mutant, where the SH3 do-
main is annotated as described by the NCBI (http://www.ncbi.nlm.nih.gov) -
accession code NP_001128605.1. The indel mutation produces a different sequence from
position 38 and a premature stop codon at position 61. This disrupts the SH3 domain,
through altering conserved amino acids ( # within Figure 6.12), and truncates the protein
part way through the SH3 encoding region. Therefore, this should be a bcar1 loss of func-
tion mutation, hence forth referred to as bcar1-, as no functional domains are translated.
These two identified zebrafish create a breeding pair within a wild type background.
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Figure 6.10: HRMA identifying germline transmission of the bcar1 mutations pro-
duced by gRNA bcar1-2, using primers bcar1 Forward 1 and Reverse 1. The
HRMA melt peaks are shown for the uninjected control and identified zebrafish
with germline transmission, bcar1-2-Fish1, bcar1-2-Fish2 and bcar1-2-Fish3, as la-
belled in the top right. HRMA was performed and analysed using the Rotor-gene
6000 (Corbett Life Science).
Figure 6.11: Deep sequencing results of the three bcar1 mutant germline trans-
mitting zebrafish that were created using the gRNA bcar1-2, named bcar1-2-Fish1,
bcar1-2-Fish2 and bcar1-2-Fish3. The bar graph shows the percentage of deep se-
quencing reads that resulted in frameshift mutations for each of these fish.
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Figure 6.12: The bcar1 loss of function mutation identified from the wild type ze-
brafish cross. The DNA sequence of zebrafish bcar1 wild type (WT) and the bcar1
identified mutant are shown on top, where the gRNA target site is highlighted yellow
and the insertion and deletion resulting in a 2bp frameshift is highlighted blue. Be-
neath is the amino acid sequence of the zebrafish bcar1 WT and identified mutant.
The red text refers to the whole of exon 1 and the green text to exon 2. Bold residues
within the mutant highlight where differences in the amino acid code lie and the as-
terisk (*) indicates a stop codon. The black square bracket shows the DNA within the
WT encoding the SH3 domain, and the hash marks (#) indicate conserved residues,
as reported by the NCBI, accession code NP_001128605.1.
A breeding pair of useful bcar1 loss of function mutants were not as easily identified
within the offspring bred from the tumour angiogenesis model line. 6 different useful
frameshift mutations were identified from 144 screened zebrafish, Table 6.6, however a
male and a female with the same mutation were not identified. One zebrafish had the same
mutation as the wild type background fish described in Figure 6.12, this was Mutation 5
within Table 6.6. Therefore, breeding could be performed between these to establish the
line for mechanistic studies of bcar1 within the context of tumour progression.
6.3.4.2 Assessing the viability of bcar1-/- zebrafish
The two identified bcar1+/- zebrafish within the wild type background were bred to iden-
tify whether the bcar1-/- genotype was viable. During development no defects, delays or
lethality were observed and 84% of the offspring reached adulthood, which is the usual
survival rate of wild type fish. A subset of the zebrafish were genotyped and bcar1+/+ and
bcar1+/- were identified, along with one bcar1-/-.
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Mutation Indel Exon 2 Amino Acid Sequence
1 10bp del NVLAKALYDNVAESPDELSFRKGDIMTVLER
AWKAGGSVRCMAGKELFLATG*
2 1bp ins NVLAKALYDNVAESPDELSFRKGDIMTVLER
DTPGLGRLVALFAAWPARNCSWQPAEDSRWHV*
3 4bp del &
6bp ins
NVLAKALYDNVAESPDELSFRKGDIMTVLER
VISRAWKAGGSVRCMAGKELFLATG*
4 2bp ins NVLAKALYDNVAESPDELSFRKGDIMTVLER
DIRRAWKAGGSVRCMAGKELFLATG*
5 1bp del &
3bp ins
NVLAKALYDNVAESPDELSFRKGDIMTVLER
DTSRAWKAGGSVRCMAGKELFLATG*
6 4bp del NVLAKALYDNVAESPDELSFRKGDIMTVLER
DRAWKAGGSVRCMAGKELFLATG*
Table 6.6: The different identified bcar1 loss of function mutations within the tu-
mour angiogenesis model offspring. The table shows the insertions (ins) and dele-
tions (dels) identified and the resulting amino acid sequence of the truncated exon
2, where the bold residues show differences in the amino acid code compared to the
wild type sequence and asterisks (*) indicates premature stop codons.
6.4 Discussion
6.4.1 Mechanistic studies of ptena and ptenb during tumour progres-
sion
Due to PTEN loss of function or deletion within human HCC increasing tumour
progression and metastatic potential mechanistic studies of this protein are of interest.
Globally researching this protein using the CS-OPT platform within a live adult organism
would complement previous in vitro and cross-sectional studies and potentially improve
the current zebrafish model to better reflect human HCC.
The zebrafish homolog ptenb was longitudinally studied within the context of tumour
progression using the TraNac Tg(KDR: mCherry:Fabp10-rtTA:TRE-eGFPKRASV 12)
zebrafish line, which can be imaged using CS-OPT to provide accurate tumour and
vasculature quantifications, as shown in Chapter 4. It was hypothesised that a deficiency
of this homolog could increase the rate of tumour formation and drive metastasis. This
was reasoned due to the known effect of Pten loss in other model organisms and the
formation of spontaneous eye tumours within ptenb deficient zebrafish (Di Cristofano
et al., 1998; Faucherre et al., 2008; Choorapoikayil et al., 2013). Within the ptenb
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heterozygous zebrafish a trend towards greater tumour progression was apparent and
two heavily tumour burdened zebrafish died by 19 dpi. However, no metastases were
observed. This mimics the findings in the study by Nguyen et al. (2011) when the
zebrafish tumour model driven by eGFPKRASV 12 expression was studied upon a p53
absent background.
Surprisingly a contrasting effect was seen for ptenb-/- zebrafish, where there was a
significantly delayed tumour onset and 75% of the fish were unable to develop tumours
over an 18 day induction period. The ptenb and eGFPKRASV 12 genotype were confirmed
and so an unexpected, underlying factor must be producing this effect. One possible
explanation is that there could be an over compensation for complete loss of functional
ptenb through an increased ptena expression. However, it was previously shown that
ptena did not compensate within the spontaneous eye tumours developed in ptenb-/-
zebrafish (Faucherre et al., 2008). The relative expression of ptena and ptenb within
zebrafish may vary between tissues, which has yet to be determined, and so it is possible
that the liver does not mimic what was observed in the eye. Livers and DNA samples
from all of the zebrafish within the study have been preserved for further research to
determine the cause. Immunohistochemistry (IHC) could be performed to determine
relative levels of phosphoinositide 3-kinase (PI3K) downstream effectors, such as
phospho-AKT/PKB and phospho-ERK (Figure 1.3), as well as TUNEL staining to
determine levels of apoptosis within the samples. Quantification of protein expression
can be achieved through both Western Blots and quantitative polymerase chain reaction
(qPCR), the latter being required to determine distinct levels of ptena and ptenb as there
are no homolog specific antibodies.
6.4.2 Generating ptena loss of function mutants
To complement the ptenb- mutant available the development of a ptena- mutant was
attempted through CRISPR mediated genome editing. Only two ptena specific gRNAs
were trialled and both failed to function. This is not uncommon, it could be due to the
specific DNA target containing epigenetic changes for example. However, the ptena-
mutant described by Faucherre et al. (2008) is now available from ZIRC. This could
be imported and the mutant could be expressed within the tumour angiogenesis line as
achieved with the ptenb- zebrafish.
Due to complete loss of both ptena and ptenb being lethal during development an
inducible knock out could be advantageous to study its role in tumourigenesis and po-
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tentially increase the metastatic potential of the zebrafish tumour model. To complement
the ptenb- zebrafish lines exon 2 of the ptena gene was targeted for removal to create the
inducible knockout phenotype. Using TALENs for gene editing was inefficient and time
consuming. After two separate attempts, with approximately 100 colonies per TALEN
arm screened in each, one TALEN pair was identified for ptenaL. The lack of production
success is likely due to inefficient ligations during the FLASH protocol by Reyon et al.
(2012), as the colony PCR amplicons are a variety of different sizes that correspond to a
distinct number of TAL subunits. This protocol could be optimised, but it is a laborious
and time consuming method. Genetic Services Inc would not disclose the method they
use to produce TALEN arms, however they were unable to produce the designed TALEN
also. The main advantage of gene editing using TALENs over CRISPRs was the reduced
likelihood of off target effects. This is due to their functioning being dependent on the
orientation and sequence of two 20 nucleotide specific DNA sequences. However, online
design tools for gRNAs consider the likelihood off target effects and score each possible
gRNA in order to minimise this, such as the CRISPR Design tool developed by Hsu et al.
(2013) used within these studies. CRISPR gRNA production is very fast and simple and
they are known to elicit gene editing at a similar efficiency to TALENs (Hwang et al.,
2013). Based upon these findings CRISPR mediated gene editing is preferable.
The one constructed TALEN was shown to function in vivo, but incorporation of
the mLoxP DNA sequence by HDR at this DSB was not achieved on three separate
occasions. Previously TALEN mediated insertion of the mLoxP site through HDR had a
10.3% efficiency, but this was targeted to an exon (Bedell et al., 2012). This efficiency
is low and methods are currently being developed in an attempt to improve this in both
TALEN and CRISPR mediated insertions. Research regarding different sizes of insert,
sizes of sequence homology, insertion methods and different DNA structures, such as
linear or circular donor DNA, is being performed by many groups (Bedell et al., 2012;
Irion et al., 2014; Boel et al., 2016; Hoshijima et al., 2016). There are contrasting results
and the zebrafish community has no optimal technique as of yet. However, circular donor
DNA and CRISPR injections with Cas9 protein, rather than mRNA, do currently appear
to have greater success (Genome Editing Session Workshop- Zebrafish Platform, The
Allied Genetics Conference 2016).
Problems were also encountered when using CRISPRs to target the intronic re-
gions surrounding exon 2 of ptena. Four gRNAs were trialled for the left hand side
of the exon and ten for the right. Whilst performing analysis of the gRNAs positive
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controls were included, such as the validated bcar1 CRISPR also described within this
chapter. Therefore, the gRNA design tool, Cas9 mRNA and injection concentrations
were all proven to work as required. It is possible that targeting intronic regions of
DNA is the primary cause for the lack of both TALEN and CRISPR function. Due to a
TALEN on the left hand side of the target exon being shown to elicit DSBs a functioning
gRNA should be possible. Furthermore research since the start of this project has shown
CRISPR mediated gene editing within an intron was possible with ∼83% efficiency (Li
et al., 2015). It is feasible that the intron between exon 2 and 3 has an unknown element
preventing gRNA and Cas9 binding within these studies and subsequently inhibiting a
DSB. This could be an unknown secondary structure or epigenetic modifications, for
example. It should not be due to SNPs in the target sequence as the intronic regions were
sequenced prior to CRISPR design. However, sequencing did reveal that this intronic
region was AT rich. This has not been previously reported to implicate CRISPR binding,
but it may be involved. Therefore, if the production of an inducible knock out of ptena
were to be pursued an intronic region further downstream could be targeted, such as the
intron after exon 3. Incorporating a mLoxP site here would still enable an inducible
knock out to be formed, where two exons are removed rather that just one.
6.4.3 Generating a bcar1 loss of function zebrafish line
There is a known correlation between p130Cas over expression and advancement of
cancer progression within humans and its function is known to be triggered through the
pro angiogenic factor VEGF (Guo et al., 2008; Barrett et al., 2013). Therapeutically
targeting p130Cas could also be beneficial on account of tumour growth being blocked
when it has been silenced (Cabodi et al., 2010; Nick et al., 2011). Due to this the zebrafish
homolog bcar1 was of interest. Two CRISPRs were generated to target exon 2 of the
bcar1 gene and one, bcar1-2, was proven to incorporate indels through producing a DSB.
20% of the tested bcar1-2 injected embryos were shown to transmit a high proportion of
frame-shift mutations through their germline.
Frame-shift mutations were found within both the wild type and tumour angiogen-
esis model outcrosses. By chance the first two frameshift mutations identified within
the wild type background were the same and within different sex zebrafish, therefore a
breeding pair was identified with ease. Breeding pairs were not easily identified within
the tumour angiogenesis model background. 6 different mutations were found, one of
which matching that found on the wild type background. These could be bred to establish
a line to study bcar1 function within tumour progression, where accurate quantitative
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imaging could be performed with CS-OPT.
The identified mutation results in a 2bp frameshift that produces a disrupted amino
acid sequence from position 38 until a premature stop codon is encountered at position
61. Consequently this will produce a truncated form of the protein, which is usually 919
amino acids in length. This truncation prevents the translation of the entire proline-rich
linker, substrate domain, serine-rich linker and the C-terminal domain. The SH3 domain
is also disrupted and only partially translated. Crucially the disruption within the
identified mutant results in 4 of the 7 conserved amino acids of the SH3 domain being
altered. This is likely to affect the binding affinity to its ligands, which are known to
bind with low affinity through 3 shallow hydrophobic pockets, (Mayer, 2001). Therefore,
the 61 amino acids translated within the CRISPR generated bcar1- mutant should not
function as an adapter protein. Importantly, the previously reported knock out within
mice by Honda et al. (1998) also disrupted and truncated p130Cas within the SH3
domain.
The breeding pair identified within the wild type background were incrossed. No
defects were observed during development and there was a normal survival rate to
adulthood. Genotyping identified a bcar1- zebrafish and so it appears that homozygous
expression of the bcar1- mutant is not lethal. Only a small subset of the fish were
genotyped, due to encountering issues with the Sanger sequencing reactions. Once
these problems have been rectified it is important that further fish are screened, to find
additional bcar1- zebrafish and elucidate whether there is a mendelian ratio within the
offspring. If this is the case it indicates that zebrafish development is not affected by
homozygous expression of the bcar1- mutant.
Further studies are required upon this bcar1- mutant line. Firstly, it is important to
determine whether the mutation has resulted in a loss of function and no wild type
bcar1 is present within the zebrafish. This can be performed through assays such as
Western blot, where antibodies specific for bcar1 and its downstream effectors can be
used alongside wild type controls in both unstimulated and stimulated contexts. Also,
qPCR can be used to confirm that both alleles produce the predicted truncated mRNA
sequence. If the mutation is proven to result in a loss of function then mechanistic studies
of both the bcar1-/- and bcar1+/- genotypes within tumourigenesis would be of interest.
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7.1 Discussion
Angiogenesis is a crucial biological process throughout development and in select adult
mechanisms, such as wound healing (Risau and Flamme, 1995). It acts to provide
oxygen and metabolites to all cells, whilst removing any waste products. Strict control
and coordination is provided through the expression of pro and anti angiogenic factors,
however when these are deregulated pathologies arise due to either unrequired or
inadequate vascularisation (Papetti and Herman, 2002; Carmeliet, 2003, 2005). A
key example of when this occurs is within the context of cancer. Angiogenesis is a
fundamental requirement for tumour progression (Gimbrone et al., 1972; Hanahan and
Weinberg, 2011). As tumours begin to increase in size the distance between the cancer
cells and the established vasculature exceeds the maximum oxygen diffusion distance
and regions become hypoxic (Thomlinson and Gray, 1955; Semenza, 2000). As a result
angiogenesis is stimulated through tumours expressing pro angiogenic factors (Semenza,
2002; Pugh and Ratcliffe, 2003). The resulting neovascularisation enables the tumours
to survive and grow and also provides a possible route for metastasis. Metastasis is the
primary cause for cancer death as a result of malignancy, therefore therapeutically pre-
venting angiogenesis is a key target (Ferrara and Kerbel, 2005; Carmeliet and Jain, 2011).
It is becoming increasingly accepted that in vitro studies of biological processes
may significantly differ from what occurs in vivo. This is due to the absence of global
systems and true cellular environments. Zebrafish have become a popular model organ-
ism for studies due to their numerous beneficial features (Serbedzija et al., 1999; Stoletov
and Klemke, 2008). One such benefit is the optical transparency of non-pigmented
mutant lines such as TraNac, which enables the use of non-invasive imaging techniques
including optical projection tomography (OPT). Therefore, adult organisms can be stud-
ied to accurately represent pathologies such as cancer, where a fully formed vasculature
and mature immune system are crucial limitations in embryonic studies (Hanahan and
Weinberg, 2011).
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The research aim was to develop a 3-D imaging modality that was capable of
quantifying tumour progression and vascularisation within live adult zebrafish. Conse-
quently this platform could be used to provide novel insights into tumorigenesis and the
accompanying angiogenesis through subsequent mechanistic studies. Furthermore, it
could be used as a platform for drug development. Within this thesis the compressive
sensing optical projection tomography (CS-OPT) platform was developed and validated,
the accompanying protocols were optimised and novel zebrafish models were developed
to address this.
7.1.1 Experimental Findings
7.1.1.1 Using CS-OPT to reduce the acquisition time when imaging adult zebrafish
When performing live, in vivo imaging acquisition time is important, whereby prolonged
periods can result in detrimental effects being experienced by the zebrafish. This is par-
ticularly true when using OPT as the organisms require deep anaesthesia (Table 1.1) to
enable motionless imaging and extended durations reduce zebrafish viability. Using con-
ventional reconstruction methods, such as filtered back projection (FBP), a minimum of
360 projections are usually required (McGinty et al., 2008, 2011). Compressive sens-
ing (CS) algorithms were applied to adult imaging due to their previous success in OPT
reconstruction of zebrafish embryos (Correia et al., 2015). Parameters within the CS al-
gorithm were optimised and the number of projections required to maintain image quality
were reduced more than 5-fold, to just 64. As a result the OPT acquisition time was
less than 3.5 minutes when imaging an eGFP-tagged liver tumour and a mCherry labelled
vasculature within an adult zebrafish. This significant reduction resolves the anaesthesia
viability issue and also provides further imaging time if required. For example, it may be
beneficial to incorporate additional fluorescent markers or utilise Förster Resonance En-
ergy Transfer (FRET) based biosensors to provide readouts of physiological interactions
through Fluorescence Lifetime Imaging Microscopy (FLIM) OPT (McGinty et al., 2011;
Andrews et al., 2016).
7.1.1.2 Accurate 3-D quantifications of tumour volume and vascularisation using
CS-OPT
Quantifications are of importance to confidently determine the relationships within
biological processes, enabling accurate conclusions. CS-OPT provides 3-D qualitative
images from which quantifications could be drawn. In order to establish these quantifi-
cations I firstly determined the performance of the system with the tumour angiogenesis
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zebrafish model, TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12). I
concluded that starved, male zebrafish with homozygous expression of mCherry within
the zebrafish vasculature would be optimal for imaging. Through performing an in
vivo cross-sectional study quantifications of tumour volume and vascularisation were
extracted. These revealed statistically significant differences throughout the course of the
study, where inducer presence caused tumour progression with increased vascularisation
and upon inducer removal tumours regressed with reduced vascularisation. Hematoxylin
and Eosin (H&E) staining confirmed what had previously been shown by Nguyen et al.
(2012) with regards to tumour growth and vascular quantifications were validated with
the well established technique of immunohistochemistry (IHC).
The CS-OPT images reconstructed from this study demonstrated the mesoscopic
imaging capability of the platform. The entire tumour was captured within the 1 cm wide
zebrafish and its corresponding vasculature was reconstructed up to 1.7 mm in depth,
which accounts for approximately a third of the tumour vasculature. The limited depth of
penetration achievable for the vasculature using CS-OPT is a result of scattering, as the
zebrafish liver tumours do not have a homogenous refractive index with regards to the rest
of the fish. This is an area that could be improved. Despite this, CS-OPT is favourable
to other mesoscopic imaging techniques. Greater penetration depths are achieved than
with intravital imaging and no invasive procedures are required that could limit studies
or affect results (Conway et al., 2014). Furthermore, live fluorescence and brightfield
imaging are possible, the system is simple and the cost of implementation is comparable
to a widefield microscope. These are all benefits over microMRI, microCT and light
sheet microscopy (Sharpe, 2003; Cheng et al., 2011; Mayer et al., 2014). Therefore,
CS-OPT is an advantageous imaging platform that enables accurate 3-D quantifications
of physiological processes, such as tumour progression and vascularisation, to be
acquired through non-invasive in vivo imaging of adult organisms.
7.1.1.3 Performing and optimising longitudinal imaging with CS-OPT
Longitudinal studies provide greater accuracy and additional temporal information
than achievable through cross-sectional studies. Consequently, fewer animals are also
required for research. In order to perform longitudinal studies of tumour progression and
angiogenesis with the CS-OPT platform demonstration of its minimally invasive nature
and optimisation of the accompanying protocols were required. Through repeatedly
imaging a single zebrafish from the larvae stage through to adulthood CS-OPT was
shown to have no impact upon zebrafish viability.
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Motionless organisms are vital during OPT acquisition, due to any movement causing
reconstruction artefacts that result in inaccurate images and quantifications. This can be
achieved through deeply anaesthetising model zebrafish, where they have no movement
or response to external stimuli, Table 1.1. It is known that prolonged exposure to 4.2%
(168 parts per million (ppm)) MS-222, the regime widely used within the zebrafish
community, results in respiratory and cardiac failure (Sun et al., 2009; Matthews and
Varga, 2012). Furthermore, I have reported that this is insufficient for maintaining deep
anaesthesia. Using a combined dose of 175 ppm of both MS-222 and isoflurane the
maintenance of deep anaesthesia has been improved, which was determined using an
external stimulus greater than experienced during CS-OPT imaging. Importantly this
regime was repeatable without impacting upon the viability of the fish and the time under
deep anaesthesia before loss of opercula movement was also increased. During these
studies the transparent gene was found to be involved in the response to anaesthesia.
This was evident due to non-pigmented TraNac fish, which lack functional copies of
the transparent gene, taking longer to anaesthetise. However, using the combination of
175 ppm of both MS-222 and isoflurane the time taken to reach deep anaesthesia, and
consequently the stress experienced by the fish, was reduced. Therefore, incorporating
this combined anaesthetic regime will enable longitudinal imaging of non-pigmented
adult zebrafish to be performed using CS-OPT with an improved efficiency.
For future mechanistic and drug development studies it was important to understand the
dose dependency of the TraNac Tg (KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12)
zebrafish model with respect to doxycycline concentration and tumour progression.
Therefore the inducer concentration could be chosen to achieve the desired rate of
tumour progression and the point of drug administration could be determined. Through
performing a longitudinal study to examine doxycycline concentration it was clear that
the dynamics of tumour progression were different within older and younger zebrafish.
The older zebrafish (425 dpf) had a delayed onset and also reduced growth rate compared
to the younger (150 dpf) group. Therefore, age should always be considered in future
studies with this zebrafish model. Unfortunately no conclusions were made with regards
to optimal doxycycline dose for future longitudinal studies. It was noticed that doxycy-
cline degradation was occurring in the fish facility system water being used, which was
affecting the rate of tumour progression. This was resolved through using Tropic Marin R©
water as an alternative. Consequently, this longitudinal doxycycline study would require
repeating to accurately determine the dynamics of tumour progression when doxycycline
degradation is not occurring.
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7.1.1.4 Mechanistic studies of ptena, ptenb and bcar1 within tumour progression
The CS-OPT platform can be used to provide accurate 3-D readouts regarding tumour
progression and vascularisation of longitudinal mechanistic studies. With this in mind
additional zebrafish models were applied.
The lipid phosphatase PTEN is frequently mutated and deleted within human can-
cer and its expression within hepatocellular carcinoma (HCC) has a negative correlation
with tumour progression and metastasis (Dong-Dong et al., 2003; Hu et al., 2003). Both
zebrafish homologs, ptena and ptenb, were studied. An initial longitudinal study of
ptenb function within tumour progression using the TraNac Tg (KDR:mCherry:Fabp10-
rtTA:TREeGFPKRASV12) zebrafish model revealed unexpected results. Most surprisingly
the ptenb-/- genotype resulted in a significantly delayed tumour onset. This was in contrast
to the ptenb+/- zebrafish, where a trend towards an increase in tumour progression was
seen compared to the ptenb wild type control. No metastasis was observed throughout
the study. The reasons behind the unanticipated phenomenon of the delayed tumour
onset are yet to be determined, but it is possible the other zebrafish homolog, ptena,
is involved. To further understand the function of ptena gene editing was attempted to
create a non-functional mutant. This was unsuccessful and abandoned due to a model
now being available by ZIRC.
Due to a loss of both ptena and ptenb being embryonic lethal it was believed an
inducible knock out would be required to increase the metastatic potential of the tumour
angiogenesis zebrafish model. This would better reflect the human pathology. The
intronic regions around ptena exon 2 were targeted. The designed TALEN for the left
hand side successfully produced a DSB and indels, but was not able to incorporate
donor DNA encoding a LoxP site. No TALEN or CRISPR successfully functioned when
targeting the intron between exon 2 and 3. It is possible there is an unknown factor
preventing nuclease binding and cleaving. Unfortunately, an inducible knockout of ptena
was not created and a significant amount of work is still required in order to do so.
The adapter protein p130Cas is overexpressed in many cancers and silencing its
expression has been seen to block tumour growth and progression in some contexts
(Cabodi et al., 2010; Nick et al., 2011; Barrett et al., 2013). The zebrafish homolog,
bcar1, was of interest and is currently uncharacterised. Therefore a non-functional form
of the protein was desirable to study its function within the tumour angiogenesis model
using CS-OPT. Using CRISPR mediated gene editing a frameshift mutant was seen
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that is expected to result in a non-functional protein. The mutant results in a truncation
at amino acid position 61, which is before the end of the SH3 domain. Prior to this
truncation conserved residues are also disrupted. The homozygous loss of bcar1 does not
appear to be lethal, unlike in other model organisms (Honda et al., 1998). It is critical
that the loss of function of this mutant is confirmed, prior to mechanistic studies.
7.1.2 Future Directions
7.1.2.1 Further improving reconstruction of undersampled datasets
Sparsity has been assessed within CS reconstruction through applying the fixed transform
of total variation and then minimising the gradient coefficients of the image. It has been
shown previously that a greater level of sparsity can be achieved through using adap-
tive techniques that learn a sparsifying transform, termed dictionary, from overcomplete
training datasets (Elad and Aharon, 2006; Liu et al., 2013). This method is known as dic-
tionary learning (DL) and has been applied to many applications including image denois-
ing and compressive sensing to optimise the subsequent image reconstruction (Tosic and
Frossard, 2011). It has been seen that dictionaries learnt from the gradient domain directly
give sparser representations and subsequently provide reconstructions with a greater ac-
curacy and improved convergence (Liu et al., 2013). Therefore DL could be incorporated
into CS-OPT reconstructions to enable faster acquisition and 3-D images with improved
quality, allowing biological conclusions to be obtained with a greater accuracy. However,
it is likely that reconstruction time would increase incorporating DL into Equation 1.3
and so it may only be worthwhile for particular applications.
7.1.2.2 Improving the depth of penetration
Within Chapter 4 I discussed the mesoscopic imaging capability of the CS-OPT platform.
Despite being an improvement on previous non-invasive techniques for live in vivo
organisms, vasculature imaging is limited to a penetration depth of ∼1.7 mm into the
zebrafish liver tumour. As eluded to within Section 4.4.4 this is a result of the emitted
fluorescence scattering, causing a reduced imaging performance towards the centre of
the adult zebrafish. As previously mentioned (Section 1.4.3) accurate images from
OPT are reliant upon transparent specimens with homogeneous refractive indexes. The
non-pigmented zebrafish are sufficiently transparent to allow imaging, but they only
lack melanocyte and iridophore production. Therefore, their organs and other internal
structures are still visible. It is important to note that the liver is one of the organs most
clearly observed within the non-pigmented mutants. This is seen in Figures 1.4 and 1.5,
159
CHAPTER 7. DISCUSSION
where the liver is the tan coloured organ to the lower right of the visible eggs. As the
inducible liver tumours within our chosen tumour angiogenesis model progress the livers
increase in size and the cells become more densely packed. As a result these internal
structures, organs and the tumour itself cause light scatter.
The capabilities and depth of penetration achievable when using CS-OPT to image
non-pigmented adult zebrafish could be improved. The odds of scattering occurring when
a photon is traveling through a uniform medium increase exponentially as the distance
travelled increases. Consequently, small improvements in scatter length, the distance
achievable before scatter of a photon occurs, can lead to substantial improvements in
imaging capabilities (Lecoq and Schnitzer, 2011). Figure 7.1 shows the improved scatter
length of infrared fluorescent protein (iRFP) in comparison to mCherry, which is used
within the tumour angiogenesis zebrafish model. Therefore altering the zebrafish models
to include fluorophores with greater wavelengths such as iRFP could give an improved
CS-OPT depth of penetration. As well as this additional advanced reconstruction
algorithms could be developed and incorporated that could predict the behaviour of the
scattered, non-ballistic light.
7.1.2.3 Mechanistic studies of ptena, ptenb and bcar1 using CS-OPT
One of the aims of my PhD was to perform mechanistic studies by developing novel
zebrafish models. This was partially achieved within Chapter 6, where a mechanistic
study of ptenb was performed. It is still desirable to produce the inducible knock out
of zebrafish ptena upon this background, as it could increase the metastatic potential of,
and therefore improve, the tumour angiogenesis zebrafish model. Since the start of my
PhD CRISPR technology has improved significantly and the zebrafish community are
using it increasingly. Many groups are attempting different knock-ins through CRISPR
gene editing (Bedell et al., 2012; Chang et al., 2013; Auer and Del Bene, 2014) and
discoveries to improve the success of this are rapidly occurring (Genome Editing Session
Workshop- Zebrafish Platform, The Allied Genetics Conference 2016). Therefore, with
perseverance, there is no reason why the ptena inducible knock out zebrafish should not
be possible as the technology develops. Once this has been achieved inducible knockouts
could also be applied to other proteins of interest.
The bcar1 mutant I have created requires verification of loss of function. Once
this has been performed the mutant can be expressed upon the tumour angiogenesis line
for mechanistic studies using CS-OPT.
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Figure 7.1: Scattering length of different fluorophores, where the length is longer
for infrared fluorescent protein (iRFP) compared to proteins emitting visible light,
such as mCherry. The black trace corresponds to a tissue sample of human skin as
an example. Figure adapted from Lecoq and Schnitzer (2011).
7.1.2.4 Longitudinal drug development study for tumour progression and angio-
genesis using CS-OPT
The research performed within my PhD developed the CS-OPT platform and the
accompanying zebrafish models and protocols. This was to enable a longitudinal
drug development study of tumour progression and angiogenesis. Zebrafish have been
favourably used for small molecule drug screens as a result of their known advantages.
These include their genetic and histological similarity to humans, broad range of disease
associated phenotypes, applicability to high-throughput large scale studies and the ability
to screen a whole intact organism (Serbedzija et al., 1999; Zon and Peterson, 2005;
MacRae and Peterson, 2015). Screens have previously been performed in embryos due
to their transparency enabling functional and morphological changes to be detected
without organism sacrifice (Zon and Peterson, 2005). Therefore, the developed CS-OPT
platform will enable adult zebrafish to be studied, providing an increased accuracy due to
assessing the drug efficacy within a mature, developed organism.
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Consequently, preparations for such a study were made with the intention to perform
and complete it prior to the end of my PhD. There were two therapeutics of interest
to be trialled, these being a tumorigenic inhibitor that targets Ras, deltarasin, and an
angiogenesis inhibitor that targets VEGFRs, Vatalanib (PTK787). Ras inhibitors are of
interest due to Ras being the most commonly mutated oncogene and its activity being
increased in the majority of human cancers (Downward, 2003), however no previous
attempts have been effective enough to make it into the clinic (Baines et al., 2011). The
small molecule deltarasin is promising as it has been shown to reduce the growth rate of
tumours in vivo through KRAS delocalisation (Zimmermann et al., 2013). Oncogenic
KRAS activity is dependent upon its membrane association once it has been farnesylated,
which is regulated by a protein called PDEδ . Deltarasin successfully binds to the
farnesyl-binding pocket of PDEδ with nanomolar affinity and consequently inhibits
KRAS oncogenic activity through delocalisation (Zimmermann et al., 2013). Vatalanib
binds the protein kinase domain of the VEGFRs and inhibits autophosphorylation and
subsequent activation, where it is most potent against KDR (Wood et al., 2000). This
anti-angiogenic has been successfully used within zebrafish where angiogenesis was
inhibited during caudal fin regeneration (Bayliss et al., 2006).
The CS-OPT platform and tumour angiogenesis model zebrafish, TraNac Tg
(KDR:mCherry:Fabp10-rtTA:TREeGFPKRASV12), were to be used to study tumour
progression and angiogenesis, through quantifying tumour volume and vascularisation as
described within Chapter 4. The optimised anaesthetic regime determined within Section
5.3.2 would have also been incorporated to increase the efficiency of imaging and reduce
the stress upon the zebrafish. Based upon the results of the longitudinal doxycycline
study within Section 5.3.3 younger zebrafish (less than 6 months of age) would have been
used. Within the study a minimum of 30 zebrafish were to be induced with doxycycline
and at the point of drug administration they were to be divided into three groups, each
with ten fish. Within these groups the zebrafish would have been distributed as equally
as possible to avoid bias. In order to do this each group would have been chosen to have
a Gaussian distribution with approximately the same mean and standard deviation with
respect to tumour size. At this point all groups would have been continually treated with
the same doxycycline concentration and additionally one group would have been treated
with Vatalanib and another one with deltarasin. The doxycycline alone would act as a
control group.
Unfortunately the longitudinal study has not yet been performed. This is due to
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awaiting licensing approval from the Home Office to enable the zebrafish to be held
over weekends within CS-OPT room at Imperial College London. This is a crucial
requirement as frequently moving the fish to and from different rooms will incur stress.
In the meantime another longitudinal doxycycline study can be performed using Tropic
Marin R© water. This study would consist of tumour angiogenesis model zebrafish being
induced with different concentrations of doxycycline within Tropic Marin R© water. Each
group would consist of n ≥ 8 fish and the tumour progression would be monitored in
each group. This would allow the level of inducer treatment to be optimised and the
optimal point for drug administration within the model to be determined.
7.1.3 Conclusion
The research presented within this thesis shows the development of CS-OPT, a novel 3-D
mesoscopic imaging platform that can provide accurate quantifications of both tumour
growth and vascularisation in live adult zebrafish. Furthermore, I have demonstrated the
use of this platform to quantitatively measure vascular development in longitudinal stud-
ies. This is an advancement on currently available mesoscopic imaging techniques due to
the depth of penetration achieved, the longitudinal capability, using a mature adult organ-
ism and also providing 3-D quantifications. The anaesthetic regime has been optimised
to improve the efficiency of the CS-OPT system, through enabling prolonged periods
of maintained deep anaesthesia that could be repeatedly used without impacting upon ze-
brafish viability. Novel zebrafish models of key proteins implicated in tumour progression
and angiogenesis have been developed. These include the generation of a bcar1 loss of
function line, a ptenb loss of function tumour model line and the attempt of an inducible
knock out ptena line. As a result, CS-OPT will be of great use in future mechanistic and
drug development studies of tumour progression and angiogenesis. In addition, the plat-
form should be of interest to the wider zebrafish community for further developmental
and pathophysiological applications.
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Appendix
Video Legends
Video 1. Reconstructed OPT images of adult TraNac Tg (KDR:mCherry: Fabp10- rtTA:
TRE-eGFPKRASV12) zebrafish expressing liver specific eGFP-labelled tumour (green)
and mCherry-labelled vasculature (red). (a) and (b) show rendered 3-D FBP reconstruc-
tions computed with 512 and 64 projections, respectively. (c) shows a CS-OPT recon-
struction from 64 projections using the TwIST algorithm. (d) shows the “vesselness” of
(c) after Hessian-based analysis and (e) shows the “final” segmented CS-OPT reconstruc-
tion with segmented vasculature following skeletonisation and dilation. Scale bar 2.5 mm.
Video 2. Representative reconstructed CS-OPT videos of adult TraNac Tg (KDR:mCherry:
Fabp10- rtTA:TRE-eGFPKRASV12) zebrafish following tumour induction for (a) one week,
(b) two weeks and (c) three weeks, with (d) imaged after three weeks of induction plus a
further week after removal of inducer treatment. Scale bar 5 mm. Each group (n=8).
Video 3. Representative reconstructed CS-OPT videos of cropped tumour regions from
adult TraNac Tg (KDR:mCherry: Fabp10- rtTA:TRE-eGFPKRASV12) zebrafish follow-
ing tumour induction for (a) one, (b) two and (c) three weeks with (d) imaged after three
weeks of induction plus a further week after removal of inducer treatment. Scale bar 2
mm. Each group (n=8).
Video 4. Fly-through videos for the reconstructed CS-OPT cropped tumour regions from
representative adult TraNac Tg (KDR:mCherry: Fabp10- rtTA:TRE-eGFPKRASV12) ze-
brafish following tumour induction for (a) one, (b) two and (c) three weeks with (d) im-
aged after three weeks of induction plus a further week after removal of inducer treatment.
Red indicates vasculature ‘outside’ the tumour, orange indicates vascular ‘inside’ the tu-
mour and green is the tumour. Scale bar 2 mm. Each group (n=8).
Video 5. Representative reconstructed CS-OPT movies corresponding to Figure 5.1
showing reconstructed images from the CS-OPT data of TraNac Tg (KDR:mCherry) ze-
brafish imaged in longitudinal study over 26 weeks showing images acquired at (a) 4, (b)
8, (c) 12 and (d) 26 weeks post fertilisation (wpf). Scale bar 2 mm.
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Figures
Figure A.1: Schematic of OPT data acquisition, registration, storage and reconstruc-
tion workflow.
(a)
(b)
Figure A.2: Confirmation that the TwIST algorithm has converged during CS re-
construction when using only 10 iterations of the main algorithm (MaxiterA). The
images show the cross-sectional reconstructions when MaxiterA is set to 10 or the de-
fault 1000 (value shown in top right hand corner of images) for both the vasculature
(a) and tumour (b) channels. Scale bars 1 mm.
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(a) Skeletonised
(b) Before Iterations (c) After Iterations
Figure A.3: Skeletonisation and vascular analysis of a region of the segmented tu-
mour vasculature CS-OPT image using Matlab. (a) shows the segmented vasculature
(grey) and the skeleton produced from the modified Matlab code Skeleton3D (red).
(b) is the result from Skel2Graph3D, where connected vessels are in red, boundary
vessels in blue and the branch points are yellow. This result is inaccurate and noisy,
which is highlighted when comparing to (a) and also the iteratively cleaned skeleton
using Graph2Skel3D (c).
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(a) (b)
(c) (d)
Figure A.4: Skeletonisation of a subregion of the segmented tumour vasculature CS-
OPT image using Amira. (a) shows the segmented CS-OPT vasculature subregion
imported into Amira and (b) is the subregion after the 3-dimensional median filter
was applied to remove residual noise. (c) shows the extracted skeleton overlaid to the
filtered CS-OPT image and (d) the skeleton dilated to correspond to the diameter
value extracted from each vessel. These highlight the accuracy of the auto-skeleton
tool.
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Figure A.5: Immunohistochemsitry of endothelial cells within the zebrafish liver
using various marker antibodies to identify a specific stain with no cross- reaction.
(A) is a negative control of a healthy liver, (B) vWF staining in healthy liver, (C) eNOS
in healthy liver, (D) CD31 in liver tumour and (E) ERG in liver tumour. All tissues
were subjected to antigen retrieval by citrate buffer and antibody concentrations of
1:100.
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(a)
(b)
Figure A.6: Confirmation of the ptenb-/- zebrafish genotype. a) Shows sequenc-
ing chromatograms for the wild type control (ptenb+/+) and 3 representative se-
quences for the 8 homozygous mutants (ptenb-/-), where the red arrow indicates
the position of the C>A point mutation within the mutant. b) is a verification of
the eGFPKRASV12 transgene presence through PCR followed by gel electrophoresis
resulting in amplicons of ∼280 bp. All 8 zebrafish from the study are shown.
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Figure A.7: HRMA to determine functional activity of CRISPRs for ptena using
validated primers stated in Table 6.3. Melt peak graphs show both uninjected and
injected samples for each gRNA, ptena-1 and ptena-2, as stated in the top right cor-
ner.
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(a) ptenaL-left
(b) ptenaL-right
Figure A.8: Verification of ptenaL-left (a) and ptenaL-right (b) colony PCR tran-
scripts through 1.6% agarose gel electrophoresis, using a 1kb ladder. The 36 sam-
ples analysed show a clear variation in size, indicating a low efficiency in the FLASH
TALENs protocol. However, one likely candidate for ptenaL-left (a) and two for
ptenaL-right (b) are observed at approximately 2.1kb within these screen, labelled
with asterisks. These were subsequently sequenced and verified as positive results.
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Figure A.9: HRMA to determine functional activity of initial CRISPRs for ptenaL
and ptenaR using validated primers stated in Table 6.3. Melt peak graphs show both
uninjected and injected samples for each gRNA, as stated in the top right corner.
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Figure A.10: Deep sequencing results of the attempted LoxP knock-in insertions
using the additional CRISPRs, Table 6.4, and synthetic DNA, Figure 6.8, along with
a positive CRISPR control from the Wilson Group (UCL). Percentage of reads that
have a cut site and have a frameshift are shown, which do not include those reads
marked as primer dimers. Results show box plots, with the median and interquartile
range along with the extreme values.
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Figure A.11: Sequencing chromatogram of bcar1-2 injections to determine whether
the CRISPR has functioned to elicit a DSB and indels through DNA repair mech-
anisms. The sequencing was performed with the bcar1 Reverse primer, Table 2.1
and the gRNA target site is highlighted. The top chromatogram shows a clean single
sequence of the uninjected control sequence. The two chromatograms beneath are
injected samples, where multiple sequences are seen once sequencing proceeds past
the final 3 bases in the gRNA target site, indicating indels at this location.
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Figure A.12: Deep sequencing results of the bcar1 mutant germline transmitting
zebrafish that were created using the gRNA bcar1-2. The bcar1 wild type (WT)
sequence is shown at the top along with the gRNA bcar1-2 target sequence. Twelve
representative reads from the deep sequencing results are shown for each of the three
germline transmitting zebrafish, bcar1-2-Fish1, bcar1-2-Fish2 and bcar1-2-Fish3, as
indicated on the left hand side. Insertions (bold bases) and deletions (dashes) are
highlighted.
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